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1.1 Colorectal cancer 
Colorectal cancer includes both types of cancer that form in the tissue of the 
colon or the tissue of the rectum [National Cancer Institute 2009]. 
1.1.1 Epidemiology and causes of colorectal cancer 
Colorectal cancer is a prevalent disease in the Western World. In Europe, there 
were an estimated 412,900 cases in 2006 and approximately 207,400 deaths 
occurred, constituting 12.2% of all cancer deaths [Ferlay et al. 2007]. Similar 
frequencies of occurrence were seen in the U.S. [Jemal et al. 2006]. 
Correspondingly, colorectal cancer is routinely listed as the second most 
common cause of cancer-related death in Germany, after lung cancer [Robert 
Koch-Institut und die Gesellschaft der epidemiologischen Krebsregister in 
Deutschland e.V. 2004]. The life-time colorectal cancer risk in the U.S. is around 
five per cent [Jemal et al. 2002]. Incidence rates vary widely between different 
geographical areas, about 20-fold in the world [Pisani et al. 1999], with highest 
rates seen in the developed countries (e.g. USA, Canada, Australia, Western 
Europe) and lowest in the developing world (Figure 1). Therefore, colorectal 
cancer is commonly regarded as a Western lifestyle disease. 
 
Figure 1. Global incidences of colorectal cancer in men (the age-standardised rate (world 
standard) is calculated using the 5 age-groups 0-14,15-44,45-54,55-64,65+), drawn using 
GLOBOCAN2002 software by the International Agency for Research on Cancer where the 
definition is also taken from. 
Only a small proportion, between 5 and 10%, of colorectal cancer cases are 
attributable to familial cancer syndromes whereas the majority seems to arise 
sporadically [Kerber et al. 1998]. The two most common inherited syndromes
Incidence is the number of 
new cases arising in a given 
period in a specified population. 
It can be expressed as an 
absolute number of cases per 
year or as a rate per 100,000 
persons per year. The latter 
provides an approximation to 
the average risk of developing a 
cancer, which is particularly 
useful in making comparisons 
between populations.  
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Table 1. Hereditary colorectal cancer. The table gives a summary of the main hereditary 
colorectal cancer syndromes [Calva & Howe 2008; da Silva et al. 2009; Fearnhead et al. 2001; 
Lindor 2009; Lynch et al. 1998; Macrae et al. 2009; Sampson & Jones 2009; Sancho et al. 2004]. 





Benign neoplasms built from glandular-
type elements or adenomas, 
numerous floric colonic adenomas (100-
2500), 
aggressive (invasiveness & metastasis) 
100% CRC at 
a mean age of 
40 years, 








Mutations in 3’ and 5’ ends of the APC 
gene and alternatively spliced exon 9 
Mean age 45-
56 





Autosomal recessive, higher APC 
mutation predisposition, 
adenomatous polyposis (‘mild FAP’), 








Mutation in BER 
(MutYH), GT 
transversions: 
APC loss, k-ras 






Predisposes to multiple primary cancers 
without intestinal polyposis, 
proximal colon 
Age of onset 
40-45 years, 
5-10% of CRC 
cases 
MSI  mutations 
in MMR genes 
(MSH2, MLH1, 
MSH6, PMS1, 









Juveniles have 50-200 polyps mostly in 
the rectosigmoid region, 
Polyps (pedunculated and spherical with 
a smooth surface) contain chronic 
inflammatory infiltrate and mucous cysts 














Pigmentation (hand, lips, feet, buccal 
mucosa), 
benign gastrointestinal hamartomatous 
polyposis,  
front-like epithelium with cystic 
dilatations, hypermucinous goblet-cells, 

























type X  
FCCTX 
 









CRC colorectal cancer, CIN chromosomal instability, APC adenomatous polyposis coli, k-ras Kirsten rat 
sarcoma, p53 tumour protein 53, MutYH MutY homolog; BER base excision repair, MSI microsatellite 
instability, MMR mismatch repair, MSH2 mutS homolog 2, MLH1 MutL protein homolog 1, MSH6 mutS 
homolog 6, PMS1 postmeiotic segregation 1, PMS2 postmeiotic segregation 2, CTNNB1 catenin (cadherin-
associated protein) beta 1, TGFRB2 tumour growth factor receptor B2, Bax Bcl2-associated X protein, GIT 
gastrointestinal, Smad4 small mothers against decapentaplegic homolog 4, BMPR1A bone morphogenetic 
protein receptor type 1A, STK11 serine/threonine kinase 11, CpG  cytosine-guanine dinucleoside, B-raf v-raf 
murine sarcoma viral oncogene homolog B1 
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associated with an increased risk of colorectal cancer are Familial Adenomatous 
Polyposis (FAP) [Macrae et al. 2009] and Hereditary Non-Polyposis Colorectal 
Cancer (HNPCC), also called Lynch Syndrome [Lynch et al. 1998]. These 
syndromes follow an autosomal dominant mode of inheritance. A summary of the 
main features of these and further principal hereditary colorectal cancer 
syndromes is given in Table 1. 
The sporadic type of colorectal cancer accounts for the majority of diagnosed 
cases in people carrying no recognised genetic predisposition. This cancer type 
is common in persons older than 50 years [Neugut et al. 1993]. Sporadic 
colorectal cancer probably arises as a result of dietary and environmental factors 
as well as ageing [Colditz et al. 2006; Doll & Peto 1981; World Cancer Research 
Fund & American Institute for Cancer Research 2007].  
Studies on migrant populations have demonstrated that populations moving from 
low-risk to high-risk countries rapidly acquire an increased cancer risk, 
suggesting that local environmental exposures, rather than ethnic differences, 
influence colorectal cancer susceptibility [McMichael & Giles 1988]. 
Additionally, a Westernisation of dietary habits in countries formerly known for 
their low-risk lifestyle, e.g. Japan [Tamura et al. 1996] and China [Ji et al. 1998], 
have resulted in a rise in incidence and mortality rates [Vainio & Miller 2003]. 
1.1.2 Organisation of human colonic crypts 
This chapter aims to summarise the morphology and cellular structure of the 
human colon. The intestinal tract consists of the small intestine (duodenum, 
jejunum, ileum) and the large intestine (caecum, colon, rectum). The length of 
the human colon is in the region of 1-1.5m. The principal functions are recovery 
of water and nutrients from the faeces and propulsion of increasingly solid 
faeces before defaecation in addition to serving as a barrier against luminal 
pathogens. The colon is inhabited by a variety of commensal bacteria which 
further degrade food residues [Marchesi & Shanahan 2007]. 
The colonic mucosa is characterised by the presence of thousands of small 
invaginations of the surface epithelium, termed crypts. The crypts themselves 
are dynamic structures which are constantly self-renewing. Intestinal crypts are 
clonal populations, ultimately derived from a single cell during development, and 
they house tissue-specific stem cells in the niche at the base of the crypt (Figure 
2). In contrast to the surface enlarging structures of the small intestine, which 
are called villi, the colonic mucosa provides a flat surface epithelium [Sancho et 
al. 2004]. Stem cells at the bottom of the crypt divide about once per day and 
allow the crypt to be replaced approximately every two days [Potten 1998].  
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Stem cells were defined as relatively undifferentiated, proliferative cells that 
maintain their number, while at the same time producing a range of 
undifferentiated progeny that may continue to divide [Potten & Loeffler 1990].  
How colon cancer arises and which molecular defects play a role is the topic of 
the next chapter. 
 
Figure 2. Scheme of a healthy human colon crypt [Sancho et al. 2004; Willis et al. 2008]. The 
figure shows a profile characterising main epithelial cell types and their basic functions. On the 
right hand a short outline on colon crypts and their features is given. 
1.1.3 Molecular changes during colon carcinogenesis 
The evolution of colorectal cancer is a multistep process whereby progression 
stages range from normal epithelium to aberrant crypt foci, to the development 
of benign adenomatous polyps, and finally to invasive cancer and metastasis (see 
Figure 3). This progression is believed to occur over several decades. The 
colorectal cancer progression sequence is associated with the accumulation of a 
series of genetic alterations. These genetic alterations and epigenetic changes 
provide a growth advantage and lead to clonal expansion of altered cells.  
The original model by Fearon and Vogelstein [Fearon & Vogelstein 1990] 
described key genetic alterations. Since then, the number of acquired genetic 
mutations in colorectal cancer that have been identified has grown and new 
pathways have been elucidated (see Figure 3). The advancement of this model 
epithelium 
There are four colonic epithelial cell lineages 
into which progenitor cells mainly mature: 
mucus-secreting goblet-cells, absorptive 
enterocytes (colonocytes), enteroendocrine cells 
(peptide-hormone secreting, less abundant), and 
Paneth cells (in the ascending colon and at 
certain disease states). 
 
crypts 
The columnar epithelium’s folding of the luminar 
surface forms thousands of crypts. Crypts are 
supported by the lamina propria and the 
muscularis mucosae (smooth muscle cells). 
Underneath this, the submucosa containing 
neural plexus (Meissner’s plexus) that innervates 
the epithelium is situated. Beneath lies the 
muscularis externa that is formed by two bands 
of smooth muscles. An outer serous coat invests 




The lower cryptal region harbours the 
multipotent stem cells (3-6 per crypt). They are 
relatively undifferentiated cells, capable of 
proliferation and the self-maintained balance of 
the offspring enabling differentiation into 
various functionally competent cell types.   
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can be summarised in the features that (a) colorectal tumours occur as a result 
of the mutational activation of oncogenes coupled with the inactivation of tumour 
suppressor genes; (b) mutations in several genes are required for malignant 
tumours to develop; (c) genetic alterations occur in preferred sequences. It is 
estimated that at least four distinct genetic changes need to occur to ensure 
colorectal carcinogenesis. Three tumour suppressor genes (Adenomatous 
Polyposis Coli, APC; small mothers against decapentaplegic homolog 4, Smad4; 
and tumour protein 53, p53) and one oncogene (Kirsten Rat Sarcoma, k-ras) are 
the main targets of these sequential changes [Fodde et al. 2001].  
 
Figure 3. Adenoma-carcinoma sequence and involved genetic alterations, [Fearon & Vogelstein 
1990; Goel et al. 2007; Jass 2007]. This chart describes the devolution of normal colonic epithelium 
during carcinogenesis. The images on the left characterise stepwise morphological changes, the 
multistep genetic changes are summarised on the right. 
DCC deleted in colorectal carcinoma, CpG cytosine-guanine dinucleotide, MGMT O-6-methylguanine-DNA 
methyltransferase 
Mutations in APC are the earliest genetic alterations and seem to be a 
prerequisite for colorectal carcinogenesis. APC mutation/inactivation is found in 
80% of sporadic colorectal cancer cases [Strimpakos et al. 2009]. In the case of 
colorectal cancer, each allele of the gene is mutated, lost (“loss of 
heterocygocity”), or silenced (by hypermethylation of the gene promotor, see 
below). APC is an important molecule in the wingless-type MMTV integration site 
family (Wnt) pathway, which is the primary driving force behind proliferation of 
epithelial cells in the intestinal crypts [Reya & Clevers 2005]. The central player 
in the canonical Wnt pathway is β-catenin. In the absence of a Wnt signal, β-
catenin is targeted for proteasomal degradation through sequential 
phosphorylations occurring at its N-terminus. A degradation complex, consisting 
of the tumour suppressor protein APC, the constitutively active kinases glycogen 
synthase kinase 3β (GKS3β) and casein kinase I (CKI), regulates β-catenin 
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phosphorylation in the cell. When Wnt ligands signal through their frizzled and 
low-density lipoprotein receptor-related protein (LRP) receptors, the destruction 
complex is inactivated. APC mutations lead to a dissociation of the APC-β-catenin 
complex, thus resulting in an excess of β-catenin in the nucleus and hence 
overactive Wnt signalling triggering uncontrolled cell growth [Peifer & Polakis 
2000]. 
Mutations in the oncogene k-ras are found in 50% of sporadic tumours and act 
synergistically together with mutated APC allowing clonal tumour expansion. 
However, 50% of the tumours do not comprise mutated k-ras indicating other 
unknown oncogenes are involved. The k-ras protein is involved in the mitogen-
activated protein kinase (MAPK) cascade-signalling pathway. Oncogenic 
mutation in k-ras results in constitutive activation of the MAPK-signalling 
pathway independent from epidermal growth factor-receptor (EGFR) activation 
by binding of its ligand. The MAPK pathway is significant in growth-promoting 
signal transduction from the cell surface receptors to the nucleus. The proto-
oncogenes belong to the ras family (h-ras, k-ras, and n-ras) and are located in the 
inner plasma membrane, binding guanosine diphosphate (GDP) and guanosine 
triphosphate (GTP) and possess an intrinsic GTPase activity. The k-ras protein is 
active and transmits signals by binding to GTP and it is inactivated by GTPase 
driven conversion of GTP to GDP. Most k-ras mutations result in depressed 
GTPase activity and thus k-ras remains active and this favours cell proliferation 
and inhibits apoptosis [Ellis & Clark 2000]. Mutations of k-ras are rather a late 
event in colorectal carcinogenesis, since it is found in only 10% of early 
adenomas but in 40-50% of carcinomas [Kruzelock & Short 2007; Vogelstein et 
al. 1988].  
Loss of Smad4 function is likely to drive malignant progression [Miyaki & Kuroki 
2003], an event occurring late in colorectal carcinogenesis [Maitra et al. 2000]. 
Smad4 is also suggested to be causative for the Juvenile Polyposis Syndrome, 
where often Smad4 loss of heterocygocity accompanies Smad4 germline 
mutation. Smad4 acts as an intracellular effector of the transforming growth 
factor receptor β (TGF-β) superfamily of secreted polypeptides. TGF-β signals are 
transduced by two kinds of receptors (TGF-β receptor I and II, TGFβRI and II) 
each of them harbouring serine/threonine kinase activity. After TGF-β binding to 
TGFβRII this receptor phosphorylates TGFβRI and in turn Smads (Smad2 and 3) 
form complexes with Smad4 in the cytosol after dissociation from the receptor. 
Regulation of gene transcription by Smad complexes is transmitted by their 
translocation to the nucleus. Here, they are able to bind to ligand-responsive 
Preface 
7 
promotor sequences. TGF-β-signalling represses epithelial cell growth in normal 
cells and thus acts in a tumour suppressive manner [Pardali & Moustakas 2007].  
Two forms of genetic instability have been described in colorectal cancers which 
contribute to tumour initiation and progression: chromosomal instability and 
microsatellite instability. The latter is caused by defects in the DNA mismatch 
repair machinery resulting in a mutator phenotype at the nucleotide level and 
consequently in instability of repetitive, non-encoding sequences such as 
microsatellites. It is found in 15% of sporadic colorectal cancer cases, however, 
it is the main genetic abnormality (>95%) of HNPCC [Grady & Carethers 2008]. 
Chromosomal instability causes defects in chromosome segregation and is 
associated with gross chromosomal abnormalities, such as gene 
deletions/insertions, activation of proto-oncogenes, inactivation of tumour 
suppressor genes, as well of aneuploidy or polyploidy of chromosomes [Lengauer 
et al. 1997]. 
Methylation of cytosine is the only known physiological modification of DNA in 
normal cells and is regarded as an important mechanism of epigenetic regulation 
[Jones & Takai 2001]. Abnormal hypermethylation of DNA promotor sequences 
occurs frequently in colorectal cancer, leading to inhibition of transcription 
factor binding and hence to the silencing of tumour suppressor genes and DNA 
repair genes [Goel et al. 2007]. If gene promotor cytosine-guanine dinucleotide 
(CpG) island hypermethylation occurs this leads to the binding of methylated 
CpG binding proteins and transcription repressors such as histone deacetylases 
and hence to a block of transcription initiation [Jones & Takai 2001]. Normally, 
CpG methylation appears throughout the genome but during carcinogenesis it 
affects mainly unmethylated gene promotor CpG islands resulting in silencing of 
normally expressed genes [Rashid & Issa 2004]. 
Furthermore, a contribution to carcinogenesis and cancer cell immortality is 
associated with telomerase activity and telomere length [Saleh et al. 2008; Valls 
et al. 2009]. Telomeres are structures at the end of chromosomes of eukaryotic 
cells. They shorten progressively in somatic cells during each cell division. This 
mechanism is important for cellular ageing. Telomerase is an enzyme mainly 
found in germ cells, which ensures the further transmission of full-length 
telomeres. An increased expression of telomerase is suggested in the frame of 
the adenoma-carcinoma sequence of colorectal cancer [Valls et al. 2009].  
The progression of colorectal cancer can be understood in terms of the 
Darwinian evolution theory. Cells are thus altered to comprise a growth 
advantage compared to unaltered cells leading to their clonal expansion. 
Whereas Fearon and Vogelstein [Fearon & Vogelstein 1990] provided a linear 
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model representing the main road to colorectal cancer, now a picture emerges in 
which alternative pathways to that described above may exist though data 
suggest a rather scarce linear occurrence of mutations in the involved genes 
[Jass et al. 2002; Jass 2007; Smith et al. 2002]. 
1.2 Dietary factors modulating colorectal cancer risk 
The contribution of diet to cancer risk has been considered to be about 30% in 
the developed world, making it second to tobacco as a preventable cause for 
cancer [Key et al. 2004]. However, in the case of colorectal cancer the 
contribution may be considerably higher [Doll & Peto 1981]. 
1.2.1 General considerations and recommendations 
Western style diets are characterised by high intakes of energy, fat, meat, 
refined grains, and sugar combined with low intake of calcium, fibre, fruits, and 
vegetables. The implication of an involvement of nutrition on the development of 
colorectal cancer is not only plausible but was also recently reviewed by the 
World Cancer Research Fund/American Institute for Cancer Research 
(WCRF/AICR)-Panel resulting in the judgement that “food and nutrition have a 
highly important role in the prevention and causation of cancer of the colon and 
rectum” [World Cancer Research Fund & American Institute for Cancer 
Research 2007]. More precisely, there is convincing evidence, that physical 
activity decreases the risk for colorectal cancer and red and processed meat as 
well as body fatness/abdominal fatness and greater adult attained height 
increase the risk. Foods containing dietary fibre, garlic, milk, and calcium 
probably protect from this type of cancer. Furthermore, there is limited evidence 
favouring that non-starchy vegetables, fruits, foods containing folate, vitamin D, 
or selenium protect against colorectal cancer. Also, support that foods containing 
iron, cheese, foods containing animal fats or sugars are causes of this cancer is 
limited (for in detail review see [World Cancer Research Fund & American 
Institute for Cancer Research 2007]).  
In addition to these dietary factors which influence the colorectal cancer risk, 
lifestyle factors such as cigarette smoking and excessive alcohol consumption 
[Hermann et al. 2009; Huxley et al. 2009] or certain types of dietary mutagens 
such as aflatoxin B1, aristolochic acid and benzo(a)pyren are known to increase 
the risk for cancer [Ferguson 2009].  
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Fat, n-3 polyunsaturated fatty acids, and colorectal cancer 
The question arises as to whether a general overconsumption or a certain type of 
fat is aetiologically important for colon cancer. Fat is the most energy-dense 
constituent of the diet. In general, dietary recommendations are given for a 
reduction of fat intake from the approximately 40% of the calories typically found 
in Western countries to 30% [Food and Agriculture Organization of the United 
Nations and the World Health Organization 1997]. Based on epidemiological 
data showing a strong inverse correlation of colon cancer rates and the per 
capita consumption of animal fat and meat, the hypothesis was developed that 
dietary fat increases excretion of bile acids which can be converted to 
carcinogens or tumour promoters [Nagengast et al. 1995]. Some studies have 
shown an association between the dietary intake of fat and colorectal carcinomas 
[Kimura et al. 2007; Willett et al. 1990] but in a recent meta-analysis no 
association was found between the highest animal fat intake category and risk of 
colorectal cancer [Alexander et al. 2009]. 
However, it is still under debate whether specific type of fatty acids might even 
exert protective effects against certain diseases associated with the Western 
lifestyle. Especially monounsaturated fatty acids (MUFA), conjugated linoleic 
acids, and fish-derived n-3 fatty acids are discussed in the context of cancer 
chemoprevention. The WCRF/AICR-Panel quoted, that there is “limited evidence 
that […] eating fish protects against colorectal cancer” [World Cancer Research 
Fund & American Institute for Cancer Research 2007]. 
In a recent meta-analysis by Geelen et al. [Geelen et al. 2007] the authors found 
a borderline significant 12% lower risk in the group with the highest fish 
consumption compared to the lowest fish consumption. This effect was even 
more pronounced when the differences between the consumption categories 
were more than seven-fold. In addition to the epidemiological proof it was also 
shown that serum eicosapentaenoic acid (EPA, C20:5n-3) and docosahexaenoic 
acid (DHA, C24:6n-3) levels are inversely associated with colorectal adenoma 
risk [Pot et al. 2008]. So, of all fatty acids n-3 PUFAs seem likely to be involved in 
protection of cancer. 
1.2.1.1 Digestion and bioavailability of fat 
In the human diet, around 95% of dietary lipids are triacylglycerols, mainly 
composed of long chain fatty acids (carbon chain length >16), the remaining 
being sterols and phospholipids. For metabolic use, triacylglycerols need to be 
hydrolysed prior to uptake into the cells lining the gastrointestinal tract. Gastric 
lipase partially digests triacylglycerols to form diacylglycerols and free fatty 
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acids in the stomach followed by the action of pancreatic lipase in the small 
intestine which leads to the release of 2-monoacylglycerol and long chain fatty 
acids [Mattson & Volpenhein 1964].  
Long chain fatty acids are only poorly soluble in aqueous solutions and exhibit 
detergent properties. To overcome these limitations, long chain fatty acids are 
successively dispersed into mixed micelles within the intestinal lumen, bound to 
soluble lipid binding proteins in intestinal absorptive cells and, after re-
esterification, are secreted into the lymph as triacylglycerol-rich lipoproteins 
[Black 2007]. 
Long chain fatty acids are hydrophobic molecules but digestion and absorption 
must be highly efficient to ensure correct supply to the body as they are key 
sources of energy and act as substrates for a range of lipid signalling molecules 
such as steroid hormones and prostaglandins [Russo 2009]. However, the 
complex mechanisms of absorption into the body remain poorly understood. It 
was thought for a long time that uptake of long chain fatty acids into the cells 
only takes place by diffusion by reason of their physicochemical properties. The 
requirement of both a spontaneous and a facilitated transfer seems to be likely 
and so the contribution of a protein-mediated transfer was suggested during the 
last decades [Mu & Hoy 2004]. Once absorbed into the small intestinal 
enterocyte, the long chain fatty acids are reversibly bound to fatty acid-binding 
proteins (FABPs) [Chmurzynska 2006] and acyl-CoA binding proteins (ACBP) 
[Kragelund et al. 1999] facilitating their intracellular transfer [Knudsen 1990]. 
1.2.1.2 Nomenclature, and dietary sources of polyunsaturated fatty 
acids 
Fatty acids can be distinguished by their chain length and degree of 
unsaturation. The fatty acid with the shortest chain is acetate (C2:0), fatty acids 
with one double bond are called MUFA (e.g. oleic acid (C18:1n-9) from virgin 
olive oil). Fatty acids with two or more methylene-interrupted double bonds in 
their carbon chain are termed n-6 and n-3 polyunsaturated fatty acids (PUFAs) 
depending on the position of the first double bond being at the sixth or third 
carbon atom from the methyl end of the fatty acid molecule, respectively.  
Mammalian cells do not contain enzymes capable of adding double bonds 
(desaturases) after the ninth carbon atom from the carboxyl end of the molecule. 
Furthermore, fatty acids of the n-6 and n-3 families are not metabolically 
interconvertible [Arterburn et al. 2006]. As such, n-3 and n-6 fatty acids cannot 
be synthesised and must be provided in the diet. The two fatty acids linoleic acid 
(LA, C18:2n-6) and α-linolenic acid (ALA, C18:3n-3) are the major parent 
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compounds of the family of n-6 and n-3 fatty acids and hence are considered to 
be essential. The main n-6 fatty acids are LA and arachidonic acid (ARA, C20:4n-
6) with the former being a mayor fatty acid in both the Western countries and 
those parts of the developing world with substantial consumptions of seed oils. 
The intake of LA increased dramatically due to the use of soybean oil, as well as 
sunflower and safflower. In contrast, the intake of n-3 fatty acid remained 
relatively constant during the past decades, though it has risen where canola oil 
has been introduced to the diet in the last two decades [Russo 2009].  
The predominant sources of n-3 fatty acids are fish, and vegetable oils being the 
main sources of ALA. Fish is the major source of EPA and DHA [Benatti et al. 
2004]. Noteworthy, the PUFA content in fish varies e.g. by feed, season, and 
species and especially oil-rich coldwater fish are known to provide a good supply 
of EPA and DHA e.g. high contents are found in mackerel (2.5g EPA+DHA / 100g 
fish), herring (1.7g EPA +DHA / 100g fish), or salmon (1.2g EPA +DHA / 100g 
fish) whereas lean fish as cod contains as little as 0.3g EPA +DHA / 100g fish 
[Holub 2002; Schmidt et al. 2001]. 
1.2.1.3 Metabolism of polyunsaturated fatty acids 
Studies on fatty acid supplementation and conversion have led to the current 
belief, that intake of ALA is effective in increasing plasma EPA and 
docosapentaenoic acid (DPA, C22:5n-3) content but has only little effect on the 
DHA content [Brenna et al. 2009]. In other words, the extent of this conversion 
of ALA to DHA in human appears to be minimal. Utilising stable isotopes, the 
conversion of ALA to DHA in omnivores was estimated to be below one per cent. 
Similarly, when evaluating the changes in plasma phospholipids’ DHA levels 
following a supplementation of ALA, it does not increase plasma or erythrocyte 
DHA phospholipid levels [Whelan & Rust 2006].  
Humans have a functional desaturation-chain elongation pathway (Figure 4) 
predominantly in the liver but also the brain that can convert LA or ALA to the 
respective long chain PUFA [Barcelo-Coblijn & Murphy 2009]. Thus, EPA and 
DHA should strictly not be considered as essential fatty acids. The relative health 
effects of various n-3 PUFA do not suffer as a result of any lack of existence of 
desaturation-chain elongation activity but rather on its poor capacity [Brenna et 
al. 2009]. Two research approaches where used to prove the conversion of the 
C18 PUFA to their C20 and C22 products: tracer studies and dietary 
supplementation studies. It is broadly agreed that the conversion of ALA to EPA 
is low (five per cent) and to DHA even lower, not greater than ~0.5% [Arterburn 
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et al. 2006; Burdge et al. 2002; Burdge & Wootton 2002]. In fact, up to 85% of 
dietary ALA appears to be oxidised for energy [Barcelo-Coblijn & Murphy 2009].  
 
Figure 4. Conversion of long chain n-6 and n-3 PUFA to their respective very long chain products 
[Arterburn et al. 2006; Nakamura & Nara 2004].  
The action of elongase allows the insertion of 2 carbon atoms to the fatty acid backbone and 
desaturases insert double bonds to the molecule. These steps occur in the endoplasmic reticulum 
of primarily the human liver, except the last step, the peroxisomal β-oxidation. Additionally, the 
structures of the fatty acids used within this work are given.  
In addition, supplementation with EPA-ethyl esters results in an increase of both 
EPA and DPA but no changes for DHA in blood and tissues [Mehta et al. 2008]. 
Additionally, one other possible fatty acid has been considered as precursor for 
long chain n-3 fatty acids in humans, namely stearidonic acid (C18:4n-3). 
Consistent with the previous studies, supplementation resulted also in altered 
EPA and DPA but unchanged DHA levels [Harris et al. 2008; James et al. 2003]. 
To note, the body’s DHA pool is greater than that of EPA [Arterburn et al. 2006], 
therefore it seems possible that it takes longer until a small contribution of 
precursor fatty acids’ conversion to the plasma DHA pool might be detected.  
The only way to enrich tissue phospholipids with DHA is apparently to consume 
the same. It was shown, that in volunteers given DHA supplements, this fatty 
acid was rapidly incorporated into their blood stream. Plasma EPA and DHA 
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phospholipids increased in a dose-dependent, but for DHA in a saturable manner 
in response to dietary fatty acids [Arterburn et al. 2006; Vidgren et al. 1997]. 
Recently, the need to establish dietary reference intakes for individual long chain 
fatty acids was claimed [Harris et al. 2009; Kris-Etherton et al. 2009] rather than 
recommendations on the total intake of e.g. EPA+DHA available from numerous 
health authorities. A summary of a subset of recommendations for fish and 
EPA+DHA intake from health officials is given in Table 2. Some of them 
recommend foods (i.e. oil-rich fish) whereas others deal with nutrients. However, 
the resulting EPA+DHA values typically suggested are between 200 and 
600mg/d. 
Table 2. Recommendations for fish and/or EPA+DHA intakes for healthy adults from governmental 
and health organisations worldwide (modified according to [Harris et al. 2009]). 
recommendation Country organisation  year 
Fish twice/week, one serving of which 
should be oily, minimum intake 
450mg/d 








442mg/d for men, 318 mg/d for 
women 
Australia & New 
Zealand 






2 servings /week of (preferably oily) 
fish 
 




Fish twice/week, one serving of which 
should be oily to achieve DRI of 
450mg/d 









Minimum of 0.3% energy for adults 
(~667 mg/d) 






2 servings/week, both servings oily 
fish or 500mg/d 




1 [United Kingdom Scientific Advisory Committee on Nutrition (SACN) 2004], 2 [Australian Department of 
Health and Ageing 2005], 3 [Lichtenstein et al. 2006], 4 [Health Council of the Netherlands 2006], 5 [Superior 
Health Council Belgium 2004] ; 6 [Kris-Etherton et al. 2007]; DRI dietary reference intake 
1.2.1.4 Eicosanoid synthesis 
The eicosanoids are very crucial metabolites of PUFAs. The term eicosanoids, 
from Greek “eicosa” standing for “twenty”, summarises biologically active 
signalling molecules which are oxygenated derivatives from three different kinds 
of PUFAs, namely EPA, ARA and dihomo-γ-linoleic acid (DGLA, C20:3n-6), being 
all of 20 carbon atoms length. In its true sense, the term is used for leukotrienes 
and the different prostanoides (prostaglandins, prostacyclines, and 
thromboxanes) but other well known metabolites such as lipoxines, hipoxilins, 
and epoxy-derivatives are widely included [Hyde & Missailidis 2009].  
The signalling pathways of ARA are governed by three classes of enzymes, 
cyclooxygenases (COX), lipoxygenases, and cytochrome P450 (Figure 5). The 
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enzymatic products originating from different biological activities in terms of 
inserting oxygen at different positions of ARA have the advantage of exerting 
various molecular properties [Cabral 2005].  
 
 
Figure 5. Arachidonic acid metabolism, summarised from [Hyde & Missailidis 2009] with 
additional remarks [Brash 1999; Fu et al. 1988; Hiratsuka et al. 1997; Jakobsson et al. 1997; Kuhn 
& Thiele 1999; Mandal et al. 2008; Soberman & Christmas 2003].  
The first step in the cyclooxygenase metabolic pathway is oxygenation of ARA by its 
cyclooxygenase activity to form prostaglandin G2 followed by a rapid conversion due to its 
peroxidase activity to prostaglandin H2. Prostaglandin H2 itself is an unstable intermediate and 
serves as precursor for a variety of prostaglandins, prostacyclins and thromboxanes. 
Prostaglandins are exported from their cells of origin through the mediation of putative 
transporters and can exert effects in both an autocrine and paracrine fashion by signalling through 
specific G protein-coupled receptors. 
Four different types of lipoxygenases have been identified in human cells, 5-, 12-, and 15-
lipoxygenases-1 and 2. Generally, they catalyse the dioxygenation of ARA into 
hydroxyperoxyeicosatetraenoic acid finally resulting in the formation of leukotriens, lipoxines and 
hipoxilins. 
The cytochrome P450 metabolic pathway is the least well described for the ARA metabolism. 
Several isoforms catalyse the NADPH-dependent conversion of ARA which causes a rise to reactive 
oxygen species called hydroxyperoxyeicosatetraenoic acids although the epoxy- and hydroxyl- 
derivatives formed are the major products. 
HETE hydroxyeicosatetraenic acid, HpETE hydroxyperoxyeicosatetraenic acid, EET epoxyeicosatetraenic acid, 
LTB4 leukotriene B4, LTA4 leukotriene A4, mGST2 microsomal glutathione S-transferase 2, LTC4 leukotriene 
C4, LTD4 leukotriene D4, LTE4 leukotriene E4, LTF4 leukotriene F4, LXA4 lipoxin A4, HXA4 hipoxilin A4, 
HXB4 hipoxilin B4, PGG2 prostaglandin G2, PGH2 prostaglandin H2, PGD2 prostaglandin D2, PGE2 
prostaglandin E2, PGF2α prostaglandin F2α, PGI2 prostacycline, TXA2 thromboxane A2, TXA3 thromboxane 
A3, TXB3 thromboxane B3 
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Eicosanoids are involved in the modulation of intensity and duration of 
inflammatory responses, have cell- and stimulus-specific sources, and frequently 
exert opposing effects [Cabral 2005]. The key link between PUFAs and 
inflammation is that eicosanoids are generated from C20 PUFAs. The 
incorporation of EPA into human inflammatory cells occurs in a dose-response 
fashion and is partly at the expense of ARA. EPA can also act as a substrate for 
lipoxygenases and COX, resulting in a production of eicosanoids with a slightly 
different structure and functional less potency than those arising from ARA 
[Calder 2008]. Additionally, EPA was found to act as a substrate for the 
generation of alternative eicosanoids, termed resolvins. E-series resolvins formed 
by the action of COX-2 appear to exert anti-inflammatory actions [Serhan et al. 
2008]. Furthermore, DHA was also described as a substrate for COX-2 yielding in 
D-series of resolvins and docosatrienes, with apparent anti-inflammatory 
properties and cellular protective actions [Serhan 2005]. Thus, this has led to the 
idea that fish oil or fish fatty acids as EPA and DHA may act anti-inflammatory.  
1.3 Molecular mechanisms of colon cancer chemoprevention 
Reduced mortality and morbidity is associated with an early detection of invasive 
lesions and precursor adenomatous polyps in the colon. However, most 
colorectal cancers are diagnosed at an advanced stage. Therefore, a lot of 
attention has focused on screening for targets to prevent initiation and 
progression of colorectal cancer in order to reduce the number of patients. 
This kind of prevention is termed chemoprevention and is defined as the use of 
pharmacological agents (including nutrients) to impede, arrest, or reverse 
carcinogenesis. Based on this idea, the efficacy of numerous nutrients and other 
dietary factors has been tested [Knasmüller et al. 2009; Martinez et al. 2008; 
Sporn 1991]. 
In chemoprevention, three main phases are distinguished [Wattenberg 1985]. 
Primary prevention describes the inhibition of initiation, the first step of 
tumourigenesis by reduction of toxification or induction of detoxification. This 
can be accomplished by preventing the formation of the ultimate carcinogen or 
reactive oxygen species as well as by antioxidative effects and is thus called 
blocking activity [Morse & Stoner 1993]. The promotion and progression of 
initiated cells to become preneoplastic is inhibited by secondary prevention, e.g. 
by reduction of cell growth or enhancement of differentiation and apoptosis in 
initiated cells. Agents that effect secondary prevention are suppressing agents. 
Blockage of progression of carcinogenic devolution is termed tertiary 
chemoprevention and includes therapeutic approaches.  
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1.3.1 Modification of biotransformation enzymes and antioxidative 
defence  
Biotransformation is the process by which both endogenous and exogenous 
compounds are modified facilitating their excretion. Often, lipophilic compounds 
are converted into more hydrophilic ones. Hence, in the so called phase I the 
molecule is activated by adding a functional group which is then used for a 
conjugation step in the so called phase II.  
Typical phase I reactions include oxidation, reduction, and hydrolysis, those of 
phase II glucuronidation, sulfatation, and conjugation with glutathione. Typical 
enzymes of both reactions are summarised in Table 3. Reactions of phase III 
represent mechanisms which facilitate the removal of metabolites from the cells. 
This is accomplished by multidrug resistance proteins (MRP) or ATP-binding 
cassette (ABC)-transporters [Jones & George 2004]. 
Table 3. Major phase I and phase II biotransformation enzymes. 
phase I enzymes phase II enzymes 






UDP-glucoronosyl-transferases superfamily (UGT) 
Glutathione S-transferase superfamily (GST) 
Sulfotransferases (SULT) 
N-acetyl-transferases (NAT) 
1.3.1.1 Modification of glutathione S-transferase T2 expression 
A well-studied family of phase II enzymes are the glutathione S-transferases 
(GSTs, EC 2.5.1.18). GSTs catalyse the nucleophilic attack by reduced 
glutathione on non-polar compounds that contain electrophilic carbon, nitrogen, 
or sulphur atoms. The result is the formation of (usually) less-reactive, more 
hydrophilic glutathione-conjugates. Substrates include a wide variety of toxic or 
carcinogenic electrophiles which are mostly either xenobiotics or products of 
oxidative stress, e.g. benzo(a)pyren, but also endogenous molecules such as 
prostaglandins [Hayes et al. 2005]. Three major families of proteins exhibit 
glutathione transferase activity [Pool-Zobel et al. 2005]. Two of them, the 
cytosolic and mitochondrial GSTs, comprise soluble enzymes that are only 
distantly related. A third family comprises microsomal GSTs and is now referred 
to as membrane-associated proteins in eicosanoid and glutathione (MAPEG) 
metabolism [Hayes et al. 2005].  
Theta class GSTs are highly conserved and consist of two cytosolic family 
members, GSTT1 and T2 [Meyer et al. 1991]. GSTT2 expression is lower in the 
human colon compared to GSTT1 or GSTP1, i.e. the major GST of the colon 
Preface 
17 
[Ebert et al. 2003]. Notwithstanding, GSTT2 has already been shown to be 
upregulated by apple polyphenols and this may be one mechanism for colon 
cancer chemoprevention by polyphenols [Veeriah et al. 2008]. Conjugation with 
the endogenous tripeptide glutathione allows lipophilic xenobiotic substances to 
become more hydrophilic and hence easier to remove. GSTT2 shows affinity to 
organic hydroperoxides such as DNA-hydroperoxides and lipid-hydroperoxides 
[Ketterer et al. 1988; Tan & Board 1996]. Accordingly, potentially harmful 
xenobiotics are excreted from the organism. Additionally to the glutathione 
transferase activity, GSTT2 also exerts peroxidase [Hurst et al. 1998] and 
sulfatase activity [Rossjohn et al. 1998].  
1.3.1.2 Modification of superoxide dismutase 2 expression 
Oxidative stress has been defined as an imbalance between oxidants and 
antioxidants in favour of the former, resulting in an overall increase in cellular 
levels of reactive oxygen species. This might for example be one source for DNA 
damage. One of the well studied oxidative DNA adducts is 8-
hydroxydeoxyguanosine in which site-specific mutations result in GT 
transversions [Shibutani et al. 1991] that are widely found in mutated oncogenes 
and tumour suppressor genes [Hussain & Harris 1998]. Thus, oxidised DNA 
bases appear to be mutagenic and capable of inducing mutations commonly 
found in neoplasia. Hydrogen peroxide is less reactive than either the hydroxyl 
radical or superoxide anion radicals and more readily diffusible and thus more 
likely to be involved in the formation of oxidised bases [Guyton & Kensler 1993]. 
Superoxide dismutases (SODs, EC 1.15.1.1) are one of the most important 
enzymes in the antioxidant defence against reactive oxygen species, particularly 
superoxide anion radicals. They catalyse the dismutation of superoxide into 
hydrogen peroxide and oxygen. At present, three isoforms are described in 
mammals. Two of them carry copper and zinc at their catalytic centre and are 
either localised in the intracellular compartment (CuZnSOD or SOD1) or the 
extracellular space (EC-SOD or SOD3). The third isoform’s cofactor is 
manganese and is localised in the mitochondria (MnSOD or SOD2) [Zelko et al. 
2002]. Among all three isoforms SOD2 is shown to be crucial for the survival of 
aerobic organisms, e.g. the very short life-span of SOD2-/- mice. Furthermore 
SOD2+/- mice feature higher concentrations of 8-hydroxydeoxyguanosine and 
suffer higher incidences of cancer [Van et al. 2003]. 
Besides the effects on the cellular antioxidant system, SOD2 has been recently 
discussed as a new type of tumour suppressor [Oberley 2005]. An overexpression 
of SOD2 correlates with decreased cell growth [Kim et al. 2004]. Additionally, 
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SOD2 overexpression leads to an alteration of different signal transduction 
pathways in different cell types via mechanisms such as inhibition of 
transcription factor activator protein-1 (AP-1) and nuclear factor of kappa light 
polypeptide gene enhancer in B-cells (NF-κB) and hence their effects might also 
affect downstream targets [Li et al. 1998b]. 
1.3.1.3 Modification of cyclooxygenase-2 expression 
COX (EC 1.14.99.1), also referred to as prostaglandin endoperoxide synthase, 
catalyses the conversion of ARA into prostaglandins (see chapter 1.2.1.4 on page 
13). COXs are bifunctional enzymes which exist as homodimers of 70kDa 
subunits, each of which contains one molecule of Fe
3+
-protoporphyrin IX. They 
contain an epidermal growth factor binding domain, a membrane binding 
domain, and two enzymatic activities with distinct active sites. To date, two 
isoforms have been identified: COX-1 and COX-2 [Chandrasekharan et al. 2002; 
Dou et al. 2004; Smith et al. 2000]. Although they differ in their pattern of 
expression and tissue distribution in human cells, they are collectively 
responsible for the stepwise conversion of ARA to the three classes of 
prostanoids. COX-1 and COX-2 are encoded by two different genes on two 
different chromosomes. The COX-1 gene is approximately 22kb long and contains 
11 exons. Typical for developmental regulated “housekeeping” genes, the COX-1 
gene lacks a TATA box. Recently, different COX-1 splicing variants have been 
detected on mRNA and protein level. Besides the appearance of only partial 
COX-1 mRNAs (PCOX-1a and PCOX-1b), mainly one variant, COX-1b which was 
earlier also referred to as COX-3 is under debate. Its mRNA was found in canines 
to be of 2.6kb length and its prostaglandin E2 production activity is 20% 
compared to COX-1 [Chandrasekharan et al. 2002; Hersh et al. 2005]. Unlike in 
dogs [Chandrasekharan et al. 2002], the human isoform contains the 94bp intron 
1 which leads to a frame shift [Dinchuk et al. 2003] and thus to a premature 
termination of the protein [Qin et al. 2005], hence its biological significance 
remains to be revealed.  
COXs are integral membrane enzymes [Smith et al. 1996] bound to the luminal 
surface of the endoplasmic reticulum and to the outer and inner membrane of 
the nuclear envelope. 
Whilst COX-1 is ubiquitous and constitutively expressed in most mammalian cells 
to maintain the baseline level of prostaglandins, COX-2 is absent under normal 
conditions. The COX-2 gene is of 8kb length and can be modulated through 
multiple signalling pathways, by growth factors or cytokines that enhance their 
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expression or inhibitors like non-steroidal anti-inflammatory drugs (NSAIDs) 
which are already used therapeutically [Cuzick et al. 2009].  
The overexpression of COX-2 has been well documented in a variety of diseases 
such as inflammation and cancer, of e.g. the breast [Visscher et al. 2008], the 
prostate [Hussain et al. 2003], head and neck [Gallo et al. 2002] and the colon 
[Kutchera et al. 1996]. In particular increased COX-2 expression is connected 
with tumour metastasis in colon cancer, where aberrant COX-2 expression was 
shown to correlate with carcinogenesis in 80% of cancers [Eberhart et al. 1994]. 
COX-2 is upregulated in most human cancers and PGE2 is produced in large 
amounts in colorectal tumours [Hendrickse et al. 1994]. A nested case-control 
study found that long-term NSAID/COX-2 inhibitor usage was associated with a 
significantly decreased risk for developing colorectal cancer [Vinogradova et al. 
2007].  
1.3.2 Induction of apoptosis 
The term apoptosis describes the morphological process of controlled cellular 
self-destruction and was first introduced by Kerr [Kerr et al. 1972]. It is a 
physiological phenomenon, in contrast to the pathological burden summarised 
under the term necrosis. 
Apoptosis signalling is triggered by two major routes, the intrinsic and the 
extrinsic pathway [Hector & Prehn 2009a]. Caspases, a family of cystein 
proteases, are key molecules within both pathways. They are synthesised as 
inactive zymogens and after proteolytical cleavage at specific aspartic acid 
residues, they form heterotetrameric active caspases (each of two small and two 
large subunits) [Chowdhury et al. 2008]. Caspase activation is an important 
regulatory step of apoptosis signalling and can be achieved by two major 
mechanisms: 1) cleavage in trans by other caspase molecules (i.e. caspase 
cascade), and 2) by binding of adaptor molecules to the prodomain which is 
thought to facilitate intramolecular cleavage [Thress et al. 1999]. 
In the extrinsic pathway, caspase activation is a result of the activation of death 
receptors (such as TNF receptor superfamily, e.g. Fas, death receptors 4 and 5, 
DR4 and DR5) on the cell membrane by their corresponding ligands (such as 
FasL or TNF-related apoptosis inducing ligand, TRAIL, respectively). This 
binding is followed by a receptor trimerisation and the recruitment of cytosolic 
adaptor molecules and procaspase 8 forming the death-inducing signal complex 
(DISC). Subsequently, procaspase 8 is activated by cleavage and hence 
activation of downstream caspases is triggered. The intrinsic or mitochondrial 
pathway is characterised by the B-cell chronic lymphocytic leukemia/lymphoma 2 
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(Bcl-2) family of protein-driven release of cytochrome c from the mitochondria 
leading to the activation of caspases. The link between the extrinsic pathway and 
the mitochondria is given by the Bcl-2 family member BH3 interacting domain 
death agonist (Bid) [Li et al. 1998a; Luo et al. 1998]. Bid is cleaved by caspase 8 
to its truncated form (tBid) which translocates to the mitochondria acting 
together with Bcl-2-associated X protein (Bax) and Bcl-2-antagonist/killer (Bak) 
to release cytochrome c to the cytosol. Cellular stress (e.g. DNA damage, 
oxidative stress, cytokine deprivation) promotes the release of cytochrome c in a 
caspase independent manner. In response, death-promoting members of the Bcl-
2 family (e.g. Bax; Bcl-2-associated agonist of cell death, Bad; Bak; Bcl-2-
interacting killer, Bik) will translocate to the mitochondria or undergo 
transformational changes with the mitochondria membrane suggested by pore-
formation through which cytochrome c might escape [Korsmeyer et al. 2000]. 
This escape can be prevented by apoptosis-inhibitory members of the Bcl-2 
family (e.g. Bcl-2 and Bcl-xL). Binding of cytochrome c with dATP and Apaf-1 
(Apoptotic peptidase activating factor 1) causes a conformational change 
allowing Apaf-1 to complex with procaspase 9 to a structure known as 
apoptosome. This so-called “wheel of death” was revealed as a seven-fold 
symmetric molecule [Acehan et al. 2002]. Activation of the apoptosome will in 
turn autoactivate caspase 9 facilitating activation of caspase 3.  
A class of cell-death inhibitors, the inhibitor of apoptosis proteins (IAPs) could 
also regulate apoptosis downstream of the apoptosome assembly [Deveraux & 
Reed 1999]. Thus X-linked inhibitor of apoptosis protein (XIAP) may inhibit 
apoptosome activity by inhibiting caspase 9 activation and thereby restraining 
the propagation of the caspase cascade. Smac/Diablo (second mitochondria-
derived activator of caspases/direct IAP binding protein with low isoelectric 
point) was found to be a protein released from the mitochondria during apoptosis 
and appears to neutralise IAP function [Hector & Prehn 2009b].  
No matter by which signalling pathway apoptosis is induced, the activation of 
effector caspases such as caspase 3 results in execution of ATP-dependent 
processes [Slee et al. 2001] characterised by PARP (poly (ADP-ribose) 
polymerase)-cleavage, enzymatic DNA degradation to 180bp fragments, 
phosphatidylserine presentation at the outer membrane layer, cellular shrinkage 
and formation of apoptotic bodies, and finally in phagocytosis of the residual cell 




Figure 6. Summary of some major extrinsic and intrinsic apoptotic signal transduction pathways 
causing the main apoptotic features. The extrinsic apoptotic pathway is a result of receptor 
activation followed by the caspase cascade. One important step of the intrinsic pathway is the 
activation of the apoptosome. 
TNF tumour necrosis factor, FasL Fas ligand, TRAIL TNF-related apoptosis inducing ligand, TNFR1 TNF 
receptor 1, FasR Fas receptor, DR3 death receptor 3, DR4 death receptor 4, DR5 death receptor 5, FADD Fas-
associated protein with Death Domain, TRADD TNFRSF1A-associated via death domain, p53 tumour protein 53, 
bid BH3 interacting domain death agonist, tbid truncated bid, bax Bcl-2–associated X protein, bcl2, NF-κB 
nuclear factor kappa-light-chain-enhancer of activated B cells, Apaf-1 apoptotic peptidase activating factor 1, 
Smac/Diablo second mitochondria-derived activator of caspases/direct inhibitor of apoptosis protein binding 
protein with low isoelectric point, XIAP X-linked inhibitor of apoptosis protein 
1.4 Use of faecal water as biomarkers for colorectal carcinogenesis 
The term biomarker comprises characteristics that are objectively measured and 
evaluated as indicators of normal biological processes, pathogenic processes, or 
pharmacologic responses to a therapeutic intervention [Biomarkers Definitions 
Working Group 2001]. They can help to understand the relationship between diet 
and health or disease and offer a useful link between the consumption of specific 
foods and the biological outcome [Branca et al. 2001]. Biomarkers of effect 
include DNA damage in peripheral lymphocytes [Glei et al. 2005], and 
biomarkers of exposure e.g. specific metabolites (e.g. 8-hydroxydeoxyguanosine). 
An example of a susceptibility biomarker for colorectal cancer is the existence of 
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mutations in tumour suppressor genes (APC-mutation carriers are at higher risk 
[see FAP, chapter 1.1.1, Table 1 on page 2]), or polymorphisms (e.g. single 
nucleotide polymorphisms [Curtin et al. 2009]). 
In addition, for studies investigating nutritional effects on chemoprevention a 
considerable interest arose in the use of the aqueous phase of faeces as a tool to 
examine mechanisms underlying the aetiology of colorectal cancer. Faeces are a 
complex mixture and the composition reflects the diet consumed. It does not only 
contain potential carcinogenic compounds (e.g. bile acids, fecapentaens, N-
nitroso compounds, and heterocyclic amines [de Kok & van Maanen 2000]) but 
also potential anticarcinogenic substances (e.g. the short chain fatty acid 
butyrate, a gut flora fermentation product of dietary fibre [Scharlau et al. 2009]). 
Therefore, analysing faecal compounds is a promising tool to assess the exposure 
of the colonic lumen to potential risk and preventive factors. Components of the 
faecal aqueous fraction are thought to be in direct contact with colonic epithelial 
cells. Faeces can be obtained easily within human intervention studies and faecal 
water can be produced by ultracentrifugation [Klinder et al. 2007]. It is 
commonly used in vitro to monitor genotoxicity of the luminal environment using 
the Comet Assay, a technique which allows the screening of DNA-damaging 
potential of the samples on a single-cell level [Hoelzl et al. 2009]. Analysis of the 
influence of the diet on the genotoxicity of faecal water has been used in several 
studies to demonstrate that a Western Style-diet can lead to a DNA-damaging 
luminal environment which is associated with a higher risk for colorectal cancer. 
Additionally it was shown that a diet high in fat and meat and low in dietary fibre 
increased faecal water genotoxicity [Rieger et al. 1999]. Also, supposedly 
beneficial nutritional regimens, such as increased intake of high-fibre bread [Glei 
et al. 2005], pre-and probiotics [Burns & Rowland 2004], or polyphenols [Veeriah 
et al. 2008] resulted in decreased faecal water genotoxicity.  
1.5 The FISHGASTRO human intervention study 
The FISHGASTRO study is a multi-centre parallel randomised controlled 
intervention trial. The trial is part of the EU-granted project SEAFOODplus and a 
collaboration of three research centres. It was carried out at the Wageningen 
University, Wageningen, the Netherlands, and the Institute of Food Research, 
Norwich, United Kingdom; the Department of Nutritional Toxicology, Friedrich-
Schiller-University of Jena, Jena, Germany was included for sample analysis and 
in study planning. Participants were recruited from out-patient colonoscopy 
clinic lists in eight clinical centres; six situated in the Netherlands and two in the 
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Figure 7. Chart giving an overview of volunteers and main target parameters of the FISHGASTRO 
study [Pot et al. 2009]. 
UC ulcerative colitis; * main refuse was second colonoscopy/sigmoidoscopy; ** allergic to fish, 
taking fish oil supplements, increased risk of gut bleeding, pregnant or breastfeeding, organ 
transplant recipients receiving immuno-suppression therapy, type I diabetics, or at an increased 
infection risk; *** reasons: fish-related, decline sigmoidoscopy, too busy, pregnancy, UC flare up, 
health problems, prostate cancer, others. 
 
Between November 2004 and December 2007, 242 male and female volunteers 
aged 18-80 years were recruited for the study from patients visiting the hospital 
for a colonoscopy, as part of their regular medical care. They were assigned to 
three groups of subjects: (i) those with previous colorectal adenomata, (ii) those 
diagnosed with non-active ulcerative colitis, and (iii) those without any 
macroscopic signs of disease in the colon. Approximately ten per cent of the 
invited patients were willing to participate in the trial. After an initial 
colonoscopy procedure, eligible subjects were randomly allocated to one of three 
dietary intervention groups: (i) the oil-rich fish group receiving two 150g 
portions of farmed salmon per week during six months, (ii) the lean fish group 
receiving two 150g portions of Icelandic cod per week during six months, and 
(iii) the dietary advice group. The fish was provided to the participants and had 
to be consumed in addition to their regular fish consumption. All three 
intervention groups received general dietary advice to achieve a healthy diet. 
Of the 242 randomly assigned volunteers, 216 completed the study. The 
additional consumption of approximately 1.4 portions of salmon/week and 1.3 
portions of cod/week provided an additional 0.99g/d and 0.05g/d very long chain 
n-3 PUFA, respectively. The trial is registered at www.clinicaltrials.gov under 
identifier NCT00145015 and was first reported in the American Journal of 




Epidemiological studies and findings from animal work suggest the involvement 
of fish consumption in colorectal cancer chemoprevention. Fish oil is rich in the 
n-3 PUFAs EPA and DHA and it is likely that above all, these fatty acids 
contribute to the chemopreventive properties of fish. However, little is known on 
the exact molecular mechanisms by which fish or fish oil exerts these 
chemopreventive effects. Thus, the aim of this study was to elucidate the impact 
of EPA and DHA on certain targets of chemoprevention on colon cells in vitro. 
Furthermore, up to now no intervention study on fish consumption and 
impairment of colon cancer has been performed. Therefore, for the first time 
biomarkers of a study intervening with lean and oil-rich fish, the FISHGASTRO 
trial, were screened ex vivo. To address these questions the following work was 
performed: 
First, the uptake of different types of fatty acids (LA, ALA, GLA, ARA, DHA and 
EPA) into human colon cells (adenoma cell line LT97 and adenocarcinoma cell 
line HT29) in vitro was measured by gas chromatography / flame ionisation 
detector. Furthermore, their impact on cell growth (DNA staining by 4',6-
diamidino-2-phenylindole) and on metabolism (conversion of resazurin to 
resofurin) was evaluated (publication I). The involvement of EPA and DHA in 
modulation of gene expression patterns of LT97 human colon adenoma cells was 
determined in a time course (10 and 24 hours) using a cDNA microarray 
(PIQOR
TM
, Miltenyi Biotec) containing 306 genes involved in e.g. stress response, 
metabolism, and apoptosis (publication II). In addition, the modulation of the 
biotransformation enzymes SOD2, GSTT2 and COX-2 in LT97 and HT29 cells was 
determined in a time course (4, 10, 24, and 48 hours) on mRNA level (Real-Time 
RT-PCR) and protein level (Western Blot) (publication III). The induction of 
apoptosis as a further mechanism to alter cell number was subject of a further 
experimental setup. Apoptosis was measured in a time series (10, 24, 24 hours) 
using a flow cytometer (cell staining with Annexin-V-fluorescein isothiocyanate 
(FITC) and 7-actinoaminomycin), by Real-Time RT-PCR (expression of the 
antiapoptotic bcl-2), and by Western Blot (PARP cleavage, bid cleavage, pro-
caspase 3, pro-caspase 8, and pro-caspase 9) in LA-, EPA- and DHA-treated LT97 
and HT29 cells (publication IV). Finally, 89 faecal water samples of a human 
intervention study giving oil-rich and lean fish in a six-month interval were 
screened ex vivo for alteration of genotoxicity in HT29 cells (Comet Assay) and 
apoptosis in LT97 cells (flow cytometrical detection of Annexin-V-FITC and 7-
actinoaminomycin) (publication V and IV, respectively). Additionally, DNA 
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damage in colonocytes from biopsies was determined by Comet Assay 
(publication IV). The modulation of global gene expression by GeneChip
®
 
(Affymetrix) was determined using a biomarker approach after incubating LT97 
adenoma cells with faecal water from a subset of the volunteers (n=39) of the 




3.1 Publication I: N. Habermann, B. Christian, B. Luckas, B. L. Pool-Zobel, 
E. K. Lund, M. Glei: „Effects of fatty acids on metabolism and cell 
growth of human colon cell lines of different transformation 
state.” BioFactors (2009) 35:460-467. 
Epidemiological studies suggest that high fish intake is associated with a 
decreased risk of colorectal cancer which has been linked to the high content of 
the n-3 PUFAs EPA and DHA in some fish. The aim of this study was to compare 
the uptake of PUFAs (EPA, DHA as well as ALA, GLA, LA, and ARA) into human 
colon cells, and the resulting growth inhibitory and metabolic effects. 
Comparatively, these effects were assessed in adenoma and adenocarcinoma 
cells (LT97 and HT29, respectively) in vitro. 
All FAs were utilised more efficiently by the human colon adenoma cell line LT97 
than by the adenocarcinoma cell line HT29. LT97 were more susceptible than 
HT29 cells to the growth inhibitory activities of all FAs except for DHA where 
both were equally sensitive. Inhibition of survival and metabolic activity by EPA 
and DHA increased with treatment time in both cell lines, but adenoma cells 
were more susceptible than the adenocarcinoma cells.  
 
 
Own contribution to the manuscript: 
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 conduct of cell culture of HT29 and LT97 
 practical work on measurement of cell growth and influence of fatty acids 
on the cells’ metabolic activity 
 preparation of cells for fatty acid uptake-studies 
 data analysis and presentation of results 
 compilation of the manuscript 
Effects of fatty acids on metabolism
and cell growth of human colon cell
lines of different transformation state
Nina Habermann,1* Bernd Christian,2 Bernd Luckas,2 Beatrice L. Pool-Zobel,1† Elizabeth K. Lund,3 Michael Glei1
1Department for Nutritional Toxicology, Institute of Nutrition, Friedrich-Schiller-University Jena, Dornburger Straße 24,
D-07743 Jena, Germany
2Department for Food Chemistry, Institute of Nutrition, Friedrich-Schiller-University Jena, Dornburger Straße 25, D-07743
Jena, Germany
3Nutrition & Gastrointestinal Health, Institute of Food Research, Norwich Research Park, Colney, Norwich, NR4 7UA, UK
Abstract.
Epidemiological studies suggest that high fish intake is
associated with a decreased risk of colorectal cancer which
has been linked to the high content of the n  3
polyunsaturated fatty acids (PUFAs) eicosapentaenoic acid
(EPA) and docosahexaenoic acid (DHA) in some fish. In this
study, two different cell lines are compared in relation to
their response to EPA and DHA versus the plant derived
PUFAs, linoleic acid (LA), c-linolenic acid (GLA), and a-
linolenic acid (ALA) and to the ubiquitous arachidonic acid
(ARA). The uptake of 100 lM of each fatty acid (FA) was
determined using GC. The 40,6-diamidino-2-phenylindole
assay for DNA quantification and the Cell-Titer-BlueTM assay
were used to determine cell survival and metabolic activity
at 2–72 h after treatment. All FAs were utilized more
efficiently by the human colon adenoma cell line LT97 than
by the adenocarcinoma cell line HT29. LT97 were more
susceptible than HT29 cells to the growth inhibitory
activities of all FAs except for DHA where both were equally
sensitive. Inhibition of survival and metabolic activity by EPA
and DHA increased with treatment time in both cell lines.
ALA or GLA were less growth inhibitory than EPA or DHA
and ARA had intermediary activity. The data show that the
tested FAs are incorporated into colon cells. Furthermore,
adenoma cells are more susceptible than the
adenocarcinoma cells.
VC 2009 International Union of Biochemistry and Molecular Biology, Inc.
Volume 35, Number 5, September/October 2009, Pages 460–467 
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1. Introduction
Colorectal cancer is one of the most common cancers in
western countries. Epidemiological studies have led to the
current belief that a significant proportion of colorectal can-
cer cases may be explained by dietary habits [1]. However,
epidemiological studies provide controversial results as to
whether or not a diet high in fish is inversely associated
with colorectal cancer risk [2]. However, recent findings from
the EPIC study in Europe [3] as well as the report of the
Physicians Health Study in the US after 22 years of follow-
up [4] found a high fish intake to be associated with a
decreased risk for colorectal cancer, and in a current meta
analysis [5], Geelen et al. argue there is sufficient epidemio-
logical evidence to suggest fish may be protective. Beneficial
effects of fish and fish oil, such as protection against cardio-
vascular diseases [6] and cancer [2], have been attributed to
the n  3 polyunsaturated fatty acids (PUFA). These include
eicosapentaenoic acid (EPA, 20:5n  3) and docosahexae-
noic acid (DHA, 22:6n  3). The intake of n  3 PUFAs dif-
fers in the world and is in direct relation to the relative fish
consumption [7–9]. Furthermore, the incidence of colorectal
cancer in countries with high fish consumption is reported to
be lower [10], but there is relatively little information on how
fish or fish specific fatty acids (FAs) could contribute to the
process of cancer prevention.
Fish oil has been shown to inhibit chemical-induced
carcinogenesis in rats and also to induce apoptosis in the
rat colon [11]. In addition, DHA has been shown to reduce
the number of azoxymethane (AOM)-induced and 2-amino-1-
methyl-6-phenylimidazo[4,5-b]pyridine (PhIP)-induced abber-
ant crypt foci in rat colon [12,13]. In living cells, linoleic
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acid (LA, 18:2n  6) is the substrate for biosynthesis of ara-
chidonic acid (ARA, 20:4n  6). a-Linolenic acid (ALA) is a
shorter chain n  3 PUFA found in some plant oils which is
variably converted to EPA and DHA, although the conversion
rate in humans is reported to be low [14]. Thus, the conver-
sion of EPA to DHA seems to be insufficient in humans [15]
but probably occurs. The PUFA c-linolenic acid (GLA) is the
n  6 equivalent of ALA and can be found in small amounts
in plant seed oils as well as in human milk [16]. It can be
synthesized from LA. The optimal intake of FAs is considered
as the ratio of n  3/n  6 FAs which is recommended to
be 1:5–10 [17], but the ideal intake of fish or fish oil as a
supplement is still unclear. Blood level of PUFAs are often
used as biomarker in human studies. Recently, it was shown
that serum n  3 PUFA are inversely and n  6 PUFA are
positively associated with colorectal adenoma risk in humans
[18]. Similarly, levels of fish fatty acids from adipose tissue
were inversely and level of ARA and the ratio of ARA to fish
oils were both positively associated with colorectal adenoma
incidence [19]. Work on human colon biopsies or primary
cells has not been widely reported.
The first question to be answered was whether or not
cells at different stages of transformation are able to utilize
FAs differently. Thus, we examined the uptake of FAs into
the cells after PUFA exposure over time. Furthermore, the
impact of PUFAs on parameters of cell growth was assessed
(cell number and metabolic activity of remaining cells). To
relate this to secondary cancer prevention, we determined
for the first time biological effects in the preneoplastic
human colon adenoma cells LT97 and compared the effects
with parameters measured in the highly transformed colon
adenocarcinoma cell line HT29. For a comprehensive assess-
ment of the n  3 PUFAs EPA and DHA which are currently
considered to be the major bioactive compounds in fish [20],
their effects were compared with those of other PUFAs. ALA
and GLA were included in this comparison, because they
presumably would have an intermediate effect on account of
the similarities in their chemical structures. ARA was
included as its metabolites are well known bioactive com-
pounds. Finally, the plant-derived n  6 FA LA, was also
included in the comparison and used as negative control,
because LA appears to be devoid of similar beneficial activ-
ities but is found in abundance in the diet [21].
2. Methods
2.1. Cells and culture
The human colorectal adenoma cell line LT97 represents an
early stage of tumor development (kind gift from Professor
Marian, Institute for Cancer Research, University of Vienna,
Austria) [22,23]. It was established from colon microadeno-
mas of a patient with hereditary familial polyposis. LT97
cells were maintained in a culture medium (MCDB 302)
which contained 20% of L15 Leibovitz medium, 0.4 mM glu-
tamine, 2% FCS (fetal calf serum), 0.2 nM triiodo-L-thyro-
nine, 1 lg/mL hydrocortisone supplemented with 10 lg/mL
insulin, 2 lg/mL transferrin, 5 nM sodium selenite and
30 ng/mL EGF (epidermal growth factor), 50 lg/mL Gentami-
cin at 37 C in a humidified incubator (5% CO2/95% humid-
ity), as described previously [24]. The cells have a stable
karyotype [24,25] are of epithelial nature [23] and have a
doubling time of 72–96 h. The LT97 cells used for the experi-
ments presented here were from passages 26–46.
The human colon adenocarcinoma cell line HT29 was
isolated in 1964 from a moderately differentiated, grade II
adenocarcinoma of the recto-sigmoid colon of a 44-year-old
Caucasian woman, and have retained a high level of genomic
stability [26,27]. HT29 cells were obtained from the American
Tissue Culture Collection (ATCC HTB-38) and maintained as a
subconfluent monolayer culture in Dulbecco’s Modified
Eagle’s Medium (DMEM) [Invitrogen GmbH, Karlsruhe, Ger-
many] supplemented with 10% (v/v) FCS at 37 C in a
humidified incubator (5% CO2/95% humidity). Passages 25–
46 of HT29 were used for the experiments in this study.
At regular intervals, a mycoplasm test was performed,
that was based on DNA fragment amplification by PCR
(VenorGeM, Minerva Biolabs, Berlin, Germany).
2.2. Uptake of FAs by LT97 and HT29 colon cells
Cells were seeded into 25 cm2 cell culture flasks (density of
4  106 cells per flask). After 24 h preincubation, they were
treated with a subtoxic concentration (100 lM in EtOH) of
the corresponding FAs for 1, 6, 24, 48, and 72 h. FAs were
prepared by mixing the purchased stock solutions with etha-
nol to yield a final concentration of 200 mM and stored in
the dark at 20 C. Before treatment of cells, FAs were fur-
ther diluted with cell culture medium to yield the final con-
centration, all with an equal ethanol concentration (0.05%).
This ethanol concentration was chosen to be the control.
The incubation supernatant was removed and cells were har-
vested and washed with PBS. The cell number was deter-
mined with a haemocytometer using the trypan blue exclu-
sion assay.
The FA content of the incubation supernatant and the
cells was determined after extraction with a modified
method according to Bligh and Dyer [28]. A mixture of chlo-
roform/methanol (2:1, v:v, 4.5 mL) was added to 1,215 lL of
the supernatant. After shaking for 10 sec and ultrasonic
treatment (15 min), the sample was heated for 60 min at 60
C. After cooling, the separation of the phases was per-
formed by addition of 1.5 mL chloroform, shaking and a fur-
ther addition of 1.5 mL saline followed by centrifugation
(700g; 3 min) if required. Subsequently, the lower chloro-
form layer was transferred in a new vial, and additional 1.5
mL chloroform was added to the remaining upper aqueous
layer. The mixture of upper aqueous layer and chloroform
was shaken (10 sec) for blending. After separation of the
phases, the lower chloroform layer was removed, and com-
bined with the first separation and evaporated in a stream
of nitrogen at a temperature of 50 C. The residue was taken
up in 900 lL toluene and 100 lL trimethyl sulphonium hy-
droxide (TMSH) was added [29]. After 30 min of incubation
at room temperature, the samples were analyzed by gas
chromatography.
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Cell pellets were resuspended in 100 lL deionized
water. An aliquot containing 4.0  106 cells was taken and
deionized water was added to a final volume of 1,173 lL
before transfer to a 10 mL vial. Lipid extraction and methyla-
tion was then carried out as described above using 4.5 mL
chloroform/methanol (2:1, v:v). Gas chromatography was
performed on a HP 5890 Series II gas chromatograph (Hew-
lett-Packard, Waldbronn, Germany), equipped with a flame
ionization detector (FID), split/splitless injector, automatic
liquid sampler HP 7673 (Hewlett-Packard, Waldbronn, Ger-
many), capillary column SP-2380 (60 m, 0.32 mm i.d., 0.2
lm film; Supelco, Bellefonte, PA), and capillary column Sta-
bilwax (30 m, 0.32 mm i.d., 0.5 lm film; Restek, Bad Hom-
burg, Germany), respectively. Helium was used as carrier gas
at a pressure of 1.5 bar and 1.2 bar, respectively. The tem-
perature was as follows: The program started at 80 C
(1 min) to reach 180 C at a rate of 25 C/min. That tempera-
ture was held for 2 min before another raise to 230 C at
5 C/min. The final temperature was maintained for 20 min.
Temperatures of injector and detector were set to 250 and
260 C. Injection (5 lL) was performed splitless; after 1 min
split was opened and set to a ratio of 1:30. We performed
an external calibration for each fatty acid by which the area
under the curve per amount fatty acid (mol/L) was deter-
mined. The fatty acid content in media and cells where inter-
polated according to the area under the curve measured in
each sample for each fatty acid. For integration of chromato-
grams, the software package HP 3365 Series II ChemStation
version A.03.34. (Hewlett-Packard, Waldbronn, Germany)
was used.
2.3. Determination of cell survival/cell growth
using the DAPI assay
HT29 cells (8,000/well) were seeded in 96 well microtiter
plates and left 24 h before treatment either with LA, ALA,
GLA, ARA, DHA [0–1 mM], EPA [0–0.5 mM], or with a solvent
control (0.05% ethanol) as described above. The LT97 cells
were grown for 2–4 days after seeding before treatment,
depending on their confluence. After 2, 4, 6 h (HT29 cells
only) 24, 48, or 72 h of incubation, the medium was
removed and cells were fixed and lysed with methanol. The
amount of DNA per well was measured after adding 100 lL
of the DNA dye 40,6-diamidino-2-phenylindole dihydrochlor-
ide (DAPI) [20 lM] (Sigma-Aldrich Chemie GmbH, Tauf-
kirchen, Germany) for at least 30 min and the resulting fluo-
rescence intensity was measured using a microtiter plate
reader (Spectra Fluor Plus, Tecan, Austria; Software: X-Fluor)
(excitation at 360 nm/emission at 465 nm). The amount of
DNA was considered to reflect the cell number. The data
were analyzed by setting the values of the control medium
to equal 100%.
2.4. Metabolic activity using the cell titer
blue assay
Cells were seeded and incubated in 96 well microtiter
plates, as described for the DAPI Assay. CellTiterBlueTM rea-
gent (Promega GmbH, Mannheim, Germany) was added 2 h
before the end of the incubation period as described previ-
ously [30]. During this time, metabolically active cells con-
vert resarufin into resazorin. The fluorescence intensity was
measured (excitation at 520 nm/emission at 595 nm).
Results were calculated on the basis of the ethanol controls’
resazorin fluorescence which were set to equal 100% and
were further related to the number of cells measured after-
wards by DAPI staining as mentioned before to calculate the
metabolic activity of the remaining cells per well. This assay
on its own gives only information on the cell viability per
well. But by comparing this value to the final cell number, in-
formation on metabolic activity of the remaining cells can be
obtained.
2.5. Statistical analysis
Statistical evaluation was performed with the GraphPad
Prism Version 4.0 for Windows (GraphPad Software, San
Diego California, www.graphpad.com). The statistical analy-
ses used depended on the respective experimental design
and are specified in the legends of the figures and tables.
3. Results
3.1. Uptake of n 2 3 and n 2 6 PUFAs into LT97
and HT29 cells
Relative bioavailability of the tested PUFAs is shown in
Tables 1 and 2. To assess this, the presence of the FAs was
measured in the cell extracts (Table 1) and the medium (Ta-
ble 2) after 1, 6, 24, 48, and 72 h treatment. It is apparent
that all tested FAs were detectable in both cell types and
that for both cell lines the greatest increases were seen af-
ter 6 h treatment. The accumulation was dependent on time
of treatment (two-way ANOVA, P < 0.001 for HT29 and LT97
cells; Table 1). The amounts measured differed between FAs
(two-way ANOVA, P < 0.001 and P < 0.01 for HT29 and
LT97, respectively) with LT97 cells accumulating generally
lower amounts of FAs when compared with HT29 cells. In
contrast, it is apparent that there was a rapid loss of FAs
from the medium even after 6 h (Table 2), which was not
accompanied by an equal accumulation rate especially in
LT97 cells.
3.2. Effects of n 2 3 and n 2 6 PUFAs on LT97
and HT29 cell growth and metabolic activity
The influence of the tested PUFAs on metabolic activity was
analyzed in HT29 cells for a short time of exposure (2, 4,
and 6 h). All concentrations up to 200 lM were noncytotoxic
as determined by the DAPI assay. It is apparent from Fig. 1
that the metabolic activity of surviving cells increased
slightly after 4 and 6 h in concentration-dependent manner,
but there were no significant differences between the tested
FAs (two-way ANOVA).
Figure 2 compares the EC50 values obtained after treat-
ing LT97 and HT29 cells with fish n  3 PUFAs (EPA and
DHA) as well as the plant-derived PUFAs (GLA, ALA) and ARA
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for 24, 48, and 72 h. EC50 values were not reached within
6 h of treatment in HT29 cells and also not after supplemen-
tation with LA, thus, these data are not presented here. It is
apparent that the EC50 values for the fish oil compounds
decreased within time of treatment from 24 to 72 h, indicat-
ing a tendency of an increased toxicity with time of expo-
sure. The plant oil derivatives, in contrast, retained similar
EC50 values throughout the duration of the experiment.
Table 1
Uptake of FAs (nmol) into HT29 and LT97 cells (n 5 3), respectively
Cells h













HT29 0 6 (3) 2 (2) 4 (5) 1 (0) 1 (0) 5 (1)
1 11 (7) 13 (3) 16 (6) 3 (0) 14 (2) 25 (10)
6 44 (14) 74 (48)* 43 (29)* 7 (2)** 47 (12)*** 55 (23)*
24 60 (47) 25 (6) 31 (1) 8 (1)** 15 (12) 32 (21)
48 57 (63) 17 (7) 14 (1) 5 (1) 7 (2) 17 (8)
72 57 (42) 20 (7) 16 (3) 5 (2) 13 (1) 14 (3)
LT97 0 2 (1) 1 (0) 1 (0) 2 (2) 2 (2) 1 (1)
1 2 (2) 2 (1) 2 (1) 3 (1) 3 (2) 3 (1)
6 7 (3) 9 (6) 4 (1) 8 (1) 7 (2) 11 (5)
24 5 (1) 7 (3) 3 (1) 6 (3) 6 (1) 11 (6)
48 5 (3) 6 (5) 2 (0) 6 (8) 5 (1) 12 (8)
72 7 (5) 6 (6) 2 (2) 12 (2) 7 (5) 12 (10)
Data represent values per 106 cells [mean (SD)]. Asterisks indicate significant increase of the FA when compared with
the amount of FA at time 0 h, * P < 0.05, ** P < 0.01, *** P < 0.001 (one-way ANOVA, Bonferroni post test). Each
column shows data relating only to the fatty acid added to the cell culture media which is indicated at the top of the
column.
Table 2
Amounts of FAs (nmol) per mL cell culture supernatant after incubation of HT29 and LT97 cells (n 5 3), respectively,
for indicated target times
Cells h













HT29 0 348 (84) 321 (121) 331 (41) 399 (178) 298 (44) 426 (167)
1 227 (32)* 285 (44) 104 (14)*** 162 (40)* 231 (17)* 319 (101)
6 95 (6)*** 143 (23)** 23 (10)*** 59 (21)** 77 (1)*** 126 (41)*
24 37 (3)*** 28 (15)*** 25 (8)*** 26 (2)*** 14 (1)*** 34 (12)***
48 38 (9)*** 24 (14)*** 25 (12)*** 21 (2)*** 12 (1)*** 32 (12)***
72 49 (6)*** 26 (16)*** 17 (9)*** 22 (2)*** 13 (1)*** 39 (17)***
LT97 0 273 (7) 347 (30) 335 (14) 351 (0) 352 (81) 333 (34)
1 179 (13)*** 196 (10)*** 195 (26)*** 249 (19)*** 219 (25)*** 248 (55)
6 81 (16)*** 68 (17)*** 47 (35)*** 75 (7)*** 72 (32)*** 113 (77)***
24 25 (7)*** 14 (4)*** 18 (2)*** 28 (6)*** 22 (2)*** 39 (9)***
48 26 (13)*** 14 (4)*** 16 (4)*** 24 (2)*** 21 (4)*** 38 (7)***
72 29 (11)*** 18 (3)*** 16 (3)*** 25 (0)*** 22 (2)*** 42 (9)***
Data represent background (medium control) subtracted values per ml [mean (SD)]. Asterisks indicate significant
reduction of the FA when compared with the amount of FA at time 0 h, * P < 0.05, ** P < 0.01, *** P < 0.001
(one-way ANOVA, Bonferroni post test). Each column shows data relating only to the fatty acid added to the cell
culture media which is indicated at the top of the column.
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Overall, LT97 cells were significantly more susceptible to the
growth inhibitory actions of the PUFAs than HT29 cells, par-
ticularly in relation to treatment with EPA and ARA (two-way
ANOVA, P < 0.01) (Fig. 3). An exception was DHA which was
of equal potency in both cell lines.
Figure 4 compares the growth inhibitory activities, in
both cell lines, of EPA and DHA in comparison to ARA and
LA over a concentration range where only the influence of
the FAs on viable cells is considered; 50 lM for LT97 and
100 lM for HT29 cells. DHA was more effective than EPA
and LA for both parameters in HT29 cells. In LT97 cells, DHA
and EPA were markedly more effective than LA, but for EPA
the effects were more pronounced in LT97 cells than in HT29
cells. Cell growth inhibition by ARA was comparable to that
of EPA and DHA in both cell types. Treatment of both cell
types with high concentrations of all PUFAs (500 lM)
resulted in microscopically detectable cytotoxic alterations
(not shown).
4. Discussion
Dietary fat has been implicated as an important factor in the
aetiology of colorectal cancer. However, not only the amount
of fat ingested but also the pattern of alimentary lipids
seems of importance [31]. Fish oil was shown to induce apo-
ptosis in vivo in the rat colon [32] as well as in vitro in HT29
cells and in CaCo-2 cells [33] as well as in other human co-
lon carcinoma cell lines [34]. Although studies comparing
the growth modulatory effect of different n  3 and n  6
FAs in the same colon cell line are rare [21], comparing the
effects between colon cell lines reflecting different stages of
colon cancer is entirely novel. Here we used LT97 cells which
are of adenomatous origin and a model of an earlier stage
of colon carcinogenesis than the more common adenocarci-
noma cell line HT29. Thus, this work covers an important
link between in vitro work and animal in vivo studies.
Fig. 1. Metabolic activity (values normalized basing on cell number measured with DAPI) after short time incubation
(2, 4, 6 h) in HT29 cells. Dots represent mean 6 SD (n 5 3) of concentrations up to 200 lM of LA, ALA, GLA, ARA,
EPA, and DHA; et 5 ethanol control.
Fig. 2. Survival of LT97 and HT29 cells after treatment
with FAs (DAPI assay) (n 5 3–6) after 24, 48, and 72 h
of incubation. The results are presented as mean
concentrations (lM) leading to a reduction of cell
growth by 50% (EC50-values). The data were calculated
using GraphPad PRISM curve fit with sigmoidal
dose-response (variable slope).
Fig. 3. Comparison of EC50 values obtained for LT97
(gray bars) and HT29 cells (white bars) after 72 h FA
treatment. P values indicated are obtained by
two-tailed unpaired t test. Results are presented as
mean 6 SD (n 5 3–6).
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The first question we addressed was the bioavailability
of FAs over a time course of up to 72 h. Efficient absorption
of FAs, predominantly in the jejunum and ileum, allows less
than 5% of the ingested lipids to reach the colon [35]. Never-
theless, a significant increase of n  3 PUFAs in colonic mu-
cosa after alimentary supplementation can be achieved
[36,37]. Lipids probably reach the colonocytes primarily via
the blood, where concentrations may reach as high as 400
lmol/L [38] following supplementation, and, although some
might escape absorption in the small intestine this would
probably be rapidly metabolized by colonic bacteria. For this
study, relevant concentrations of nonesterified FAs dissolved
in ethanol as suitable solvent for in vitro-studies [39] were
used and it was shown, that LT97 and HT29 cells are able to
accumulate FAs, as the amount of FAs measurable within the
cells increased (Table 1). This is an important finding as the
modification of cell FA composition has been shown to affect
signaling pathways [40], lipid peroxidation and oxidative
stress [41], gene expression [42], and eicosanoid synthesis
[43]. The minor differences of measured FAs can be
explained by different utilization and metabolism of the FAs
in the cells. ARA was found only in small amounts in HT29
cells. It seems likely, that ARA is further metabolized possi-
bly by cyclooxygenase 2 (COX-2), which is over expressed in
colon cancer tissue [44] and what may result in higher
amount of prostaglandin E2 [45]. Prostaglandin E2 itself was
shown to be an important factor for cell proliferation in car-
cinoma cells [46]. In this study, the amounts of FAs within
the adenomatous LT97 cells was much lower than in the
HT29 cells even though the loss of FAs from the cell culture
supernatant was comparable. This could be observed in dif-
ferent culture conditions between both of the cell lines.
Although each cell line was grown to a consistent level of
confluence there were differences. LT97 grow as a multilayer
and thus 3–4 times more cells were present at the start of
incubation compared to the HT29 cells which grow as a
monolayer (14–18  106 vs. 4–6  106 cells per flask). Alter-
natively, it is possible that LT97 cells are able to metabolize
FAs better than HT29, a hypothesis which is supported by
the increase in metabolic activity of the cells possibly due to
FAs providing metabolic fuel especially when providing lon-
ger chain PUFAs. This effect was slightly stronger in LT97
than in HT29 cells (Fig. 4). Interestingly, LT97 medium con-
tains lower concentration of glucose compared to HT29 me-
dium (1,442 mg/L vs. 4,500 mg/L). Thus, LT97 cells might
more readily use added FAs for b-oxidation than HT29 cells.
In contrast to the n  6 PUFA LA, both fish n  3
PUFAs are potent inhibitors of colon adenocarcinoma cell
growth by affecting cell number. EC50 values for DHA treat-
ment (Fig. 2) reflect concentrations which can be found in
human plasma under physiological conditions following a
diet based on fish (168 6 8 lM) [47]. However, EPA EC50 lev-
els were higher than found physiologically (64 6 5 lM) fol-
lowing a fish-based diet [47].
The location of double bonds apparently had no impact
on growth inhibition, because different FAs (ALA, GLA) with
the same chain length (C18) and same number of double
bonds (18:3) were equally effective. It can be speculated
that the number of double bonds might be important in pre-
dicting the growth inhibitory action of different FAs in human
colon carcinoma cell lines [33]. This is in agreement with our
results, as the most unsaturated FA DHA containing six
Fig. 4. Comparison of survival curves and metabolic activities of LT97 and HT29 cells after 72 h treatment with the FAs
LA, ARA, EPA, and DHA as detected with the method of the DAPI staining and CTB, respectively. The results are
presented as background subtracted concentrations (mean, n 5 3–6).
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double bonds had the highest growth inhibitory effect, fol-
lowed by EPA (five double bonds) and ARA (four double
bonds). LA, only containing two double bonds, affected cell
growth only at concentrations >500 lM. Therefore, lipid per-
oxidation can be considered at least in part one reason for
the cytotoxic mechanism of PUFAs [48].
Dommels et al. [21] showed a dose-dependent
decrease in CaCo-2 cell proliferation by treatment with DHA
but not in HT29 cells (48 h incubation, concentration of 0–
160 lM). We also only found a significant inhibition of HT29
cell growth after 48 h for DHA at concentrations above 200
lM (Fig. 2).
Comparing a nonmalignant mouse fibroblast cell line
(NIH3T3) with its malignant human colon cancer transform-
ants (SIC), Tsai et al. [49] only found inhibition of cell prolifer-
ation, following treatment with EPA and DHA, in malignant
cells. Similarly, it has been reported that in breast cell lines
EPA and DHA selectively inhibited growth of the adenocarci-
noma cell line MCF-7 when compared with noncancerous
MCF-10A cells [50]. In our study, the growth inhibition in colon
cells of adenomatous origin was similar (DHA) or even more
pronounced (EPA) when compared with adenocarcinoma cells
after treatment with FAs supporting the hypothesis that less
transformed cells are more susceptible to the effects of very
long chain PUFAs. However, studies in animal models suggest
that the pro-apoptotic effects of fish oils are less marked in
the healthy colon than in one exposed to carcinogens [11]. To
answer the question as to whether healthy and premalignant
and malignant colon epithelial cells react differently to the
growth inhibitory action of FAs using cell culture models then
ideally primary colonocytes should be used. To some extent
this question has been addressed by Engelbrecht et al. [40]
using the ‘‘normal’’ cell line NCM460 and CaCo-2 cells to com-
pare the effects of palmitic acid (16:0), oleic acid (18:1n  9),
ARA, and DHA. In their study, the only FA found to be growth
inhibitory was DHA and that only in the adenocarcinoma cell
line. Thus, combining the data in this study with this data, it
would suggest that fish-oil derived PUFAs are growth inhibi-
tory to both malignant and premalignant colonocytes but not
to the untransformed cell line NCM460.
This study is novel in that it focuses for the first time
on effects of PUFAs on a premalignant colorectal cell line
when compared with a colon adenocarcinoma cell line which
is important in relation to understanding chemoprevention at
the early stages of tumor initiation and progression and may
also better reflect normal patterns of FA uptake and metabo-
lism. The data are integrated with an assessment of utiliza-
tion of a range of PUFAs, highlighting how fast turnover of
PUFAs is in this system. These results show that while both
colon adenoma and adenocarcinoma cells are able to incor-
porate the tested FAs this is not the predominant fate of the
FAs for either cell line. In fact most FA is lost from the sys-
tem, presumably utilized as a metabolic fuel. Most interest-
ingly though is the observation that adenoma cells appear
to be more susceptible to the growth inhibitory effects of
n  3 PUFAs than the adenocarcinoma cells; an observation
in contrast to the lower susceptibility of ‘‘normal’’ cells
reported previously.
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3.2 Publication II: N. Habermann, E.K. Lund, B. L. Pool-Zobel, M. Glei: 
„Modulation of gene expression in eicosapentaenoic acid and 
docosahexaenoic acid treated human colon adenoma cells.” 
Genes and Nutrition (2009) 4:73–76. 
The potential colon cancer chemopreventive effect of fish, which has been linked 
to the high content of the n-3 PUFAs EPA and DHA in some fish, is hypothesised 
to be caused by an alteration of gene expression after application of the PUFAs. 
The aim of the study was to compare the modulation of gene expression in LT97 
colon adenoma cells in response to EPA and DHA treatment. Therefore, we used 
custom-designed cDNA arrays containing probes for 306 genes related to stress 
response, apoptosis and carcinogenesis and hybridised them with cDNA from 
LT97 cells which were treated for 10 or 24 hours with 50µM EPA or DHA. 
Preneoplastic cells reflecting target cells for chemoprevention were chosen for 
this study. 
There was a marked influence of n-3 PUFA on the expression of several gene 
types, such as detoxification, cell cycle control, signalling pathways, apoptosis, 
and inflammation. DHA and EPA generally modulated different sets of genes, 
although a few common effects were noted.  
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Abstract Epidemiological studies suggest that high fish
intake is associated with a decreased risk of colorectal
cancer which has been linked to the high content of the n-3
polyunsaturated fatty acids (PUFAs) eicosapentaenoic
acids (EPA) and docosahexaenoic acid (DHA) in some
fish. The aim of the study was to compare the modulation
of gene expression in LT97 colon adenoma cells in
response to EPA and DHA treatment. Therefore, we used
custom-designed cDNA arrays containing probes for 306
genes related to stress response, apoptosis and carcino-
genesis and hybridised them with cDNA from LT97 cells
which were treated for 10 or 24 h with 50 lM EPA or
DHA. There was a marked influence of n-3 PUFA on the
expression of several gene types, such as detoxification,
cell cycle control, signaling pathways, apoptosis and
inflammation. DHA and EPA generally modulated differ-
ent sets of genes, although a few common effects were
noted. In our approach, we used preneoplastic adenoma
cells which are a relevant model for target cells of che-
moprevention. If verified with real time PCR, these results
identify genes and targets for chemoprevention of colon
cancer.
Keywords cDNA array  n-3 polyunsaturated fatty acids 
Colon cancer  Gene expression
Short communication
Epidemiological studies suggest that high fish intake is
associated with a decreased risk of colorectal cancer (2, 3,
7). Most of the beneficial effects have been linked to
the high content of the n-3 polyunsaturated fatty acids
(PUFAs) eicosapentaenoic acid (EPA) and docosahexae-
noic acid (DHA) in some fish. EPA and DHA are essential
for humans and found most notably in oily fish like salmon
or herring. The intake of n-3 PUFAs in the world differs
and is in direct relation to the relative fish consumption.
The incidence of colorectal cancer in countries with high
fish consumption such as Greenland or Japan is reported to
be lower (9). Also, in vivo studies in rats have shown
antitumourigenic effects of a diet rich in fish oil compared
to other oils, such as corn oil (5). Evidence suggests that
fish-related compounds act post-initiation to reduce tran-
sition of adenomas to tumours. However, the molecular
mechanisms behind the anticancer effects of a diet rich in
fish are not yet clarified.
The aim of the present study was to examine the mod-
ulation of expression of 306 genes related to stress
response, apoptosis and carcinogenesis by comparing the
effects of EPA and DHA. Human colon adenoma cells
were chosen since they are a model for target cells for
chemoprevention in vivo. Previous in vitro studies in this
field have used cancer cell lines such as HT29 (1) or Caco-2
(6) rather than cells derived from adenomas, for example
LT97.
Materials and methods
Gene expression studies were performed using LT97 human
colon adenoma cells (4, 8) treated with a non-cytotoxic
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concentration (50 lM) of EPA (n = 3), DHA (n = 2) or
alternatively 0.1% ethanol. The stock solution of each non-
esterified fatty acid was purchased and dissolved in etha-
nol, thus ethanol was chosen to be the appropriate control.
RNA was extracted after 10 and 24 h of incubation with
the RNeasy Mini PLUS Kit (Qiagen GmbH, Hilden, Ger-
many). RNA was quantified with the Nanodrop (Peqlab,
Erlangen, Germany) and RNA integrity number (RIN)
measured by Bioanalyzer (Agilent Technologies Deutsch-
land GmbH, Böblingen, Germany). A control RNA which
was labelled with Cy3 for each array was produced
using untreated HT29 human colon carcinoma cells. Equal
amounts of RNA (1 lg, RIN 8.5–10) were used for syn-
thesising first strand of cDNA by Superscript II reverse
transcriptase. A second strand cDNA was synthesized
afterwards using Polymerase I, RNaseH and E.coli DNA
ligase (Invitrogen GmbH, Karlsruhe, Germany). After
clean-up of the product the double stranded cDNA was
used for amplifying cRNA in order to increase the amount of
RNA used for cDNA labelling with Cy3- and Cy5-dCTPs
(GE Healthcare, Braunschweig, Germany). The reaction
product was purified to yield clean, labelled and single
Table 1 Summary of selected genes that are modulated by treatment of LT97 human colon adenoma cells with 50 lM EPA (n = 3) or DHA
(n = 2)
Accession Gene name Gene symbol FC SD p value
(t test)
EPA 10 h
NM_001228 Caspase 8 CASP8 0.10 0.17 0.17
NM_001074 UDP glucuronosyltransferase 2 family, polypeptide B7, 8, 10, 11 UGT2B7_8_10_11 0.23 0.39 0.39
NM_000410 Hemochromatosis HFE_3 0.25 0.43 0.37
NM_000578 Solute carrier family 11, member 1 SLC11A1 0.29 0.50 0.92
NM_030753 Wingless-type MMTV integration site family, member 3 WNT3 0.30 0.53 0.95
NM_022467 Carbohydrate sulfotransferase 8 CHST8 2.02 2.66 0.54
NM_000854 Glutathione S-transferase theta 2 GSTT2 4.04 3.71 0.31
EPA 24 h
NM_000463 UDP glucuronosyltransferase 1 family, polypeptide A1 UGT1A1 2.00 1.06 0.29
NM_004985 v-Ki-ras2 kirsten rat sarcoma viral oncogene homolog KRAS2A-B 2.02 0.31 0.26
NM_002502 Nuclear factor of kappa light polypeptide gene enhancer in B cells 2 NFKB2 2.12 0.92 0.41
NM_003998 Nuclear factor of kappa light polypeptide gene enhancer in B cells 1 NFKB1 2.16 1.08 0.19
NM_000854 Glutathione S-transferase theta 2 GSTT2 2.41 1.65 0.46
NM_000178 Glutathione synthetase GSS 2.54 2.31 0.30
NM_001461 Flavin containing monooxygenase 5 FMO5 2.58 0.54 0.15
DHA 10 h
NM_001228 Caspase 8 CASP8 0.15 0.21 0.80
NM_000617 Solute carrier family 11, member 2 SLC11A2_2 0.27 0.16 0.30
NM_000410 Haemochromatosis HFE_3 0.28 0.37 0.41
NM_001074 UDP glucuronosyltransferase 2 family, polypeptide B7, 8, 10, 11 UGT2B7_8_10_11 0.29 0.41 0.91
NM_000963 Cyclooxygenase 2 COX2 0.32 0.45 0.98
NM_030753 Wingless-type MMTV integration site family, member 3 WNT3 0.33 0.32 0.34
NM_001880 Activating transcription factor 2 ATF2 3.08 1.88 0.41
DHA 24 h
NM_000778 Cytochrome P450, family 4, subfamily A, polypeptide 11 CYP4A11 0.07 0.10 0.12
NM_000848 Glutathione S-transferase mu 2 GSTM2 0.12 0.11 0.11
NG_002601 UDP glucuronosyltransferase 1 family, polypeptide A3 UGT1A3_4_5 2.24 0.60 0.09
NM_004324 BCL2-associated X protein BAX_2 2.25 2.26 0.53
NM_000146 Ferritin FTL 2.43 0.84 0.04
NM_000765 Cytochrome P450, family 3, subfamily A, polypeptide 7 CYP3A7 3.02 3.20 0.43
NM_014465 Sulfotransferase family 1B, member 1 SULT1B1 3.02 3.60 0.52
Data are presented as fold change (FC) compared to the respective ethanol control for each experiment. A FC C2 was defined as gene up-
regulation whereas a FC B0.33 was used as cut-off for down-regulated genes. Two-tailed t test was performed using Excel software
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stranded cDNA which was hybridised with a customised
cDNA array (PIQOR, Miltenyi Biotec, Bergisch-Gladbach,
Germany) containing 300 genes of interest and 6 house-
keeping genes as described previously (11). Prior to this,
the glass slide arrays were preheated and prehybridised.
The final hybridisation step was carried out overnight in a
water bath (65C) in a humidified hybridisation chamber.
After this, the custom arrays were washed and dried prior
to scanning (MArS array reader, Ditabis, Pforzheim, Ger-
many). Fluorescence intensities were analysed using the
GeneSpotter software (MicroDiscovery, Berlin, Germany).
LOESS-corrected raw data were normalised first in relation
to the reference sample and second by setting the value for
the housekeeping gene GAPDH equal to one. Data are
presented as fold change (FC) compared to the respective
ethanol control for each experiment.
Results and discussion
Using a stringent cut-off criteria (B0.33, C2) for the
obtained FC, 16 genes were differentially expressed in
LT97 after treatment with DHA for 10 h (2 up, 14 down)
and 14 (10 up, 4 down) after 24 h. Using the same criteria,
treatment with EPA resulted in a higher number of dif-
ferentially expressed genes after both treatment times: 83
(37 up, 46 down) genes were modulated after 10 h, 83 (78
up, 5 down) after 24 h. Examples of modulated genes are
given in a summarised form in Table 1. Only a few genes
were modulated by both DHA and EPA in the same
manner: 9 of the genes were down-regulated by both
PUFAs after 10 h and 2 of the genes were up-regulated
after 24 h (see Fig. 1).
There was a marked influence of n-3 PUFA on the
expression of several gene types (Table 1). Of these, some
could result in functional effects such as altered biotrans-
formation of phase I [e.g., up-regulation of CYP3A7 and
FMO5 (24 h)] and phase II [up-regulation, e.g. GSTT2
(10), SULT1B1, CHST8, UGT1A family, UGT2B family
down-regulation (10 h)], cell cycle control (e.g. up-regu-
lation of cyclin dependent kinase 2), modulation of
signalling pathways [e.g. down-regulation of Wnt3 (10 h),
up-regulation of NFkB (24 h)], apoptosis [e.g., down-reg-
ulation of casp8 (10 h), bax up-regulation (24 h)], and
inflammation (e.g. down-regulation of COX2). The modu-
lation of gene expression by the n-3 PUFAs EPA and DHA
has to be verified using real time PCR.
Our data show that n-3 PUFAs from fish oils may have a
chemoprotective effect by modulating gene expression,
which may prevent the development of adenomas to
tumours. Our novel approach of studying this specific
profile of gene expression modulation in preneoplastic
human cells provides a rationale and relevant approach to
identify target genes and agents that can contribute to
chemoprevention.
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3.3 Publication III: N. Habermann, J. Helmbrecht, M. Glei:
 
“Omega-3 
polyunsaturated fatty acids alter SOD2, GSTT2 and COX2 in 
colorectal cell lines.” Manuscript submitted to the British Journal of 
Nutrition. 
EPA and DHA have been shown to affect gene expression using cDNA arrays 
(publication II). The aim of this study was to validate and compare the 
modulation of SOD2, GSTT2 and COX-2 expression in LT97 colon adenoma and 
HT29 adenocarcinoma cells in response to EPA and DHA treatment by Real-Time 
RT-PCR. Additionally, SOD2 and COX2 protein was determined by Western blot. 
We show effects on oxidative stress reduction by SOD2 induction and probably 
by enhanced peroxidase activity of GSTT2. A modulation of GSTT2 though 
opposing for EPA and DHA was found in HT29 cells. We propose anti-
inflammatory action by two mechanisms, first, by a reduction of COX-2 
expression which may result in a reduced level of prostaglandin E2, and second, 
in terms of a potentially reduced level of pro-inflammatory lipid derivatives 
arising from the fatty acids. 
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Abstract:  26 
Epidemiological studies suggest that high fish intake is associated with a decreased risk of 27 
colorectal cancer which has been linked to the high content of the n-3 PUFAs EPA and 28 
DHA in some fish. The aim of the study was to compare the modulation of superoxide 29 
dismutase 2 (SOD2), glutathione S-transferase T2 (GSTT2), and cyclooxygenase-2 (COX-2) 30 
expression in response to EPA and DHA. Two human colon cell lines of different stage of 31 
tumourigenesis, namely LT97 adenoma cells and HT29 adenocarcinoma cells, were treated 32 
with 50 µM EPA or DHA for 4, 10, and 24 h. Gene expression analysis was carried out for 33 
SOD2, GSTT2 and COX-2 by real-time RT-PCR using Sybr green. SOD2 and COX-2 34 
protein were determined by Western Blot. SOD2 was found to be up regulated in LT97 cells 35 
(24 h). On protein level this effect was less pronounced. GSTT2 was up regulated by EPA 36 
(24 h) and down regulated by DHA (10 h) in HT29 cells. COX-2 decreased when 37 
supplementing the medium of LT97 (10 h) and HT29 cells (10 h and 24 h) with DHA. EPA 38 
induced COX-2 in LT97 cells (24 h). This COX-2 modulation was found on protein level as 39 
well. Reduction of oxidative stress by induction of SOD2 and by enhanced peroxidase 40 
activity of GSTT2 is hypothesised. Anti-inflammatory action can be proposed by reduction 41 





Epidemiological studies suggest that high fish intake is associated with a decreased risk of 45 
colorectal cancer
(1,2,3)
. Most of the beneficial effects have been linked to the high content of 46 
the n-3 PUFAs EPA and DHA in some fish. EPA and DHA are essential for humans and 47 
found most notably in oil-rich fish like salmon or herring. The intake of n-3 PUFAs in the 48 
world differs and is in direct relation to the relative fish consumption. The incidence of 49 
colorectal cancer in countries with high fish consumption such as Greenland or Japan is 50 
reported to be lower
(4)
. Furthermore, in vivo studies in rats have shown antitumourigenic 51 
effects of a nutrition rich in fish oil against a carcinogenic burden compared to other oils, 52 
such as corn oil
(5)
.  53 
Chemoprevention is defined as the use of pharmacological agents (including nutrients) to 54 
impede, arrest or reverse carcinogenesis
(6,7)
. According to Wattenberg
(8)
, blocking agent 55 
activity during primary chemoprevention prevents the formation of compounds, which 56 
might act as carcinogens. We hypothesise, that fish fatty acids EPA and DHA might 57 
influence colon carcinogenesis by different mechanisms, therefore we have chosen to 58 
analyse the modification of enzymes involved in oxidative response, biotransformation and 59 
inflammation. This can be achieved by the induction of phase II enzymes, such as 60 
glutathione S-transferase T2 (GSTT2). Generally spoken, GSTs as biotransformation 61 
enzymes are capable to detoxify a number of endogenous (e.g. lipidperoxidation products as 62 
4-hydroxynonenal
(9)





Since their induction is understood to reduce cancer initiation, they can be considered as 64 
blocking agents. Additionally, the decrease of reactive oxygen species can be related to 65 
chemoprevention, such as the detoxification of superoxide to hydrogen peroxide and 66 
diatomic oxygen by superoxide dismutase 2 (SOD2)
(13)
. Also, it is well known that within an 67 
inflammatory environment cells tend to facilitate carcinogenesis
(14)
. Hence, reduction of a 68 




To answer the question which genes are altered by the n-3 PUFAs EPA and DHA in colon 71 
adenoma cells we examined the modulation of expression of 306 genes related to stress 72 
response, apoptosis and carcinogenesis by comparing the effects of these fatty acids
(16)
. 73 
Human colon adenoma cells (LT97) were chosen since they are an appropriate model for 74 
target cells for chemoprevention in vivo. There was a marked influence of n-3 PUFA on the 75 
expression of several gene types. SOD2, GSTT2 and COX-2 have been chosen to be verified 76 
by real-time RT-PCR in this study. A summary of the fold changes of these genes found by 77 
custom array analysis is given in table 1. Additionally to the human adenoma cell line we 78 
4 
 
also examined the effects of both fatty acids on an adenocarcinoma cell model, namely 79 
HT29 cells after treatment of the cells for 10 h or 24 h. Finally, Western Blot explorations 80 





Cells and Culture 84 
The human colorectal adenoma cell line LT97 (kind gift of Prof. B. Marian, University of 85 
Vienna) represents an early stage of tumour development
(17)
. It was established from colon 86 
microadenomas of a patient with hereditary familial polyposis. LT97 cells were maintained 87 
in a culture medium (MCDB 302) as described previously
(18)
. The cells have a stable 88 
karyotype
(19,20)
, are of epithelial nature
(17)
 and have a doubling time of 72-96 h. The LT97 89 
cells used for the experiments presented here were from passages 24-38. The human colon 90 
adenocarcinoma cell line HT29 was isolated in 1964 from a moderately differentiated, grade 91 
II adenocarcinoma of the recto-sigmoid colon of a 44-year-old Caucasian woman, and have 92 
retained a high level of genomic stability
(21,22)
. HT29 cells were obtained from the American 93 
Tissue Culture Collection (HTB-38) and maintained as a subconfluent monolayer culture
(18)
 94 
in Dulbecco‟s Modified Eagle‟s Medium (DMEM) [Invitrogen GmbH, Karlsruhe, 95 
Germany]. Passages 19-34 of HT29 were used for the experiments in this study. At regular 96 
intervals, a mycoplasm test was performed (VenorGeM, Minerva Biolabs, Berlin, 97 
Germany). 98 
Treatment of cells with fatty acids  99 
LT97 and HT29 (4 x 10
6
) cells were seeded in 25 cm
3
 cell culture flasks and incubated until 100 
LT97 cells reached 70-80% confluence or in case of HT29 for 24 h. Prior to the 101 
experiments, LT97 and HT29 cells were treated with 50 µM EPA or 50 µM DHA. This 102 
concentration was shown to affect the expression of genes
(16)
. For this, the supernatant was 103 
removed and fresh medium containing respective PUFA or 0.1% ethanol control was 104 
applied. The stock solution of each non-esterified fatty acid was purchased dissolved in 105 
ethanol, thus ethanol was chosen to be the appropriate control. All experiments were 106 
performed in triplicates. 107 
Isolation of RNA and quality control  108 
RNA was extracted after 4, 10 and 24 h of incubation with the RNeasy Mini PLUS Kit 109 
(Qiagen GmbH, Hilden, Germany) according to the manufacturer‟s protocol. RNA was 110 
quantified with the Nanodrop (Peqlab, Erlangen, Germany) and RNA Integrity Number 111 
(RIN) was measured by Bioanalyzer (Agilent Technologies Deutschland GmbH, Böblingen, 112 
Germany). 113 
Real-Time qRT PCR 114 
The modulation of SOD2, GSTT2 and COX-2 mRNA was performed by an independent 115 
measurement of the mRNA levels. For quantitative RT-PCR-analysis we used the system of 116 
iCycler iQ (Bio-Rad GmbH, Munich, Germany), enabling quantitative analysis of the 117 
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mRNA expression levels. Therefore, aliquots of 2 µg total RNA from each sample were 118 
reverse transcribed using reagents from SuperScript II reverse transcriptase (Invitrogen 119 
GmbH, Karlsruhe, Germany) according to the manufacturer‟s protocol. For each reaction 2 120 
µl of cDNA was mixed with PCR master mix iQ
TM
 SYBR1 Green Supermix (SYBR Green 121 
I, iTaq DNA polymerase, reaction buffer, deoxynucleotide triphosphate mix, 10 mM MgCl2, 122 
20 nM fluorescein, and stabilisers; BioRad GmbH, Munich, Germany), and 10 pmol of the 123 
gene-specific primers for target SOD2, COX-2, and GSTT2 and for the housekeeping gene 124 
GAPDH (table 2) in a final volume of 25 µl. All experiments were performed in triplicate 125 
and the PCR reaction mixture was set in an iCycler iQ 96-well PCR plate (Bio-Rad GmbH, 126 
Munich, Germany). The relative fluorescence signal was captured at the primer nucleotide 127 
extension step of each cycle. At the end of the reaction the melting curve analysis was 128 
conducted with temperature gradient from 60 to 95°C at 0.108°C/s to differentiate 129 
nonspecific primer dimers and specific amplicon. The iCycler iQ1 optical v3.0a software 130 
was utilised for obtaining the relative threshold cycle number (CT) and the data 131 
normalisation and analysis was carried out as previously described
(23)
. Results were 132 
expressed as fold change (FC) compared to the ethanol control. 133 
Western Blots targeting SOD2 and COX-2  134 
Cells were cultured, incubated and harvested as described above. After a washing step in 135 
PBS, cells were chemically lysed in lysis buffer (20 mM Tris/HCl pH 8.0, 150 mM NaCl, 136 
10% glycerin, 2 mM EDTA, 1% Nonidet P40) containing a freshly added mixture of 1 mM 137 
DTT (reducing agent), 1 mM sodiumorthovanadate (phosphatase inhibitor) and several 138 
protease inhibitors (0.5 mM Pefabloc SC, 1 mM PMSF, 1 g/ml pepstatin A, 1 g/ml 139 
leupeptin). Total protein concentrations were determined by Bradford assay
(24)
. 140 
Equal amounts of total protein (10-20 µg) were diluted with SDS-PAGE loading puffer (125 141 
mM Tris/HCl pH 6.8, 2% SDS, 10% glycerin, 0.0005% bromphenol blue, 100 mM DTT) 142 
and proteins were separated using discontinuous SDS polyacrylamid gel electrophoresis 143 
(stacking gel: 3%, separating gel: 15%). After separation, the proteins were transferred to 144 
nitrocellulose membranes (Schleicher & Schuell, Dassel, Germany) using a wet blotting 145 
system (Bio-Rad GmbH, Munich, Germany). After Ponceau staining membranes were cut 146 
beween the 55 and 60 kDa band and beyond the 35 kDa band of the PageRuler
TM
 147 
(Fermentas GmbH, St. Leon-Rot, Germany). Subsequently, unspecific binding sites on the 148 
membranes were blocked with 5% nonfat dried milk powder (AppliChem, Darmstadt, 149 
Germany) in TBS (100 mM Tris, 150 mM NaCl, pH 7.4). Primary antibody (mouse anti-150 
SOD2, rabbit anti-COX-2, mouse anti-β-actin (Cell Signaling, Frankfurt/M., Germany)) 151 
were diluted in blocking solution (1:1000 for SOD2, 1:250 for COX-2 and 1:10000 for β-152 
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actin) and the respective part of the membrane was incubated with antibody solutions 153 
overnight at 4°C. Horseradish peroxidise (HRP)-labeled secondary antibodies (goat anti-154 
rabbit IgG-HRP and rabbit anti-mouse-HRP (Cell Signaling, Frankfurt/M., Germany)), were 155 
diluted in blocking solution 1:1000 and were used to visualise primary antibodies. After 1 h 156 
incubation with secondary antibodies, membranes were washed twice with TBST and 157 
afterwards once with TBS (each 5 min) incubated with ECL Plus Western Detection reagent 158 
(Amersham Biosciences Europe GmbH, Freiburg, Germany). Hyperfilm
TM
 ECL (Amersham 159 
Biosciences Europe GmbH, Freiburg, Germany) chemiluminescence films were then placed 160 
on the membrane to visualise bands. Exposed and developed films were then scanned using 161 
Fluor-S documentation system (Bio-Rad GmbH, Munich, Germany). 162 
Statistical analysis 163 
Statistical evaluation was performed with the GraphPad Prism
TM
 Version 5.0 for Windows 164 
(GraphPad Software, San Diego California, USA, www.graphpad.com). Means and SD of 3 165 
independent repeats were calculated and afterwards One Way ANOVA with Dunnett‟s post 166 





SOD2, COX-2, and GSTT2 gene expression 170 
Verification of the array data was performed after treating both HT29 (right panel figure 1) 171 
and LT97 (left panel figure 1) cells with EPA as well as DHA for 4, 10 and 24 h. Real-time 172 
RT-PCR analysis showed enhanced expression of SOD2 which was significant for LT97 173 
cells after 24 h treatment with EPA (FC 2.5±0.6; P<0.05) or DHA (FC 2.0±0.4; P<0.05). 174 
Expression of COX-2 was repressed by DHA after 10 h (LT97: FC 0.4±0.1; P<0.001 and 175 
HT29: FC 0.4±0.2; P<0.001) and 24 h in HT29 (FC 0.7±0.1; P<0.05) but not by EPA, 176 
which induced COX-2 gene expression only in LT97 cells after 24 h of treatment (FC 177 
1.9±0.5; P<0.05). GSTT2 was repressed by DHA 10 h after treatment (FC 0.7±0.1; P<0.05) 178 
and induced by EPA after 24 h (FC 1.4±0.1; P<0.05) in HT29. GSTT2 gene expression was 179 
not significantly altered in LT97 by any treatment condition. 180 
SOD2 and COX-2 protein expression 181 
In order to prove whether enhanced mRNA expression is also accompanied by enhanced 182 
protein expression, we performed Western Blot analysis over a period up to 48 h specifically 183 
for the proteins SOD2 and COX-2. For human GSTT2 no appropriate antibody is available, 184 
thus, we had to exclude this issue from our experiments. 185 
An alteration of SOD2 protein was hardly to find in our experiments. Neither n-3 PUFA nor 186 
treatment time seems to impair the expression of this protein (figure 2 above panel) in HT29 187 
or LT97 cells. 188 
In contrast, we found a down regulation for COX-2 in LT97 (figure 2 left panel) and HT29 189 
(figure 2 right panel) cells after treatment with DHA (10, 24, and 48 h). But we did not find 190 





Colorectal carcinogenesis is a long-standing process which was described in a multistep 194 
model to be the result of accumulation of numerous defined mutations
(25)
. Many of them 195 
cause the activation of oncogenes or the inactivation of tumour suppressor genes. There are 196 
multiple reasons for these mutations.  197 
One crucial factor for mutations is oxidative stress, which has been defined as the imbalance 198 
between oxidants and antioxidants in favour of the former, resulting in an overall increase in 199 
cellular level of reactive oxygen species which e.g. might be one source for DNA damage. 200 
One of the most studied oxidative DNA adducts is 8-hydroxydeoxyguanosine which leads to 201 
site-specific mutations and produces GT transversions
(26)
, that are widely found in 202 
mutated oncogenes and tumour suppressor genes
(27)
. Thus, oxidised DNA bases appear to be 203 
mutagenic and capable to induce mutations commonly found in neoplasia. The first step in 204 
the removal of superoxide is enabled by the enzymatic action of SOD2. So it is plausible 205 
that SOD2
-/-
 mice were found to be letal and SOD2
-/+
 mice bear higher concentrations of 206 
8-hydroxydeoxyguanosine and higher incidences of cancer
(28)
. 207 
We found an increase of SOD2 mRNA which was significant for adenoma LT97 cells after 208 
treatment with EPA and DHA for 24 h. This SOD2 up regulation in cells of a premalignant 209 
state of degeneration as seen on our results can be considered as suppressing agent activity 210 
since a further transformation is potentially repressed. In our results an up regulation on 211 
protein level was only hardly to be found. This can be caused by lacking protein translation. 212 
Whether the reason for this effect is an effect of an already high SOD2 protein level in cells 213 
in vitro or a result of a lacking cofactor, namely manganese, cannot be distinguished. Other 214 
reasons for “hidden effects” could be mRNA instability coinciding with unchanged protein 215 
synthesis.  216 
Besides the effects on the antioxidant system of the cells, SOD2 had been recently discussed 217 
as a new type of tumour suppressor gene
(29)
. An overexpression of SOD2 decreased cell 218 
growth
(30)
. Additionally, SOD2 overexpression leads to an alteration of different signal 219 
transduction pathways in different cell types via mechanisms such as inhibition of 220 




GSTT2 is a member of the phase II enzymes superfamily of GSTs which play a role as 223 
transferases in the detoxification of a wide variety of toxic or carcinogenic electrophiles. 224 
Theta class GSTs are highly conserved and consist of 2 family members, GSTT1 and T2
(32)
. 225 
GSTT2 is a minor GST in human colon compared to GSTT1 or the major family member, 226 
namely GSTP1
(33)
. Nevertheless, they have already shown to be up regulated by polyphenols 227 
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and, however, their up regulation might be one mechanism for colon cancer 228 
chemoprevention
(34)
. Conjugation of the endogenous tripeptide glutathione allows lipophilic 229 
xenobiotic substances to become more hydrophilic and hence further easier to be removed. 230 
Accordingly, potentially harmful xenobiotics are excreted from the organism. Additionally 231 
to the glutathione transferase activity GSTT2 also exerts peroxidase
(35)
 and sulfatase 232 
activity
(36)
. GSTT2 shows affinity to organic hydroperoxides as DNA-hydroperoxides and 233 
lipid-hydroperoxides
(37,38)
. As shown by our results, EPA exerts a GSTT2 mRNA-inducing 234 
effect which was significant for HT29 cells after 24h. Interestingly, DHA repressed GSTT2 235 
mRNA after 10 h in HT29 cells (figure 1). Since both n-3 PUFAs act opposing as GSTT2 236 
modulator on gene level, more specific mechanisms than simple lipid peroxidation and 237 
resulting oxidative stress must account for these effects. The GST theta class genes lack both 238 
TATA and CAAT boxes in their 5‟ flanking region thus multiple heterogeneous 239 
transcription boxes had been described (SP1, PU-1, PEA3, AP-2)
(39)
. Whether or not EPA 240 
and DHA or their derivatives impair gene expression by alteration of these transcription sites 241 
and hence alter gene expression via downstream pathways was not yet examined and needs 242 
further clarification. 243 
Cyclooxygenase (COX), also referred to as prostaglandin endoperoxide synthase, catalyses 244 
the conversion of arachidonic acid into prostaglandins. Whilst COX-1 is ubiquitous and 245 
constitutively in most mammalian cells to maintain the baseline level of prostaglandins, 246 
COX-2 is normally absent
(40)
. It is well investigated that COX-2 is over expressed in a 247 




, and 248 
the colon
(43)
. Particularly increased COX-2 expression is connected with tumour metastasis 249 
in colon cancer, where aberrant COX-2 expression was shown to correlate with 250 
carcinogenesis in 80% of the cancers
(44)
. The effect of COX-2 down regulation by non-251 
steroidal anti-inflammatory drugs such as aspirin is proposed to be a chemopreventive 252 
mechanism regarding colon cancer
(45)
. Our results show a down regulation of COX-2 253 
mRNA and COX-2 protein by DHA in both LT97 colon adenoma and HT29 254 
adenocarcinoma cells. COX-2 inhibition was already shown in HT29 cells by 255 
supplementation with EPA and DHA in vitro
(46)
. Conversely, we found a COX-2 induction 256 
by EPA in LT97 cells. The key link between PUFAs and inflammation is that eicosanoids 257 
are generated from C20 PUFAs. Noteworthy, EPA can also act as a substrate for 258 
lipoxigenases and COX, resulting in the generation of eicosanoids with a slightly different 259 
structure than those from arachidonic acid
(47)
. The functional consequence is, that those 260 
mediators which are formed appear to be less potent then arachidonic acid derivatives. 261 
Additionally, EPA and DHA were found to act as a substrate for the generation of 262 
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alternative eicosanoids, termed resolvins
(48)
. Resolvins are formed by the action of COX-2 263 
and appear to exert antiinflammatory actions and this pathway may be enhanced when 264 
supplementing LT97 adenoma cells with EPA. Previously it was shown that COX-2 265 
regulation is facilitated in a prostaglandin E2-dependent (via NR4A2) but also in a 266 
prostaglandin-independent manner
(49)
. Taken together, this has led to the idea that fish oil or 267 
fish fatty acids as EPA and DHA act anti-inflammatory.  268 
To summarise, our data indicate different mechanisms by which the n-3 PUFA fish oil 269 
components EPA and DHA may exert colon cancer chemopreventive effects. To our 270 
knowledge, this is the first time that such effects were described not only in cancer cells but 271 
also including an adenoma cell line in vitro. First, we showed potential effects on oxidative 272 
stress reduction by SOD2 induction and probably by enhanced peroxidase activity of 273 
GSTT2 (HT29, EPA 24 h). SOD2 was significantly induced in LT97 cells (24 h) and in 274 
HT29 cells as a trend. This links to a reduction of the harmful potential of superoxide to 275 
damage e.g. DNA in premalignant cells. Further, we saw a modulation of GSTT2 though 276 
opposing for EPA (up regulation of GSTT2 mRNA after 24 h) and DHA (down regulation 277 
of GSTT2 mRNA after 10 h) in HT29 cells. Whether or not these effects can be translated 278 
for protein levels in the cells needs further clarification. And finally, we propose anti-279 
inflammatory action by two mechanisms, first by a reduction of COX-2 expression (by 280 
DHA on mRNA and protein level) which may result in reduced level of prostaglandin E2 281 
from the ubiquitous arachidonic acid, and second in terms of a induced level of 282 
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Table 1. Fold changes of COX-2, GSTT2 and SOD2 gene expression after treatment of 294 
LT97 cells with 50 µM EPA or DHA for 10 or 24 h, respectively. Given are means and 295 
standard deviation (SD) of 3 independent repeats, data modified from 
(16)
. 296 
      EPA 10h   EPA 24h   DHA 10h   DHA 24h 
locus ID gene name   mean SD   mean SD   mean SD   mean SD 
NM_000963 COX-2   1.15 0.88   1.62 0.51   0.21 0.37   0.07 0.13 
NM_000854 GSTT2   4.04 3.71   2.41 1.65   0.24 0.42   0.33 0.13 





Table 2. Sequences of primers used for real-time RT-PCR. 299 
locus ID gene name sense primer 5‟... 3‟ antisense primer 5‟... 3‟ 
fragment 
size (bp) 
NM_002046 GAPDH acc cac tcc tcc acc ttt gac  tcc acc acc ctg ttg ctg tag  110 
NM_000963 COX-2 tcc tcc tgt gcc tga tga ttg c  act gat gcg tga agt gct ggg 170 
NM_000854 GSTT2 tga cac tgg ctg atc tca tgg cc gcc tcc tgg cat agc tca gca c 142 
NM_000636 SOD2 gcc ctg gaa cct cac atc aac caa cgc ctc ctg gta ctt ctc 111 





Legends to figures 303 
 304 
Figure 1. Gene expression of SOD2, GSTT2 and COX-2 in LT97 (left panel) and HT29 305 
(right panel) after indicated times of treatment by 50 µM EPA and DHA, means + SD (n=3), 306 
asterisks indicate differences to the ethanol control (dashed line) by One Way ANOVA 307 
followed by Dunnett‟s multiple comparison test, * P<0.05, *** P<0.05. 308 
 309 
Figure 2. Western Blot analysis for SOD2 and COX-2 protein in LT97 (left panel) and 310 
HT29 (right panel) after indicated times of treatment by 50 µM EPA and DHA. The figure 311 
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3.4 Publication IV: N. Habermann, A. Schön, E. K. Lund, M. Glei: „Fish 
fatty acids alter markers of apoptosis in colorectal cell lines 
but fish consumption has no impact on apoptosis-induction ex 
vivo.” accepted by Apoptosis, DOI: 10.1007/s10495-010-0459-y. 
Studies suggest the n-3 PUFAs EPA and DHA, natural food ingredients found in 
fish, exerting chemopreventive action in colon cancer. One of the involved 
mechanisms is the facilitation of apoptosis. While pro-apoptotic potential of n-3 
PUFAs is suggested, it is still unclear whether an additional uptake of fish will 
also point to comparable results. The aim of this study was to assess EPA- and 
DHA-mediated effects on different endpoints of apoptosis and to use a novel 
biomarker-approach to measure modulation of apoptosis by consumption of fish.  
Apoptosis was detected by flow cytometry after 24 hours treatment of LT97 
human colon adenoma cells with 50µM EPA or DHA, by bcl-2 decrease using 
Real-Time RT-PCR in LT97 cells after 10 hours treatment, by measuring the 
decrease of procaspases 3 and 8, PARP cleavage, and truncation of bid in cells 
treated with 100µM DHA using Western Blot analysis. DHA was more effective in 
inducing apoptosis compared to EPA. LT97 cells were more prone to the 
apoptosis-inducing potential of DHA and EPA compared to HT29 cells. Treatment 
of LT97 cells with faecal water obtained from 89 volunteers of an intervention 
study giving fish (FISHGASTRO) did not result in changes of apoptosis markers. 
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Fish fatty acids alter markers of apoptosis in colorectal adenoma
and adenocarcinoma cell lines but fish consumption has no impact
on apoptosis-induction ex vivo
Nina Habermann • Adrienne Schön •
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 Springer Science+Business Media, LLC 2010
Abstract Previous studies suggest that the n-3 polyun-
saturated fatty acids (PUFAs) eicosapenteinoic acid (EPA)
and docosahexaenoic acid (DHA), constituents of fish oil,
exert chemopreventive activity in colon cancer. One of the
mechanisms involved is the facilitation of apoptosis. While
a pro-apoptotic potential of n-3 PUFAs has been suggested,
it is still unclear whether additional consumption of fish
will also lead to comparable results. The aim of this study
was to assess EPA- and DHA-mediated effects on end-
points of apoptosis and to use a novel biomarker-approach
to measure modulation of apoptosis by consumption of
fish. LT97 human colon adenoma and HT29 human colon
adenocarcinoma cells were used to investigate modulation
of apoptosis by EPA, DHA or linoleic acid (LA) using a set
of endpoints, namely phosphatidylserine staining with
Annexin-V (flow cytometry), Bcl-2 expression (Real-time
RT–PCR), and Bid, caspase 3, 8 and 9 expression as well
as PARP cleavage (Western Blot). Furthermore, faecal
water (FW) of volunteers (n = 89) from a human trial
intervening with fish was used to investigate changes in
apoptosis by flow cytometry. DHA was more effective at
inducing apoptosis than EPA. LT97 cells were more prone
to DHA and EPA induced apoptosis than HT29 cells.
Treatment of LT97 cells with FW from volunteers con-
suming fish did not result in any changes in apoptosis.
Taken together, our results show that adenoma cells are
highly susceptible to n-3 PUFA-induced apoptosis. By
using a biomarker-approach (FW) to measure apoptosis-
induction ex vivo no change in apoptosis after additional
fish consumption was detectable.
Keywords Apoptosis  Colon cancer  n-3 PUFA 
Fish consumption  Faecal water
Introduction
Colorectal cancer is the second most common malignancy in
the Western world [1, 2]. The sporadic form of colorectal
cancer arises over many years as a result of accumulation of
genetic errors, many of which affect the control of apoptosis
[3]. Effective chemoprevention strategies aim to decrease
the accumulation of genetic and epigenetic alterations [4, 5].
Apoptosis is an important chemopreventive mechanism that
can be modified by diet e.g. by fish oil [6, 7], resulting in the
removal of damaged cells.
Diets high in fish-oil are protective against chemically
induced colon cancer in animal models [8–10] and in
human populations high fish consumption appears to be
chemopreventive [9, 11]. The two major fatty acids eico-
sapentaenoic (EPA—C20:5) and docosahexaenoic
(DHA—C22:6) are naturally occurring n-3 polyunsaturated
fatty acids (PUFAs) which can only be synthesised in
humans from alpha-linolenic acid (C18:3 n-3) and then
only to a very limited degree [12, 13]. Dietary intake from
oil-rich fish such as salmon or mackerel is therefore rec-
ommended [14]. In the 1,2-dimethylhydrazine (DMH) rat
model of colorectal cancer apoptosis has been shown to be
enhanced by fish oil [9] and in human studies consumption
of high doses of fish oil has been reported to increase
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apoptosis in the colonic mucosa after 2 years [6]. Recently
it has become clear, that PUFAs and some of their deriv-
atives are able to modulate the molecular pathways
involved in apoptosis [15]. However, it still needs to be
established how apoptosis is induced by n-3 PUFAs.
In contrast to studies using high doses of fish oil, an
additional intake of salmon (2 portions fish per week giving
approximately 1 g EPA ? DHA/d over 6 months) failed to
show an apoptosis-inducing effect in humans [16]. To our
knowledge the question as to whether a high-fish diet in
humans can alter the colonic lumen environment in a pro-
apoptotic manner has never been assessed. Thus, to test the
hypothesis that fish consumption might alter the luminal
environment in a pro-apoptotic manner, we have exposed
cell lines to faecal water collected during the FISHGAS-
TRO study. Faecal water (FW) is the aqueous phase
extracted from stool samples and has been widely used as a
non-invasive biomarker for a multitude of tests proving the
influence of nutrition on colonic health [17].
The aim of this study was therefore to investigate the
impact of n-3 PUFAs on cell signalling in apoptosis with a
focus on comparing the sensitivities of LT97 and HT29
cells. In addition we wanted to assess whether fish con-




The human colorectal adenoma cell line LT97 (kind gift of
Prof. Marian, Vienna) represents an early stage of tumour
development. It was established from colon microadenomas
of a patient with hereditary familial polyposis [18]. LT97
cells were maintained in a culture medium (MCDB 302) as
described previously [19]. The cells have a stable karyotype,
are of epithelial nature and have a doubling time of 72–96 h
[20]. The human colon adenocarcinoma cell line HT29 was
isolated in 1964 from a moderately differentiated, grade II
adenocarcinoma of the recto-sigmoid colon of a 44-year-old
Caucasian woman [21], and have retained a high level of
genomic stability [22]. HT29 cells were obtained from the
American Tissue Culture Collection (HTB-38) and were
maintained as a subconfluent monolayer culture [19] in
DMEM [Invitrogen GmbH, Karlsruhe, Germany]. At reg-
ular intervals, a mycoplasm test was performed (Myco-
Alert Lonza, Cologne, Germany).
Subjects and study design, FW preparation
The design of the intervention study ‘FISHGASTRO’ has
been described in detail elsewhere [16]. The ethical
approval was obtained from the Medical Ethical Commit-
tee of Nijmegen University Medical Centre St. Radboud
(reference 2004/111) and King’s Lynn Local Research
Ethics Committee (reference 04/Q0105/8). The trial has
been registered at www.clinicaltrials.gov under identifier
NCT00145015. All subjects gave their written informed
consent and a subsample of subjects consented separately
for collection of faecal samples.
Three groups of subjects were recruited: (i) those with
(previous) colorectal adenomas (ii) those diagnosed with
non-active ulcerative colitis (UC), and (iii) those without
any macroscopic signs of disease in the colon. The design
of the study was a multi-centre parallel randomised con-
trolled intervention trial. After an initial colonoscopy pro-
cedure, 242 eligible subjects were randomly allocated to
one of three dietary intervention groups: (i) oil-rich fish
group receiving two 150 g portions of salmon per week
during 6 months (ii) lean fish group receiving two 150 g
portions of cod per week during 6 months, and (iii) only
dietary advice (DA) group. All three intervention groups
received dietary advice to achieve a healthy diet. The fish
was provided to the participants at their home and had to be
consumed in addition to their regular fish consumption.
Salmon and cod provided approximately 1.4 g/d and
0.09 g/d of very long chain n-3 PUFA, respectively [16].
A total faeces sample was collected pre- and post-
intervention and stored in a cooled container for transport
to the laboratory within 4 h. At the laboratory, samples
were homogenised, aliquoted and stored at -80C until
further processing. The pre- and post-intervention samples
from individual volunteers were analysed in parallel.
Samples were defrosted, homogenised by stirring and then
transferred to aluminium cap-locked polycarbonate tubes
(Beckman Coulter GmbH, Krefeld, Germany), mixed with
the same amount (w/v) of ice chilled PBS and centrifuged
(Optima LE-80 K Ultracentrifuge, Beckman Coulter
GmbH, Krefeld, Germany) at 25,000 g for 2 h at 4C as
described previously [17]. The supernatants, representing
the FW were aliquoted and stored at -20C. Faeces of 89
volunteers were used for this study and characteristics of
this population is given elsewhere [23].
Treatment of cells with fatty acids, caspase inhibitors,
and FW
LT97 and HT29 (1 9 106) cells were seeded in 6-well plates
and pre-incubated until LT97 cells reached 70–80% con-
fluence or in case of HT29 24 h (confluency 60–70%). Prior
to the experiments (n = 3), LT97 and HT29 cells were
treated with 50 (only LT97), 100 and 200 lM (only HT29)
EPA, DHA or LA, respectively. Controls were exposed to an
equal concentration of ethanol to that in the fatty acid
exposed samples. For a subset of the experiments using
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caspase-inhibitors (Axxora Deutschland GmbH, Grünberg,
Germany) 0.002% DMSO was added to the ethanol control.
All caspase-inhibitors were dissolved in DMSO and added
directly to the DHA-containing cell culture medium. The
inhibition of apoptosis caused by 50 lM DHA was tested by
co-incubating LT97 cells with 20 lM caspase 3-inhibitor
(Ac-DEVD-CHO), caspase 8-inhibitor (Ac-IETD-CHO),
caspase 9-inhibitor (AC-LEHD-CHO), or pancaspase-
inhibitor (Z-VAD-CHO) for 24 h.
For FW studies, FW was diluted to yield the final con-
centration of 3.5% FW and afterwards sterile filtered using
a 0.45 lm syringe filter before applying to LT97 cells.
Supernatant was removed and fresh medium containing
PUFAs or FW was applied. Preliminary experiments with
FW (3.5, 5 and 10%, n = 4) revealed 3.5% as suitable
concentration.
Flow cytometry using Annexin-V
and 7-aminoactinomycin D
Cells were cultured and incubated as described above. For
PUFA experiments, cell culture supernatants were removed
and LT97 and HT29 cells were harvested after 24, 48 or 72 h
by trypsination for 10 or 5 min, respectively and cells were
collected by centrifugation (4C, 5 min, 400 g). For the work
with caspase-inhibitors LT97 cells were harvested as
described above after 24 h co-incubation with 50 lM DHA
and 20 lM of the corresponding caspase-inhibitor. Cell
pellets were resuspended in 1 ml cell culture medium for
determination of cell number and viability. For staining,
1 x 106 cells were resuspended in calcium-buffer (Beckman/
Coulter GmbH, Krefeld, Germany) after centrifugation
(4C, 5 min, 400 g) and mixed with 10 ll 7-aminoactino-
mycin D (7-AAD) and 5 ll Annexin-V and incubated on ice
for 15 min. Fluorescence was measured using Cell Lab
Quanta
TM
(Beckman Coulter GmbH, Krefeld, Germany) and
cells were distinguished by the presence of Annexin-V (early
apoptotic), 7-AAD and Annexin-V (late apoptotic/necrotic),
and 7-AAD (dead cells). Viable cells do not exert any
detectable fluorescence. The distribution by percentage was
calculated.
Real-time PCR targeting Bcl-2
After 10 or 24 h cells were harvested and RNA extracted
using RNeasy Mini PLUS Kit (Qiagen, Hilden, Germany)
according to the manufacturer’s instructions. RNA was
quantified with Nanodrop (Peqlab, Erlangen, Germany)
and the RNA integrity number (RIN) was measured with
Bioanalyzer (Agilent, Böblingen, Germany). No RNA was
used with a RIN below 8.5.
The modulation of Bcl-2 mRNA was performed by an
independent measurement of mRNA levels. For quantita-
tive RT–PCR-analysis we used the system of iCycler iQ
(Bio-Rad GmbH, München, Germany), enabling quantita-
tive analysis of the mRNA expression levels. Therefore,
aliquots of 1.5 lg total RNA from each sample were
reverse transcribed using SuperScript II reverse transcrip-
tase (Invitrogen GmbH, Karlsruhe, Germany) according to
the manufacturer’s protocol. For each reaction 10 ll of
cDNA (1:20 dilution) was mixed with PCR master mix
iQ
TM
SYBR1 Green Supermix (SYBR Green I, iTaq DNA
polymerase, reaction buffer, deoxynucleotide triphosphate
mix, 10 mM MgCl2, 20 nM fluorescein, and stabilisers;
BioRad, Munich, Germany), and 10 pmol of the gene-
specific primers for Bcl-2 and for the reference gene
GAPDH (Table 1) in a final volume of 25 ll. Primer
annealing temperature was 57C. All samples were ana-
lysed in duplicates and the PCR reaction mixture was set in
an iCycler iQ 96-well PCR plate (Bio-Rad GmbH, Munich,
Germany). The relative fluorescence signal was captured at
primer nucleotide extension step of each cycle. At end of
the reaction the melting curve analysis was conducted with
temperature gradient from 57 to 95C at 0.108C/s to
differentiate nonspecific primer dimer and specific ampli-
con. The iCycler iQ1 optical v3.0a software was utilised
for obtaining the relative threshold cycle number (CT) and
the data normalisation and analysis was carried out as
previously described [24]. Results were expressed as fold-
change induction relative to the respective ethanol control.
Western blots targeting PARP, Bid, caspase 3,
caspase 8 and caspase 9
Cells were cultured, incubated and harvested as described
above. After washing in PBS, cells were chemically lysed
in buffer (20 mM Tris/HCl pH 8.0, 150 mM NaCl, 10%
glycerin, 2 mM EDTA, 1% nonidet P40) containing a
freshly added mixture of 1 mM DTT (reducing agent),
1 mM sodiumorthovanadate (phosphatase inhibitor) and
several protease inhibitors (0.5 mM pefabloc SC, 1 mM
PMSF, 1 lg/ml pepstatin A, 1 lg/ml leupeptin). Total
protein concentrations were determined by Bradford assay
[25].
Table 1 Sequences of primers
used
Gene Sense primer 50-30 Antisense primer 50-30 Fragment size (bp)
GAPDH acc cac tcc tcc acc ttt gac tcc acc acc ctg ttg ctg tag 110
Bcl-2 gag gat tgt ggc ctt ctt tg gcc ggt tca ggt act cag tc 116
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Equal amounts of total protein (20–30 lg) were diluted
with SDS–PAGE loading buffer (125 mM Tris/HCl pH 6.8,
2% SDS, 10% glycerine, 0.0005% bromphenol blue,
100 mM DTT) and proteins were separated using SDS
polyacrylamide gel electrophoresis (stacking gel: 3%, sep-
arating gel: 15%). After separation, the proteins were
transferred to nitrocellulose membranes (Schleicher and
Schuell, Dassel, Germany) using a wet blotting system
(Bio-Rad GmbH, Munich, Germany). Subsequently,
unspecific binding sites on the membranes were blocked
with 5% non-fat dried milk powder (AppliChem, Darms-
tadt, Germany) in TBST (100 mM Tris, 150 mM NaCl, pH
7.4). Primary antibody (rabbit anti-PARP, rabbit anti-Bid,
rabbit anti-caspase 3, mouse anti-caspase 8, and rabbit anti-
caspase 9 (Cell Signaling, Frankfurt, Germany)) was diluted
in blocking solution (1:1,000) and the membrane was
incubated with antibody solutions overnight at 4C. HRP-
labelled secondary antibodies (goat anti-rabbit IgG-HRP
(Cell Signaling, Frankfurt, Germany), rabbit anti-mouse
IgG-HRP (Dako, Hamburg, Germany)), were diluted in
blocking solution (1:1,000) and were used to visualise
primary antibodies. After 1 h incubation with secondary
antibodies, membranes were washed twice with TBST and
once with TBS (each 5 min) incubated with ECL Plus
Western Detection reagent (Amersham Biosciences Europe
GmbH, Freiburg, Germany). Hyperfilm
TM
ECL chemilu-
minescence films (Amersham Biosciences Europe GmbH,
Freiburg, Germany) were then placed on the membrane to
visualise bands. To detect the housekeeping-protein the
membranes were stripped to wash off the hybridised anti-
bodies and subsequently incubated in the same manner with
mouse anti-b-actin (1:1,000, Sigma–Aldrich, Steinheim,
Germany) and secondary antibody. Again, Hyperfilm
TM
was
used for detection of chemiluminescence. Exposed and
developed films were then scanned using the Fluor-S
documentation system (Bio-Rad, Munich, Germany).
Optical density units (OdU) were captured and normalised
to the OdU of the b-actin band of the same sample. A fold
change of the resulting values to the respective ethanol
control value was calculated. Experiments were performed
with three independent cell lysates to analyse statistical
variance.
Statistical analysis
Statistical evaluation was performed with the GraphPad
Prism Version 5.0 for Windows (GraphPad Software, San
Diego California, USA, www.graphpad.com). Means and
SD of 3 independent repeats were calculated and after-
wards statistical analysis was performed. The statistical
analyses used depended on the respective experimental
design and are specified in the legends of the figures.
Results
Induction of apoptosis in LT97 cells by DHA
Apoptosis was measured following cell treatment by flow
cytometric measurement of stained DNA (7-AAD) together
with the presence of flipped phosphatidylserine at the outer
membrane layer (Annexin-V). Cells can be distinguished
from each other in terms of being viable, dead, early
apoptotic or late apoptotic/necrotic, respectively. Figure 1
shows that induction of apoptosis as measured by increase
in early apoptosis was more pronounced in LT97 compared
to HT29 cells. In LT97 cells 50 lM DHA and EPA
increased the percentage of early apoptotic cells whereas
higher concentrations of DHA (100 lM) resulted in sub-
stantial increases in late apoptosis/necrosis after 24 h
treatment. In HT29 cells apoptosis induction was low
except at the highest concentration of DHA (200 lM)
which led to an increase in late apoptosis/necrosis. LA
failed to induce apoptosis in both cell types. After 48 and
72 h effects on early apoptosis were less pronounced
whereas late apoptosis/necrosis remained at the same level
(data not shown).
The mRNA expression of Bcl-2 markedly decreased in
EPA- and DHA-treated LT97 cells (100 lM, 10 h) with
DHA having a stronger effect than EPA; LA had no effect
(Fig. 2). After 24 h Bcl-2 was non-significantly reduced. In
HT29 cells no effect was detectable after either 10 or 24 h.
To verify the pro-apoptotic capacity of DHA and EPA a
subset of caspase were measured by Western Blot. Pro-
caspase 8, the inactive zymogen which will then be cleaved
into the active caspase 8, which is a major initiator caspase
of extrinsic apoptosis, was significantly decreased by
incubation with 100 lM DHA in LT97 cells (Fig. 3). EPA
was less active as were the effects in HT29 cells. Again,
LA failed to induce apoptosis. Decline of procaspase 9, the
inactive form of the initiator caspase of the intrinsic
apoptosis-pathway, was not measureable in any cell line or
treatment (Fig. 3). However, decline in the uncleaved form
of Bid was detected after treatment with fish-specific fatty
acids in both cell types (Fig. 4) and, this loss was partic-
ularly apparent for DHA treatment in LT97 cells (50 and
100 lM, P \ 0.05). As before, the effects were less pro-
nounced in HT29 cells. There was a significant reduction in
procaspase 3 in LT97 in response to treatment with the
highest concentration of DHA (100 lM, P \ 0.05) but no
such clear effect was seen in HT29 cells (Fig. 4).
Confirmation that apoptosis had occurred was also car-
ried out by measuring PARP cleavage. When PARP is
cleaved by the terminal caspase 3, cell death is induced.
Figure 5 shows that 100 lM n-3 PUFAs EPA (non-sig-
nificantly) and DHA (P \ 0.01) were able to reduce unc-
leaved PARP in LT97 cells. While the more tumour-like
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HT29 cells only showed induction of apoptosis by DHA at
a concentration of 200 lM (P \ 0.001). LA had no effect
on PARP cleavage.
An additional experiment using caspase inhibitors was
included to verify the role of the caspases examined in
DHA-driven apoptosis (Fig. 6). Analogous to the DHA-
caused apoptosis in Fig. 1, LT97 cells were treated with
50 lM DHA for 24 h. The detected level of early apoptosis
by flow cytometry was found to decrease when co-incu-
bating the cells with caspase 3-inhibitor and the caspase
family-inhibitor. This is in agreement with Fig. 3 which
reveals the role of caspase 3 in DHA-driven apoptosis. The
addition of inhibitors for caspase 8 and caspase 9 resulted
only in a marginal inhibition of apoptosis.
No induction of apoptosis by FW following
lean or fatty fish consumption
FW was tested for apoptosis-inducing potential in LT97
cells. Cells were treated for 24 h with 3.5% FW and
afterwards apoptosis was measured by staining cells with
Annexin-V/7-AAD and detection of resulting dye
Fig. 1 Fold change of early
apoptotic (above panel) and late
apoptotic/necrotic (below panel)
LT97 and HT29 cells treated
with indicated concentrations of
EPA, DHA and LA for 24 h.
Relative counts of Annexin-V
positive and Annexin V ?
7-AAD positive cells were
measured using flow cytometry.
Data are given as means ? SD
(n = 3). Asterisks indicate
significant changes relative to
the ethanol control (dashed
line), * P \ 0.05, ** P \ 0.01
(One Way ANOVA with
Dunnett’s post test)
Fig. 2 Bcl-2 mRNA expression
in 100 lM EPA, DHA or LA
treated LT97 cells (left panel)
and HT29 cells (right panel)
after 10 h and 24 h measured by
Real-Time RT–PCR. Data are
shown as means ? SD (n = 3)
of the fold changes (ratio
treatment/EtOH). Asterisks
indicate significant changes to
the ethanol control (dashed
line), * P \ 0.05,
*** P \ 0.001, and the square
the difference to LA # P \ 0.05




fluorescence using a flow cytometer. The mean (SD)
detected level of early apoptotic cells before intervention
was 31.9 (14.4)%. As the participants’ health status did
not influence the changes in apoptosis (data not shown)
Fig. 7 only shows detected changes in apoptosis (after
intervention minus before intervention) for the three
different intervention groups (salmon, cod and dietary
advice). However, there was no detectable modulation
of apoptosis-inducing potential of FW after fish-
consumption.
Fig. 3 Apoptosis measured by
procaspase 3, 8 and 9 decline
after 24 h treatment of LT97
cells (left panel) and HT29 cells
(right panel) with indicated
fatty acid concentrations (50,
100 or 200 lM). Bar charts
represent mean ? SD (n = 3)
of the relative expression
normalised to b-actin. Asterisks
indicate significant changes to
the ethanol control (EtOH),
* p \ 0.05 (One Way ANOVA
with Dunnett’s post test).
Western Blot pictures represent
an example experiment of the
triplicates
Fig. 4 Apoptosis measured by Bid cleavage after 24 h treatment of
LT97 cells (left panel) and HT29 cells (right panel) with indicated
fatty acid concentrations (50, 100 or 200 lM). Bar charts represent
mean ? SD (n = 3) of the relative expression normalised to b-actin.
Asterisks indicate significant changes to the ethanol control (EtOH),
* P \ 0.05 (One Way ANOVA with Dunnett’s post test). Western




It has been reported that elevated n-3 PUFA intake over
2 years results in markedly increased apoptosis measured
using TUNEL assay and immunohistochemical staining of
bax, in the colonic mucosa of humans [6]. In this study we
have focussed on expanding our understanding of how
apoptosis may be mediated and, by comparing two cell
lines, one composed of relatively well differentiated ade-
noma cells (LT97), the other the carcinoma cell line HT29,
investigated at what stage in the colorectal carcinoma
sequence fish oil is likely to be most protective.
It is hypothesised that PUFA incorporation into cell
membranes increases susceptibility towards oxidative
damage, and hence cells undergo apoptosis. Furthermore it
is probable that an alteration of the membrane composition
by n-3 PUFA enrichment might also influence downstream
signalling pathways and so support apoptosis [26–30]. An
increase of n-3 PUFAs in cell membranes has previously
been demonstrated to occur in humans eating a high-fish
diet [31, 32] as well as in rats provided a fish-oil enriched
feed [33] and in vitro by supplementing cell cultures with
PUFAs [34]. Thus, it is already acknowledged that DHA
and EPA in vitro are likely to exert apoptosis-inducing
effects in human colon adenocarcinoma cells such as HT29
and Caco-2 [28, 30, 35–37]. In addition fish-oil causes
apoptosis in rat models [9, 33]. It was shown that DHA
leads to modulation of PI3 kinase and p38 MAPK path-
ways [28, 30] and a down regulation of Bcl2 and increased
caspase 3 activity [35, 37].
Fig. 5 Apoptosis measured by
PARP cleavage after 24 h
treatment of LT97 cells (left
panel) and HT29 cells (right
panel) with indicated fatty acid
concentrations (50, 100 or
200 lM). Bar charts represent
mean ? SD (n = 3) of the
relative expression normalised
to b-actin. Asterisks indicate
significant changes to the
ethanol control (EtOH),
** P \ 0.01. *** P \ 0.001
(One Way ANOVA with
Dunnett’s post test). Western
Blot pictures represent an
example experiment of the
triplicates
Fig. 6 The percentage of cells in early apoptotis for both LT97
and HT29 cells treated with 50 lM DHA 24 h in combination with
either caspase 3-inhibitor (C3I), caspase 8-inhibitor (C8I), caspase
9-inhibitor (C9I), or pancaspase-inhibitor (PCI) as indicated. Relative
counts of Annexin-V positive and Annexin V ? 7-AAD positive cells
were measured using flow cytometry. Data are given as means ? SD
(n = 4). Asterisks and P values indicate changes relative to DHA, the
square indicates a significant change to the ethanol ? DMSO control
(dashed line), # or * P \ 0.05 (t test)
Fig. 7 Early apoptotic LT97 cells caused by FW (3.5%) treatment
for 24 h. Annexin-V positive cells were measured using flow
cytometry (relative counts). The data show individual results for the
change in apoptosis (after intervention minus before intervention)
after intervention with salmon (n = 28), cod (n = 35), and dietary
advice (n = 26)
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Increased apoptosis was detected in the present study
using flow cytometry 24 h after treatment (figure 1) in
LT97 colon adenoma cells. More cells were found in early
apoptosis in response to 50 lM DHA and EPA while
higher concentrations (100 lM) caused an enhancement in
late apoptosis/necrosis. Analyses at 48 and 72 h did not
result in such clear effects (data not shown) and the
tumour-like HT29 cells did not show elevated levels of
early apoptosis. Our results (Fig. 5) show that both colon
adenomatous and adenocarcinoma cells catalyse PARP-
cleavage when treated for 24 h with the n-3 PUFA DHA,
so the effects detected by flow cytometry appear to be late
apoptotic events rather than necrosis. Alternatively, since
caspase-dependence has previously shown in PUFA-trea-
ted HT29 cells [33], the detected PARP cleavage in HT29
cells may reflect an earlier caspase dependent signalling by
DHA not detectable in the time frame of this experiment.
In LT97 cells the intrinsic apoptosis pathway was triggered
by DHA treatment. Our observation in LT97 cells that
addition of caspase inhibitors (for all caspases and for
caspase 3) decreased the level of early apoptosis supports
the hypothesis that caspases, particularly the effector cas-
pase 3, are involved in DHA mediated apoptotic cell death.
The flow cytometry data only suggested a trend towards a
possible involvement of caspase 8 and caspase 9.
Procaspase 8 was cleaved (Fig. 3), which is likely to
have resulted in the elevation of the active form of caspase
8 while there was a marked decrease in the level of Bid for
DHA (Fig. 4) and again, the effects on HT29 adenocarci-
noma cells were less clear-cut. In the mitochondria, tBid
oligomerises with itself and induces the oligomerisation of
Bax and Bak which is accompanied by cytochrome c
leakage from the mitochondria. It is hypothesised that
Bcl-2 suppresses tBid insertion to the mitochondrial
membrane which thus results in the preservation of mito-
chondrial integrity [38]. Therefore our data suggests that
DHA [ EPA facilitates cytochrome c release in colon
adenoma cells first, by downregulation of Bcl-2 and sec-
ond, by enhanced proteolytic cleavage of Bid by caspase 8
resulting in tBid production.
We have also shown that DHA is more active than EPA
in inducing apoptosis, especially in LT97 cells. Apart from
the carbon chain length, the main difference between these
two n-3 PUFAs is the higher degree of unsaturation of
DHA. These double bounds can also serve as a substrate
for peroxidation reactions resulting in reactive oxygen
species and a pro-oxidant environment [39] which has been
shown to induce apoptosis [40]. It has also been shown that
increasing the antioxidant potential of cells (e.g. by accu-
mulating ascorbic acid or induction of catalase) can
diminish TRAIL- or Fas-induced apoptosis in cancer cells
[41, 42] and that lipid soluble antioxidants preloaded into
cells block EPA induced apoptosis [33].
Efficient absorption of fatty acids, predominantly in the
jejunum and ileum, allows less than 5% of the ingested
lipids to reach the colon [43], equivalent to about 15 mmol/l
[44]. However this is likely to be rapidly metabolised by the
luminal bacteria and the significant increase of n-3 PUFAs
in colonic mucosa after alimentary supplementation is
assumed to be absorbed from the blood where concentra-
tions may reach as high as 400 lmol/l following supple-
mentation [45–47]. We have therefore taken a novel ex vivo
biomarker approach to investigate this possibility. To do
this we have treated the human colon adenoma cell line
LT97 with FW from an intervention study. Human inter-
vention studies measuring apoptosis in vivo are scarce as
collection of biopsies is invasive and time consuming on a
large scale. Thus, we aimed to use a non-invasive biomarker
and, as FW is often used in the context of colon cancer
chemoprevention ex vivo, e.g. in Comet Assay studies
measuring health beneficial effects of different diets by
alteration of DNA-damaging potential [48], we used a
similar approach to investigate apoptosis. However, we
were not able to detect any additional apoptosis-inducing
effects after supplementary consumption of oil-rich or lean
fish (salmon or cod, respectively), so one could argue, that
this biomarker is not an appropriate one. However, in the
same study we also found no effect of fish-supplementation
on apoptosis in colonic biopsies from the same volunteers;
the reasons as to why no effect was found are discussed by
Pot et al. [16]. The validity of this method should be tested
in future in a situation where increased apoptosis in the
mucosa is established, perhaps using symbiotics [49]. We
found no correlation between apoptosis induction after
treatment of LT97 cells ex vivo with FW and apoptosis
detected in biopsies from the same volunteers [16] (Spear-
man correlation coefficient was found to be r = 0.19; data
not shown).
Taken together, our results show pro-apoptotic effects of
DHA on LT97 human colon adenoma cells in vitro. The
less unsaturated fatty acid EPA is less effective and the
more transformed cell line HT29 is less susceptible. Thus,
DHA might be the more effective chemopreventive n-3
PUFA found in fish oil and fish probably with greatest
effect on apoptosis at earlier stages in the adenoma-carci-
noma sequence. However, effects of the n-3 PUFAs and
fish still need to be clarified in humans in vivo.
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Abstract  35 
Observational studies suggest that fish consumption is associated with a decreased colorectal 36 
cancer (CRC) risk. A possible mechanism by which fish could reduce CRC risk is by decreasing 37 
colonic genotoxicity. However, concerns have also been raised over the levels of toxic 38 
compounds found in mainly oil-rich fish, which could increase genotoxicity. Therefore, the 39 
objective was to investigate the effects of fish on genotoxicity markers in the colon in a 40 
randomized controlled parallel intervention study. For a period of six months, subjects were 41 
randomly allocated to receive two extra weekly portions of (i) oil-rich fish (salmon), (ii) lean fish 42 
(cod), or (iii) just dietary advice. The Comet Assay was used to measure the DNA damage-43 
inducing potential of fecal water (n=89) and DNA damage in colonocytes (n=70) collected pre- 44 
and post-intervention as markers of genotoxicity.  45 
Genotoxicity of fecal water was not markedly changed after fish consumption: 1.0% increase in 46 
tail intensity (TI) (95% confidence interval (CI) -5.1; 7.0) in the salmon group and 0.4% increase 47 
in TI (95% CI -5.3; 6.1) in the cod group compared with the dietary advice group. DNA damage 48 
in colonocytes was also not significantly changed after fish consumption, in either the salmon 49 
group, (-0.5%TI, 95% CI -6.9; 6.0), or cod group (-3.3%TI, 95% CI -10.8; 4.3) compared with the 50 
dietary advice group. Measurements of genotoxicity of fecal water and DNA damage in 51 
colonocytes did not correlate (r=0.06, n=34). In conclusion, increasing consumption of either oil-52 




Colorectal cancer (CRC) is one of the most commonly occurring cancers worldwide and has 56 
been associated with dietary habits [1]. CRC develops over many years as a result of 57 
accumulation of DNA damage and mutations, resulting in a loss of control of cell proliferation 58 
and failure of damaged cells to undergo apoptosis [1,2]. DNA damage is thought to be caused 59 
by genotoxic insults and factors in the diet may modulate genotoxicity in the colon. One of the 60 
dietary habits that possibly influences the risk of CRC is consumption of fish. Several 61 
observational studies have shown that high intakes of fish could be related to a decreased risk 62 
of CRC [1,3-7]. This potential benefit on CRC could be mediated by apoptosis and mitosis, 63 
which has been shown in several intervention studies [8-12]. Genotoxicity could be decreased 64 
by the intake of fish by modulation of enzymes involved in detoxification of phase I or II 65 
enzymes like glutathione S-transferase [13], by a decrease in inflammatory processes via 66 
oxidative stress pathways  [14,15], or by decreasing the bacterial conversion of bile acids into 67 
more genotoxic secondary bile acids [16,17].  68 
Whilst the focus has been on the beneficial effects of fish consumption, concerns have been 69 
raised as to whether it could also have unfavorable effects, due to the possible presence of 70 
toxins. Toxic compounds such as dioxins or polychlorinated biphenyls (PCBs), which can 71 
accumulate in the food chain and which are mostly found in oil-rich fish [18,19], could increase 72 
colonic genotoxicity. Although mostly associated with beneficial effects, n-3 polyunsaturated 73 
fatty acids (PUFA), highly abundant in oil-rich fish, could potentially increase genotoxicity as 74 
they are readily oxidized and could enhance lipid peroxidation [20] and oxidative stress [21] 75 
leading to an increase in endogenous DNA damage. Thus, oil-rich fish could have differential 76 
effects on CRC risk compared with lean fish. To the best of our knowledge, no intervention 77 
study has been performed examining the genotoxic effects of consumption of either oil-rich or 78 
lean fish in the colon.  79 
Colorectal genotoxic effects can be measured indirectly by determining the DNA-damage 80 
inducing potential of fecal water in human colon adenocarcinoma cells (e.g. HT29 cells) in vitro, 81 
or directly by measuring DNA damage in colonocytes extracted from colorectal biopsies in vivo. 82 
Fecal water represents the aqueous fraction of the feces and diet has been shown to affect 83 
fecal water genotoxicity [22-25]. Moreover, it has been demonstrated that fecal water can 84 
influence processes related to colorectal carcinogenesis, such as apoptosis [26] and 85 
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proliferation [27]; patients with colorectal polyps differ in fecal water biochemistry compared with 86 
healthy controls [27]. However, it is not clear how genotoxicity of fecal water translates to DNA 87 
damage in the colonic epithelium, and ultimately we are interested in the processes in the colon. 88 
Therefore, we also included measurements of DNA damage in colonocytes. To sum up, the aim 89 
of the current study was to study the effects of fish consumption on markers of genotoxicity in 90 
the colon.  91 
92 
 5 
Subjects and Methods 93 
Subjects and study design 94 
The design of the study was a multi-centre parallel randomized controlled intervention study and 95 
has been described in detail elsewhere (GK Pot et al, in preparation). Three groups of subjects 96 
were recruited: those with (previous) colorectal polyps, those diagnosed with non-active 97 
ulcerative colitis (UC), and those without any macroscopic signs of disease in the colon. After 98 
an initial colonoscopy procedure, 242 eligible subjects were randomly allocated by an 99 
independent person to one of three dietary intervention groups: (i) oil-rich fish group receiving 100 
two 150g portions of farmed salmon per week for six months, (ii) lean fish group receiving two 101 
150g portions of Icelandic cod per week for six months, and (iii) dietary advice (DA) group. All 102 
three intervention groups received dietary advice on achieving a healthy diet [28,29]. The fish 103 
was delivered to the participants in their home and they were instructed to consume it in 104 
addition to their regular fish intake. We provided the participants with fish from the same batch 105 
as much as possible.  106 
The fatty acid content of the fish provided to the participants was measured using established 107 
methods, in the different batches of fish [30]. Salmon provided approximately 3.3g of long chain 108 
n-3 PUFA (eicosapentaenoic acid [EPA] + docosahexaenoic acid [DHA]) per 100g fish and for 109 
cod this was 0.2g/100g fish. Furthermore, we measured 2,3,7,8-tetrachlorodibenzo-p-dioxin 110 
(TCDD) equivalents (TEQ) in the fish provided, in a pooled sample of batches provided to the 111 
participants [31]. Salmon contained 0.45 TCDD equivalents (TEQ)/g fish and cod contained 112 
0.04pg TEQ/g fish. We chose a study duration of six months since this would be sufficient to 113 
incorporate n-3 PUFAs into the colonic epithelium [32]. Compliance was checked by food 114 
diaries and regular phone calls every two to four weeks, and in the salmon group by serum 115 
levels of the long chain n-3 PUFA. 116 
Feces was collected by a subgroup (n=128) of the subjects 1-3 weeks prior to the collection of 117 
colonic biopsy samples; 89 pairs of pre- and post-intervention fecal samples were randomly 118 
selected among those who collected feces and processed for the Comet Assay. Colorectal 119 
biopsy samples were collected at baseline during a colonoscopy procedure and post-120 
intervention during a sigmoidoscopy procedure. The preparation of the colonoscopy procedure 121 
consisted of Macrogol (Kleanprep, Norgine BV, Amsterdam, NL) in NL, or Picolax (Ferring 122 
Pharmaceuticals Limited, Berkshire, UK) in UK; the preparation of sigmoidoscopy procedure 123 
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consisted of an enema in both NL and UK. Distal colon biopsies were obtained from mucosa of 124 
normal-appearance at about 20- 30cm from the anal verge during the colonoscopy or 125 
sigmoidoscopy.  126 
A subset of complete sets of pre- and post-intervention samples collected in the Netherlands 127 
(NL) could be used for the Comet Assay (n=70) based on practical reasons associated with the 128 
need to process colorectal biopsies within 24h. A total of 34 subjects had DNA damage 129 
measured both in fecal water-treated HT29 cells and in colonocytes at baseline.  130 
Fasted blood samples were taken on the day of the colonoscopy or sigmoidoscopy procedure 131 
and serum was stored at -80ºC prior to analysis. Serum cholesteryl fatty acids were measured 132 
as previously described, in all three intervention groups [30].  133 
Life style factors including smoking, weight and height measures were obtained by 134 
questionnaire at the start; overall diet and specifically the frequency of fish consumption was 135 
assessed pre- and post-intervention by questionnaire.  136 
Ethical approval was obtained from the Medical Ethical Committee of Nijmegen University 137 
Medical Centre St. Radboud in NL (reference 2004/111) and King’s Lynn Local Research Ethics 138 
Committee in the United Kingdom (UK) (reference 04/Q0105/8). The trial has been registered at 139 
www.clinicaltrials.gov under identifier NCT00145015. All subjects gave their written informed 140 
consent and a subset of subjects consented separately for collection of fecal samples. 141 
 142 
Preparation of fecal water and treatment of HT29 cells 143 
The DNA-damage inducing potential of fecal water in the colonic HT29 cell line was determined 144 
as previously described [33]. Cells (passage 14-46) were grown to 70-85% confluence as a 145 
monolayer [34] before harvesting. A total fecal sample from one bowel movement was collected 146 
and stored in a cooled container for transport to the laboratory within 4h. At the laboratory, 147 
samples were homogenized, aliquoted and stored at -80ºC until further processing. Samples 148 
were defrosted, homogenised by stirring, mixed with the same amount (w/v) of ice chilled PBS 149 
and centrifuged at 25,000xg for 2h at 4°C as described previously [35]. The pre- and post-150 
intervention samples from individual volunteers were analyzed in parallel. After incubation 151 
(30min at 37°C) of the cells with fecal water (50% concentration) or control treatments (PBS or 152 
75µM H2O2) an aliquot was taken and cell viability was assessed by staining the cells with 153 
Trypan blue and dead and viable cells were counted using a haemacytometer.  154 
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 155 
Preparation of colonic biopsies 156 
Primary colonocytes were isolated from colonic biopsies within 24h of the endoscopy procedure 157 
and  kept in Hank’s balanced salt solution (HBSS) at 4ºC, as described previously [36]. Briefly, 158 
biopsy samples were incubated with 1mg/ml collagenase P and 2mg/ml proteinase K in HBSS, 159 
for approximately 90min at 37ºC. The suspension was centrifuged for 5min at 400xg. The pellet 160 
was re-suspended in fresh HBSS for further processing. Cell numbers and viability were 161 
determined using the Trypan blue exclusion test [35].  162 
 163 
Alkaline Comet Assay 164 
DNA damage was determined by the Comet Assay as previously described [37] and expressed 165 
as % tail intensity (TI), with a higher score indicating more DNA damage. For the Comet Assay 166 
in colonocytes, a single batch of HT29 cells which had been treated with or without a known 167 
genotoxin (75µM H2O2) served as positive and negative control. Colonocytes (2x10
6
) were 168 
mixed with 50μl 0.7% low-melting agarose and distributed onto microscope slides (Trevigen, 169 
Gaithersburg, US). Alternatively, fecal water treated HT29 cells (2x10
6
) were distributed in 90μl 170 
0.7% low-melting agarose on agarose pre-covered microscope slides and after 10min covered 171 
with another layer of agarose. Slides were then immersed into lysis solution (pH 10) for at least 172 
1h. Cells were allowed to unwind in alkaline electrophoresis solution (pH>13) for 20min prior to 173 
start of the 20min electrophoresis (pH>13, 300mA and 20V). The slides were removed from the 174 
alkaline solution and washed three times with neutralization buffer (pH 7.5). Only slides with 175 
colonocytes or controls were treated with 99% ethanol for 10min allowing them to dry prior to 176 
storage and shipment. All slides were stained with SYBR Green (2 μg/ml, Trevigen Inc.) and 177 
microscopical images were quantified using the image analysis system of Perspective 178 
Instruments (Halstead, UK); 50 images were evaluated per slide and the percentage of 179 
fluorescence in the tail, %TI was scored. For fecal water genotoxicity mean values of three 180 
parallel slides were determined with a coefficient of variation (CV) of 23-26%,and for 181 
colonocytes mean values of four replicate slides were determined with a CV of 26-27%. All 182 




Statistical analyses  186 
Changes in outcome variables were evaluated using an analysis of covariance (ANCOVA) 187 
adjusting for baseline values. The data of the baseline and end measurements were not 188 
normally distributed, while the changes in outcome measures were normally distributed. We 189 
compared the changes in outcome measures in the salmon and cod group with the changes in 190 
the DA group and therefore changes are presented as mean change compared to DA (with a 191 
95% confidence interval). We explored if fecal water genotoxicity correlated with measurements 192 
of DNA damage in colonocytes using the Spearman correlation coefficient (n=34) and by cross-193 
classification based on the median value. We also explored whether results were different 194 
between smokers and non-smokers as it has been shown that smoking could affect genotoxicity 195 
[24,38]. We performed analyses using the SAS statistical software program (SAS version 9.1) 196 
and considered a p-value <0.05 as significant. The researchers performing the statistical 197 




Baseline characteristics of subjects whose fecal water was used for the Comet Assay are 201 
shown in Table I. The DA group included more women compared with the salmon and cod 202 
group. The cod group had a lower percentage of current smokers and was less physically 203 
active. Further, subjects in all three intervention groups did not differ in terms of age or BMI. 204 
Subjects in whom DNA damage was determined in colonocytes (n=70, data not shown) were 205 
comparable in terms of age and BMI. The cod group included somewhat fewer females, no 206 
current smokers, and was more physically active. The DA group included fewer polyp patients 207 
compared with the salmon or cod group.  208 
 209 
Baseline values of genotoxicity in fecal water was 9.9 ± 7.5% TI in the salmon group, 7.5 ± 210 
6.2%TI in the cod group, and 13.9 ± 10.4% TI in the DA group. DNA damage in colonocytes 211 
was 17.8 ± 11.1% TI in the salmon group, 17.6 ± 7.0% TI in the cod group, and 15.0 ± 7.5% TI 212 
in the DA group at baseline.   213 
The Spearman correlation coefficient between fecal water genotoxicity and DNA damage in 214 
colonocytes was 0.06 (n=34). The overlap of the cross-classification based on the median 215 
values of genotoxicity of fecal water and DNA damage of colonocytes was 19 out of 34 subjects 216 
(56%). 217 
 218 
At baseline genotoxicity was higher in smokers than in non-smokers: for fecal water genotoxicity 219 
values were 13.6 ± 8.3% TI for smokers (n=15) and 9.3± 8.2% TI for non-smokers (n=74, 220 
p=0.07); for colonocytes these values were 18.0 ± 13.9% TI for smokers (n=14) and 16.6 ± 221 
8.2% TI for non-smokers (n=55, p=0.63). 222 
 223 
Before the start of the intervention, subjects (n=89) consumed on average 1.1 ± 0.8 portions fish 224 
per week. Fish consumption increased by 0.7 ± 0.6 weekly portions in the salmon group, 0.9 ± 225 
0.9 in the cod while the DA group changed their fish consumption with 0.2 ± 0.9 weekly portions 226 
of fish.  227 
Subjects in whom DNA damage was measured in colonocytes (n=70) consumed on average 228 
0.8 ± 0.6 portions fish per week at baseline. Fish consumption increased by 0.8 ± 0.7 weekly 229 
portions in the salmon group and 0.4 ± 0.7 weekly portions in the cod group while the DA group 230 
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changed their fish consumption by 0.0 ± 0.4. Overall, diet was not changed in any of the 231 
intervention groups (results not shown).  232 
Subjects in all three intervention groups had similar levels of serum n-3 VLC-PUFA at baseline, 233 
as is shown in Table II. Serum n-3 VLC-PUFA levels significantly increased in the salmon group 234 
and not in the cod or DA group compared to baseline. This indicated that subjects in the salmon 235 
group generally complied with the salmon intervention.  236 
 237 
Fecal water 238 
At baseline, viabilities of the HT29 cells after 30min incubation with 50% fecal water ranged 239 
from 62 to 100%, post-intervention this ranged from 61 to 100%. 240 
Changes in genotoxicity of fecal water are presented in Figure 1A. We observed changes of 5.8 241 
± 10.6% TI (mean ± SD) in the salmon group, 5.3 ± 10.4% TI in the cod group, and 4.8 ± 11.9% 242 
TI in the DA group. The changes in the salmon and cod group compared with DA were 1.0%TI 243 
(95% CI -5.1; 7.0) and 0.4%TI (95% CI -5.3; 6.1), respectively.  244 
 245 
Colonocytes  246 
At baseline, viabilities of the fresh colonocytes ranged from 70 to 100%, post-intervention this 247 
ranged from 84 to 100% indicating that cells were viable for DNA damage measurement. 248 
Changes in DNA damage measured in colonocytes are presented in Figure 1B. We observed 249 
changes of -0.1 ± 14.3% TI in the salmon group, -2.9 ± 9.8% TI in the cod group, and 0.3 ± 250 
8.4% TI in the DA group. After intervention, levels of DNA damage in colonocytes were not 251 
changed compared with DA in the salmon group, -0.5%TI (95% CI -6.9; 6.0), or in the cod 252 




This intervention study showed that increasing fish consumption for six months neither 256 
positively nor negatively altered the genotoxicity of fecal water or DNA damage in colonocytes 257 
and that results of both measurements did not correlate. To the best of our knowledge, this is 258 
the first intervention study that has examined the effects of increasing fish consumption on 259 
genotoxic effects in the colon, in both fecal water and colonocytes. We included two types of 260 
fish in this trial to study the possible differential effects of oil-rich and lean fish but observed no 261 
marked differences between the two types.  262 
  263 
The Comet Assay, which we used in this trial, is considered to be a rapid, simple, economical, 264 
and sensitive method to measure DNA damage [39-41]. However, the Comet Assay also has 265 
limitations [42]. First, it does not specifically identify the type or site of DNA damage, and 266 
second, based on the variation in responses we observed in this study, it appears that a large 267 
number of subjects would be necessary to detect subtle effects of for example nutritional 268 
interventions. In comparison to previous nutritional intervention studies on DNA damage, 269 
however, the number of subjects in this intervention study was comparable [43] or larger 270 
[24,44]. In general, there are several aspects that contribute to the internal validity of the Comet 271 
Assay [45]. By including positive and negative controls throughout the study, by including a 272 
control group (DA group) to compare our results with, and by scoring the slides and analyzing 273 
the data in a blinded manner, we have optimized our internal validity. 274 
 275 
In most dietary intervention studies, blood lymphocytes have been used to study the effects of 276 
diet on DNA damage. However, DNA damage in lymphocytes does not necessarily represent 277 
DNA damage in all cells, tissues, or organs [42,45,46]. Since we are specifically interested in 278 
colorectal carcinogenesis, we measured the genotoxicity of fecal water and DNA damage in 279 
colonocytes. In previous studies, genotoxicity of fecal water has been considered a suitable 280 
marker for the assessment of the rapid changes in genotoxicity in the gut in response to diet 281 
[27,37,47]. Previous studies demonstrated that several specific dietary modifications could 282 
influence fecal water genotoxicity [23,24,37,48,49], while other studies showed no effect 283 
[24,25,37,44,48]. An advantage of using fecal water genotoxicity in intervention studies is that 284 
this does not require an invasive procedure to obtain biological material, which decreases the 285 
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burden on participants. However, the use of fecal water as a marker of genotoxicity also is 286 
restricted. For example, for patients with active UC, constipation or other bowel complaints it 287 
might not be feasible to collect feces. In our study, we were only able to collect feces from about 288 
half of the subjects; a possible reason for this could be that subjects who did not collect feces 289 
had more bowel complaints compared with those who did collect feces. It may be possible that 290 
more pronounced effects would have been observed in their feces.  291 
More importantly, we would like to know the effect of diet specifically in the colon itself. Only one 292 
previous dietary intervention study has assessed DNA damage in colonocytes, which 293 
demonstrated that levels of colorectal DNA damage were reduced after intervention with a 294 
synbiotic preparation containing both pre- and probiotics for 12 weeks [43]. Thus, measuring 295 
DNA damage in colonocytes is applicable in intervention studies, though due to the invasive 296 
method of obtaining tissue this method is not always preferred or possible. Therefore, we also 297 
explored the correlation between measurements of fecal water genotoxicity and DNA damage in 298 
colonocytes, but found no agreement between these methods. One reason for this could be that 299 
genotoxicity of fecal water and DNA damage in colonocytes do not measure exactly the same 300 
endpoint; the fecal water induced DNA-damage represents the genotoxic burden of excreted 301 
feces, which is mainly modulated by dietary exposure and processes of the gut flora [50], 302 
whereas the DNA damage measured in colonocytes also reflects the effects in the cells which 303 
additionally depends on the expression of biotransformation enzymes or the extent of DNA 304 
repair mechanisms [51]. However, since the number of subjects in whom both outcomes were 305 
measured was low (n=34), this analysis was explorative, and needs to be confirmed in larger 306 
studies. 307 
 308 
A limitation of this study was that subjects were all fish consumers at baseline. Subjects in 309 
whom fecal water genotoxicity was determined consumed 1.1 ± 0.8 portions of fish week before 310 
the start of the intervention. It seems inevitable that in recruiting subjects to an intervention 311 
study with fish, mainly fish consumers will volunteer. Another limitation was that whilst the 312 
subjects were asked to increase their consumption of salmon or cod by two portions per week, 313 
the actual average increase was ranged from 0.7 to 0.9 weekly portions of fish, probably due to 314 
the relatively high habitual fish consumption at baseline. This resulted in smaller differences 315 
 13 
between the fish intervention groups and the DA group than anticipated which could have led to 316 
smaller effects of the intervention.  317 
Another methodological issue was the use of different bowel preparations pre- and post-318 
intervention. Previous studies have shown that bowel preparation can affect cell proliferation 319 
levels in the colon [52], but if this could be expected to affect DNA damage is not known. 320 
However, since results are presented as changes in the fish intervention groups as compared 321 
with changes in the dietary advice group, where the same protocol of bowel preparation was 322 
used, this could not have affected the outcome of the study.  323 
An additional limitation was the coincidental imbalance in numbers of smokers between the 324 
intervention groups. We observed higher levels of DNA damage in current smokers compared 325 
with non-smokers in both fecal water and colonocytes; however, the study lacked power to 326 
further investigate the possible effect modification of smoking in our data. It is known that 327 
smokers may differ in their enzyme expression of detoxifying enzymes [38] and it could be that 328 
smokers respond differently to a possible beneficial diet compared with non-smokers [24]. 329 
Subjects also differed in baseline levels of physical activity, but since we do not expect that this 330 
could have affected our results, we did not further explore this.  331 
A strength of this study was that we included two types of fish, salmon and cod, though we did 332 
not observe differential effects on genotoxicity. It has been hypothesized that the possible 333 
beneficial effects of fish could be outweighed by potential unfavorable effects by toxins, 334 
peroxidation, or oxidative stress [53]. We only measured the levels of dioxin equivalents and 335 
found that the levels of dioxin equivalents in intervention fish were well below the current 336 
maximum tolerable intake of 8 pg TEQ/100g fish [54], and thus the unfavorable effects in this 337 
fish intervention due to toxins were considered to be small. However, more studies are needed 338 
to further investigate the effects of fish consumption on genotoxicity.  339 
In conclusion, increasing consumption of oil-rich and lean fish over six months did not result in 340 
genotoxic effects in the colon.   341 
342 
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Figures and Tables 343 
Table I Baseline characteristics of the FISHGASTRO population for whom fecal water 344 
genotoxicity was determined by the Comet Assay (n=89) 345 




Dietary advice (DA)  
(n=29) 
Characteristic    
Age (year, mean ± SD) 57.8 ± 12.6 57.9 ± 8.5 55.6 ± 10.5 
Sex (% female) 46 47 58 
Smoking (% current) 31 9 15 
BMI  (kg/m
2
, mean ± SD) 25.2 ± 3.7 26.0 ± 4.3 25.9 ± 3.2 
Physical activity (% high) 46 24 31 
Patient group 
(% polyp/ UC / healthy) 
 
50/ 19/ 31 
 
50/ 21/ 29 
 
42/ 15/ 42 
Country (% NL)  58 56 69 




Table II Serum measures of very long chain n-3 PUFA (EPA + DHA) per intervention group of 349 
participants that completed the intervention, presented as mean ± SD mass% of total fatty acids 350 
in cholesteryl esters 1 351 
Intervention group: Salmon Cod Dietary advice (DA) 
Serum very long chain n-3 PUFA n=26 n=34  n=29 
Baseline 3.00 ± 1.18 3.02 ± 1.29 2.63 ± 1.20 
End 4.07 ± 1.39 2.80 ± 1.12 2.74 ± 1.27 
Change 1.06 ± 1.45 -0.23 ± 0.88 0.03 ± 0.82 
Difference in change compared 
with DA (mean, 95% confidence 
interval) 




 missing values due to technical reasons,  in salmon group n=2, in cod group n=1, and in DA n=2  352 





A. Changes in DNA-damage
inducing potential of fecal water


































B. Changes in DNA damage
in colonocytes



































Figure 1 Results of changes in DNA-damage inducing potential of fecal water (Figure 1A, n=89) 359 
and DNA damage of colonocytes (Figure 1B, n=70). The horizontal lines indicate the mean 360 
values per intervention group. 361 
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4. ADDITIONAL RESULTS 
4.1 Modulation of LT97 global gene expression by faecal water 
We hypothesised, that ex vivo faecal water-treated human colon cells are able to 
reflect nutritional changes of the faeces donors. More specifically, we speculated 
that these gene expression patterns could show effects of fish consumption/ n-3 
PUFAs by an additional consumption of oil-rich fish (salmon) compared to a lean 
fish (cod) in healthy volunteers (n=18) and colon polyp patients (n=21). Thus, 




Human colon adenoma LT97 cells were treated with 3.5% faecal water from a 
subset of the FISHGASTRO study participants. Faecal water was isolated from 
faeces collected at the beginning of the study and after a six month intervention 
with either salmon or cod (two 150g portions per week). After 24 hours 
incubation RNA was isolated from all faecal water-treated LT97 cells using a 
Qiagen RNeasy Mini Plus kit (Qiagen, Hilden, Germany). The RNA yield was 
quantified with a Nanodrop ND 1000 spectrophotometer (Nanodrop 
Technologies/Peqlab, Erlangen, Germany), and RNA integrity was measured with 
an Agilent 2100 Bioanalyzer with RNA 6000 Nano chips (Agilent Technologies, 
Böblingen, Germany).  
Microarray analyses were performed on before intervention and after fish 
intervention samples of 20 volunteers receiving cod and 19 volunteers receiving 
salmon. Total RNA from LT97 cells treated with these 78 samples was labeled 
using a one-cycle cDNA labeling kit (MessageAmp II-Biotin Enhanced Kit; 
Ambion Inc, Nieuwekerk a/d Ijssel, Netherlands) and hybridised to human whole-
genome NuGO GeneChip® arrays encoding 16,554 genes, designed by the 
European Nutrigenomics Organisation and manufactured by Affymetrix 
(Affymetrix Inc, Santa Clara, USA). Sample labelling, hybridisation to chips, and 
image scanning were performed according to the manufacturer’s GeneChip® 
Expression Analysis Technical Manual (Affymetrix). 
Microarrays were analysed using the reorganised oligonucleotide probes as 
described by Dai [Dai et al. 2005]. Expression values were calculated using the 
Robust Multichip Average method and background adjustment by justifying 
unspecific hybridisation (http://www.bioconductor.org). The Robust Multichip 
Average signal value estimates are based on a robust average of background-
corrected perfect match intensities, and normalisation was performed by using 
quantile normalisation [Bolstad et al. 2003]. Only genes with normalised signals 
Additional results 
92 
present on ≥20 arrays were defined as “expressed” and selected for further 
analysis. Genes were defined as “changed” when comparison of the normalised 
signal intensities showed a false discovery rate q value [Storey & Tibshirani 
2003] <0.25 in a two-tailed paired t test with Bayesian correction (Limma) 
[Smyth 2004].  
Pathway analysis was performed using Gene Ontology Analysis 2.1.17 
(http://www.bioinformatics.ubc.ca/ermineJ/) [Lee et al. 2005], Gene Set 
Enrichment Analysis 2.0.4 (http://www.broad.mit.edu/gsea/) [Subramanian et al. 
2005], and Ingenuity Pathway Analysis 7.5 (www.ingenuity.com). Pathways were 
defined as significantly changed with a p value <0.05. 
From the 16,554 genes present on the microarray, 11,846 were defined as 
expressed in faecal water-treated LT97 cells. A six month consumption of cod 
and salmon resulted in differential expression of 88 and 159 genes, respectively, 
with a fold change of >1.1 (Appendix: Table 5, page 120 and Table 6, page 122). 
Of these genes, only four were overlapping in both groups, which results in 155 
uniquely expressed genes in the salmon group (Figure 8). 
 
 
Figure 8. Venn diagram representing number of differentially expressed genes with a fold change 
>1.1 (p<0.05) after intervention with cod (20 volunteers) and salmon (19 volunteers). 
To determine the role of the genes which were found as differentially expressed, 
we performed pathway analysis. Cod consumption resulted in higher number of 
upregulated gene sets compared to salmon intervention, only one gene set was 
found to be downregulated by salmon intervention but this was also 
downregulated by cod (Figure 9).  
 
Figure 9. Venn diagram representing number of differentially upregulated (“up”) and 
downregulated (“down”) genes sets (false discovery rate <0.25) after intervention with salmon (19 
volunteers) and cod (20 volunteers). 
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The affected pathways determined by Gene Set Enrichment Analysis are 
presented in Table 4. Intervention with salmon affected e.g. pathways involved in 
glycolysis, fatty acid metabolism and bile acid metabolism. Intervention with cod 
had an effect on signalling pathways (NF-E2-related factor 2 (Nrf2)-regulated 
genes, Wnt signalling, EGF signalling, MAPK cascade etc.) and xenobiotic 
metabolising enzymes (as glutathione). 
Table 4. Differentially expressed pathways (gene set enrichment analysis) after intervention with 
salmon (n=19, left hand side) or cod (n=20, right hand side). 
salmon up-regulated NES p value FDR cod up-regulated NES p value FDR 
INTEGRIN SIGNALING PATHWAY 2,0668 0,0020 0,0279 NRF2-REGULATED GENES COMBINED 2,2097 0,0000 0,0061
ERK AND PI-3 KINASE (COLLAGEN BINDING) 1,9177 0,0000 0,1169 GLUTATHIONE METABOLISM 2,0585 0,0000 0,0148
GLYCEROLIPID METABOLISM 1,8528 0,0000 0,1584 HS ADIPOGENESIS 1,9770 0,0000 0,0342
ARGININE AND PROLINE METABOLISM 1,6940 0,0021 0,1839 CHOLESTEROL SYNTHESIS/ESTERIFICATION 1,8728 0,0036 0,0672
HS CALCIUM REGULATION IN CARDIAC CELLS 1,6720 0,0000 0,1839 HS IL-1 NETPATH 13 1,8041 0,0000 0,0753
HS ALPHA6-BETA4-INTEGRIN NETPATH 1 1,6726 0,0022 0,1981 METABOLISM OF XENOBIOTICS BY CYTOCHROME P450 1,8773 0,0000 0,0800
LIPOGENESIS 1,6947 0,0077 0,2016 HS EGFR1 NETPATH 4 1,8086 0,0000 0,0808
HS FATTY ACID BETA OXIDATION 1 BIGCAT 1,7535 0,0101 0,2091 TOLL-LIKE RECEPTOR PATHWAY 1,8114 0,0000 0,0894
BILE ACID BIOSYNTHESIS 1,7006 0,0021 0,2143 HS IL-4 NETPATH 16 1,8230 0,0000 0,0924
ROLE OF MAL IN RHO-MEDIATED ACTIVATION OF SRF 1,7122 0,0060 0,2196 REGULATION OF ACTIN CYTOSKELETON 1,7130 0,0017 0,1369
INSULIN SIGNALING PATHWAY KEGG 1,6378 0,0038 0,2211 PYRUVATE METABOLISM 1,7264 0,0055 0,1450
HS FATTY ACID BETA OXIDATION 1,7236 0,0064 0,2301 TGF BETA SIGNALING PATHWAY BIOC 1,7166 0,0112 0,1456
HS GLYCOLYSIS AND GLUCONEOGENESIS 1,7834 0,0000 0,2399 MAPK SIGNALING PATHWAY 1,6771 0,0000 0,1744
RHO CELL MOTILITY SIGNALING PATHWAY 1,7554 0,0077 0,2466 ST ERK1 ERK2 MAPK PATHWAY 1,6522 0,0127 0,2011
ST GAQ PATHWAY 1,5507 0,0460 0,2069
NF-KB SIGNALING PATHWAY 1,5548 0,0406 0,2082
WNT SIGNALING PATHWAY BIOC 1,5657 0,0273 0,2127
CITRATE CYCLE (TCA CYCLE) 1,5605 0,0294 0,2134
HS MAPK CASCADE 1,5381 0,0187 0,2148
HS MONOAMINE GPCRS 1,5548 0,0349 0,2153
HS INTEGRIN-MEDIATED CELL ADHESION KEGG 1,5856 0,0034 0,2155
STEROL TRANSPORT/TRAFICKING 1,5333 0,0218 0,2156
HS INFLAMMATORY RESPONSE PATHWAY 1,6038 0,0237 0,2160
SIG CHEMOTAXIS 1,5672 0,0271 0,2187
ST INTEGRIN SIGNALING PATHWAY 1,5275 0,0136 0,2188
TNF STRESS RELATED SIGNALING 1,5387 0,0331 0,2202
LIPOGENESIS 1,5713 0,0199 0,2215
PORPHYRIN AND CHLOROPHYLL METABOLISM 1,6071 0,0231 0,2218
HS FOCAL ADHESION KEGG 1,5876 0,0000 0,2221
MTOR SIGNALING PATHWAY KEGG 1,5753 0,0135 0,2231
AXON GUIDANCE 1,5166 0,0082 0,2235
ST INTERLEUKIN 4 PATHWAY 1,5204 0,0461 0,2237
HS INSULIN SIGNALING 1,5905 0,0016 0,2272
FMLP INDUCED CHEMOKINE GENE EXPRESSION IN HMC-1 CELLS 1,5003 0,0319 0,2334
GALACTOSE METABOLISM 1,6071 0,0110 0,2339
HS ALPHA6-BETA4-INTEGRIN NETPATH 1 1,5031 0,0236 0,2339
PENTOSE PHOSPHATE PATHWAY 1,5054 0,0444 0,2358
FOCAL ADHESION 1,6202 0,0000 0,2361
HS STATIN PATHWAY PHARMGKB 1,4754 0,0538 0,2370
ALK IN CARDIAC MYOCYTES 1,4785 0,0512 0,2371
HYPOXIA AND P53 IN THE CARDIOVASCULAR SYSTEM 1,4806 0,0464 0,2388
NFKB ACTIVATION BY NONTYPEABLE HEMOPHILUS INFLUENZAE 1,4837 0,0618 0,2392
FRUCTOSE AND MANNOSE METABOLISM 1,4869 0,0239 0,2393
PDGF SIGNALING PATHWAY 1,4930 0,0504 0,2394
ST GRANULE CELL SURVIVAL PATHWAY 1,6099 0,0248 0,2417
ST P38 MAPK PATHWAY 1,4881 0,0374 0,2424
EGF SIGNALING PATHWAY 1,6217 0,0204 0,2477
salmon down-regulated NES p value FDR cod down-regulated NES p value FDR 
HS DNA REPLICATION REACTOME -2,0449 0,0000 0,0130 CELL CYCLE -1,9536 0,0000 0,0338
ROLE OF BRCA1, BRCA2 AND ATR IN CANCER SUSCEPTIBILITY -1,8307 0,0022 0,0681
HS DNA REPLICATION REACTOME -1,7456 0,0000 0,0970
MATURITY ONSET DIABETES OF THE YOUNG -1,6322 0,0169 0,1477  
NES normalised enrichment score, p value normalised p value of the NES, FDR false discovery 
rate; the estimated probability that the NES represents a false positive finding 
 
Yet, it is not clear whether faecal water can serve as an appropriate ex vivo 
biomarker reflecting the colonic gene expression pattern. Consequently it is of 
major importance to compare the response of LT97 on faecal water treatment 
with the gene expression modulation measured in human biopsy samples of the 
same volunteers (experiments conducted by E.K. Lund, IFR/UK). This 




Cancer chemoprevention has attracted much attention as one of the most 
practical and realistic strategies in reducing the global burden of cancer. It has 
been estimated, that 70% of colon cancer could be avoided by changes in 
lifestyle. Lifetime non-smoking, physical activity, moderate red-meat 
consumption, moderate alcohol consumption, a body mass index of < 25, and 
folic acid supplementation are believed to be of benefit [Willett 2002].  
This study focused on colon cancer chemoprevention with a biomarker approach 
regarding both, in vitro effects of n-3 PUFA which are abundant in oil-rich fish, 
and ex vivo assessments of samples obtained during a randomised human 
controlled trial [Pot et al. 2009] intervening with lean (cod) and oil-rich (salmon) 
fish. 
5.1 Chemopreventive mechanisms of n-3 PUFAs in vitro 
The first epidemiological evidence on the beneficial effects of dietary fish arose 
in the 1960/70’s when incidences of cardiovascular diseases in Greenland Inuit 
were found to be lower compared to those in Europe [Bang et al. 1971]. Also 
other diseases connected with a Western lifestyle had been found to be lower in 
these populations. During the second half of the 20
th
 century this picture 
changed and led to a rise in “lifestyle” diseases and now colon cancer is the 
leading cause of malignancy in the Inuit population. The most likely reason for 
this is the noticeable nutritional change from a diet based on fish and sea 
mammals towards a diet more dependent on imported food [Friborg & Melbye 
2008].  
The outcomes of epidemiological studies on fish consumption and colorectal 
cancer risk appear to some extent contradictory. But when comparing the 
studies on the background of the n-3 PUFA intake, the situation gains clarity. Of 
advantage are large-scale studies which address the role of n-3 PUFA on 
colorectal carcinogenesis in populations with a high range of fish consumption 
and thus a high range of n-3 PUFA intake. Examples are the Fukuoko Colon 
Cancer Study in Japan [Kimura et al. 2007], the European Prospective 
Investigation into Cancer and Nutrition [Norat et al. 2005] and the Physician’s 
Health Study in the U.S. [Hall et al. 2008] which all find an inverse association of 
n-3 PUFA/fish intake and colon cancer risk. Also Geelen at al. quoted that the 
relative protective effect was stronger when differences between highest and 
lowest fish intake were more pronounced [Geelen et al. 2007]. Most studies with 
fewer participants and investigating smaller differences failed to find an 
association [Lüchtenborg et al. 2005; Tiemersma et al. 2002]. 
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A significant increase of EPA and DHA in the colonic mucosa is found in 
volunteers taking fish oil capsules providing 1.4+1.0g/d EPA+DHA [Gee et al. 
1999] or 3.2+2.2g/d EPA+DHA [Hillier et al. 1991] for up to 12 weeks. For 
human colonocytes it is likely, that exposure with n-3 PUFA is accomplished 
above all via the lymphatic system (see chapter 5.2.2, page 108). EPA levels in 
blood respond rapidly (within a week) to dietary changes, whereas DHA changes 
are much slower [Metherel et al. 2009]. Physiological DHA concentrations in 
plasma following a fish-based diet are found to be 168±8 µM, thus they are 
higher than EPA concentrations (64±5 µM) [Pawlosky et al. 2003]. The 
concentrations used for the in vitro experiments of this study were covering this 
range. 
5.1.1 n-3 PUFA impair cell number by affecting cell growth and 
apoptosis 
The first study (publication I) demonstrated that PUFAs are incorporated into 
colon epithelial cells in vitro. Of importance, no different effects were elucidated 
for the tested fatty acids; all fatty acids (EPA and DHA as well as ALA, GLA, LA 
and ARA) were taken up by the cells in a comparable manner. This finding is not 
surprising because PUFA incorporation into erythrocyte membranes is an 
accepted biomarker to reflect rapid changes of the dietary fatty acid profile 
[Baylin & Campos 2006]. However, it appeared that LT97 cells more readily 
consumed fatty acids compared to HT29 cells.  
If PUFAs reach the cell, it is likely that they exert cellular responses after their 
incorporation. In contrast to the n-6 PUFA LA, both fish n-3 PUFAs were potent 
inhibitors of colon adenocarcinoma cell growth by affecting cell number 
(publication I). Half maximal effective concentration (EC50) values reached 
after DHA treatment (HT29 72h: 124±10µM, LT97 72h: 128±117µM) reflect 
levels which can be found in humans under physiological conditions in plasma 
following a diet based on fish [Pawlosky et al. 2003]. In HT29 cells, DHA was a 
more potent inhibitor of cell growth. This effect was also seen in other studies 
treating carcinoma cells [Chamras et al. 2002; Schley et al. 2005; van Beelen et 
al. 2006]. 
EPA and DHA are already known to have growth inhibitory or anti-proliferative 
potential in vitro and in vivo. In cell-culture models similar effects were 
described e.g. in human cell lines of the breast [Chamras et al. 2002; Noguchi et 
al. 1995; Schley et al. 2005; Senzaki et al. 1998], the pancreas [Shirota et al. 
2005], the prostate [Pandalai et al. 1996], lymphocytes [Verlengia et al. 2004b; 
Verlengia et al. 2004a], and the colon [Clarke et al. 1999; Tsai et al. 1998; van 
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Beelen et al. 2006]. EPA and DHA also reduced cell growth of tumours obtained 
by inoculating HT29 cells in nude mice [Calviello et al. 2004] or by implanting 
Walker 256 tumours in Wistar rats [Colquhoun et al. 2001]. Other rodent animal 
models revealed reduced tumour growth after fish oil-feed in chemically induced 
colon cancer models, e.g. following azoxymethane [Dommels et al. 2003] or 1,2-
dimethylhydrazine [Latham et al. 1999] treatments in rats. 
Additionally, in our study it was shown, that cell growth inhibition was more 
readily achieved in the adenomatous cell line LT97 compared to the 
adenocarcinoma cell line HT29 (significant for EPA and ARA). Most often in 
literature the consensus is quoted, that carcinoma cells are more sensitive to 
growth inhibitory/anti-proliferative effects of PUFAs than normal cells 
[Grammatikos et al. 1994; Tsai et al. 1998]. But in vitro comparisons between 
human cancer cells and human non-cancer cells of the same tissue are rare, due 
to the unavailability of a “normal” cell line from for example the colon. To the 
best of my knowledge, there is no comparison of human normal and carcinoma 
cells from the same organ. For such comparisons mostly fibroblasts [Tsai et al. 
1998] or non-human cells [Griffiths et al. 1997] were used to represent the 
behaviour of normal cells. Hence, tissue and species specific effects must be 
taken into consideration when interpreting these results. As no normal cell line 
exists some researchers take the approach to compare cancer cell lines with non-
cancerous cell lines of the same tissue, but the results from these were rather 
inconsistent. Some found non-cancer cell lines to be more susceptible to PUFAs 
(e.g. non-neoplastic canine prostate epithelial (CAPE) cells vs. adenocarcinoma 
canine prostatic (CPA) cells [Griffiths et al. 1997]), while others found the cancer 
cell more sensitive (e.g. epithelial breast cancer (MCF-7) vs. non-cancerous 
mammary epithelial (MCF-10A) cell line [Grammatikos et al. 1994]). For colon 
cancer, normal colon mucosa cells (NCM460) were not affected whereas the 
growth of colon adenocarcinoma epithelial cells (CaCo2) was reduced [Toit-Kohn 
et al. 2009]. Our results showed, what appears to be the opposite in that 
adenomatous cells were generally more susceptible. Other factors should be kept 
in mind when evaluating the response of diverse cells in vitro to PUFAs. Not only 
the growth rate is important (doubling time ~24 hours and ~72 hours, for HT29 
and LT97 cells, respectively), but the density of the cells at the beginning of 
treatment (LT97 cells grow as a multilayer, thus, even at the same confluency, a 
larger number of cells are incubated), but also final density, confluency, and cell 
number. Additionally, different media (DMEM or MCDB) substituted with 
different foetal calf serum concentrations (ten or two per cent) are used for 
HT29 and LT97, respectively. All this means that HT29 are difficult to compare 
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with LT97 cells as they show a different growth pattern. Altogether, the above 
mentioned cell culture criteria bias all data published so far. Ideal cell models do 
not exist and hence PUFA-independent parameters may also alter the effects of 
the treatment.  
It is possible, that a different enzyme system in malignant and non-malignant 
cells led to a different pattern of PUFA utilisation. In addition, intracellular lipid 
peroxidation may differ between colon tumour and colon non-tumour cells [Das 
1999]. For a characterisation of both in vitro cell lines used, an estimation of 
these markers would be useful for future studies. 
A mechanism to control the number of cells and to counteract an excessive cell 
number is by facilitation of apoptosis (publication IV). The effect of EPA and 
DHA on triggering apoptosis in cancer cells has been described in a range of in 
vitro models such as the breast [Chamras et al. 2002; Sun et al. 2008] and the 
colon [Hofmanova et al. 2005; Narayanan et al. 2001], but still the nature of any 
underlying mechanism in the colon remains speculative. 
Previously, it has been found that n-3 PUFAs exert only marginally apoptotic 
effects on HT29 cells. DHA was seen to have no effect on PARP cleavage and 
caspase 3 or 8 expression [Hofmanova et al. 2005; Vaculova et al. 2005]. This is 
in concordance with the findings of this study since LT97 cells were found to be 
much more susceptible to n-3 PUFA-induced apoptosis than HT29 cells in terms 
of the effective concentration needed. Furthermore, the involvement of caspase 
8, indicating the contribution of death receptor activation, and bid-cleavage as 
well as Bcl-2 decrease, indicating mitochondria-mediated apoptosis has been 
proven for the first time in LT97 cells. The link between caspase 8 and the 
mitochondrion is provided by tBid which is formed from Bid. In the mitochondria, 
tBid oligomerises with itself and induces oligomerisation of Bak and Bax wich is 
accompanied by cytochrome c leakage from the mitochondria. It is hypothesised 
that Bcl-2 suppresses tBid insertion to the mitochondrial membrane which thus 
results in the preservation of mitochondrial integrity [Yi et al. 2003]. This work 
provides support that n-3 PUFAs facilitate cytochrome c release first, by 
downregulation of Bcl-2 and second, by enhanced proteolytic cleavage of Bid by 
caspase 8 resulting in tBid. All the described effects were particularly apparent 
after treatment with DHA in LT97 cells. Downstream effects such as caspase 3 
release and PARP cleavage were also detected in HT29 cells but using higher 
concentrations compared to concentrations needed to affect LT97 cells (200 vs. 
100µM). 
One finding of our study is that DHA is more active compared to EPA in inducing 
apoptosis especially considering LT97 cells. Ignoring the carbon chain length, 
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the main difference between both n-3 PUFAs is the higher degree of 
unsaturation of DHA. These double bonds can also serve as substrate for 
peroxidation reactions hence resulting in reactive oxygen species [Vaculova et al. 
2005]. It has previously been shown that reactive oxygen species lead into 
apoptosis [Simon et al. 2000]. Fish oil-supplementation results in higher 
oxidative burst of peripheral mononuclear cells of healthy young men [Bartelt et 
al. 2008] and this increase in oxidative burst, especially by DHA in LT97 cells, 
might have led to apoptosis-favouring conditions. It was also revealed that an 
increasing antioxidative potential of cells (e.g. by accumulating ascorbic acid or 
induction of catalase) might diminish TRAIL- or Fas-induced apoptosis in cancer 
cells [Perez-Cruz et al. 2003; Perez-Cruz et al. 2007]. Such findings support the 
evidence of animal models showing that the chemopreventive effects of n-3 
PUFAs involved increased oxidative stress [Latham et al. 2001]. 
Concluding remarks: 
Following EPA and DHA incorporation both fatty acids affect cellular 
mechanisms commonly attributed to secondary chemoprevention. Initiated cells, 
in this in vitro work modelled by LT97 cells, may be reduced as a result of on the 
one hand inhibition of cell growth (publication I) and on the other hand by 
induction of apoptosis (publication IV). Assessed effects were less strong in 
HT29 cells which represent highly altered cells. 
5.1.2 Gene expression alteration by n-3 PUFAs 
Since n-3 PUFA are known to alter gene expression, they are candidate nutrients 
to study the gene expression of possible target genes. The regulation of gene 
transcription by fatty acids seems to be due to changes in the activity or 
abundance of transcription factor families as e.g. peroxisome proliferator-
activated receptor (PPAR), liver x receptor (LXR), hepatic nuclear factor 4α 
(HNF-4α), and sterol regulatory element binding protein (SREBP) [Jump 2002]. 
These transcription factors play a major role in hepatic carbohydrate, fatty acid, 
triglyceride, cholesterol, and bile acid metabolism (Figure 10).  
In the liver, the principal action of n-3 PUFAs involve a shift from lipid synthesis 
and storage to lipid oxidation [Jump 2002; Wang et al. 2009]. These effects are 
primarily described for hepatic metabolism and may contribute to the regulation 
of whole body lipid metabolism and the control of blood triglycerides and 





Figure 10. Regulation of transcription factors by non-esterified fatty acids and fatty acid acyl 
coenzyme A thioesters (modified according to Jump [Jump 2002]). Free fatty acids and fatty acid 
acyl coenzyme A thioesters serve as potential regulators of nuclear receptors. It is not clear 
whether free fatty acids or fatty acid acyl coenzyme A thioesters control the turnover of SREBP 
mRNA.  
PPAR peroxisome proliferator-activated receptor, LXR liver x receptor, HNF-4α hepatic nuclear factor 4α, 
SREBP sterol regulatory element binding protein, + positive association, - negative association, mechanisms in 
brackets are proposed ones. 
To examine direct whole-genome transcriptional changes by n-3 PUFA, 
microarrays are highly valuable as they allow the simultaneous analysis of 
thousands of genes. Previous studies showed that n-3 PUFAs are effective 
modulators of gene expression in vitro. These include whole-genome array 
analysis of DHA and EPA treated breast cancer cells [Hammamieh et al. 2007], 
and DHA incubated hepatic [Wang et al. 2009], and prostate cancer cell lines 
[Shaikh et al. 2008]. The first study examining the influence of DHA on human 
colon adenocarcinoma cells (CaCo2, 15µM DHA, 48h) using cDNA microarrays 
showed an inhibition of cell proliferation, induction of apoptosis, regulation of 
cell cycle, and alteration of COX-2 target genes [Narayanan et al. 2001]. In 
humans, the supplementation of 0.4 or 1.8g EPA+DHA per day (26 weeks) 
resulted in a shift of the gene expression profile of peripheral blood mononuclear 
cells to a more anti-inflammatory and anti-atherogenic status [Bouwens et al. 
2009]. 
For this study, a custom-designed dual colour cDNA array on a glass slide 
(PIQOR
TM
, Miltenyi Biotec) targeting 306 genes was performed. Noteworthy, 
publication II is the first to date which examined the gene expression alteration 
in an adenomatous type of colon cells in vitro by EPA and DHA. It was shown 
that EPA and DHA affect gene expression in partially different ways 
(publications II and III). Affected genes include those relating to 
biotransformation (EPA: GSTT2 upregulation), inflammation (DHA 10 hours: 
COX-2 downregulation), apoptosis (EPA and DHA 10 hours: caspase 8 
downregulation), and signalling pathways (EPA and DHA 10 hours: Wnt3 
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downregulation). Furthermore, effects after 10 and 24 hours were found to be 
partially different.  
In nature EPA and DHA mostly appear concomitantly. Therefore, future studies 
on expression patterns after simultaneous treatment would be of interest to 
elucidate probable additive, synergistic, or inhibitory effects. 
Concluding remarks: 
There are two main conclusions from these results. Firstly, for in vitro analyses 
there is a time-effect of exposure. As time-course studies are rare [Hammamieh 
et al. 2007], the effects of genome wide studies must be understood in terms of 
reflecting a small sample in the range of physiological effects on gene 
expression. For gene expression analysis of specific genes, a suitable treatment 
time must be considered. Secondly, the verification of the array analysis is 
indispensable. The results of this study were shown to vary in a wide range, thus 
the p values after t test are comparably high. Verification can be accomplished 
on mRNA level (e.g. Real-Time RT-PCR) or targeting protein (e.g. Western Blot, 
activity assay, or enzyme-linked immunosorbant assay). 
5.1.3 Modulation of expression of antioxidative and inflammatory 
enzymes by n-3 PUFAs 
To examine the effects in more detail and verify the results from arrays, genes 
which are involved in colorectal carcinogenesis were chosen for examination in a 
time course in both adenomatous and adenocarcinoma cells (publication III).  
One mechanism by which n-3 PUFAs can avoid oxidative stress and 
detoxification of electrophilic compounds and thus prevent against cancer was 
suggested by the induction of electrophile-responsive element 
(EpRE)/antioxidant responsive element-mediated phase II detoxification enzymes 
thereby increasing the defence capacity against potential carcinogens. The major 
transcription factor involved in EpRE-mediated gene expression is Nrf2. Under 
normal physiological conditions, Nrf2 forms an inactive complex with the 
negative regulator Kelch-like ECH-associated protein 1 (Keap1). By 
conformational change of Keap1, Nrf2 is released and can translocate to the 
nucleus. Heterodimerisation with other transcription factors allows interaction 
with EpRE in the promotor region of various antioxidant and phase II enzymes. 
Downstream target genes include GSTP1 [Rushmore & Pickett 1990] and 
NADP(H):quinone oxidoreductase 1 (NQO1) [Tanigawa et al. 2007]. Peroxidation 
products of PUFAs have been linked with Nrf2-related modulation of gene 
expression [van Beelen et al. 2006]. Using a luciferase assay a clear response of 
EpRE after incubation with EPA<DHA was found, which was much higher fold 
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than that of ARA [van Beelen et al. 2006]. SOD2 has been predicted to be a novel 
Nrf2 target in an array based assay in mouse lung cells [Taylor et al. 2008] and 
also SOD enzyme activity was found to be altered in human kidney tubulus cells 
and fibroblasts in an Nrf2-dependent manner [Boesch-Saadatmandi et al. 2008; 
Zhu et al. 2005], which suggests an EpRE in the SOD2 promotor.  
An upregulation of SOD2 mRNA caused by EPA and DHA was found in both LT97 
and HT29 cells (24 hours). The significant SOD2 upregulation in cells of a 
premalignant state of degeneration as seen in our results can be considered as a 
suppressing agent activity since a further transformation is potentially 
repressed. The first step in the removal of superoxide anion radicals is enabled 
by the enzymatic action of SOD2. Induction of SOD2 and GSTT2 (publication 
III) can be explained by the Nrf2-pathway. 
Besides the effects on the antioxidant system of the cell, SOD2 has been recently 
discussed as a new type of tumour suppressor gene [Oberley 2005]. An 
overexpression of SOD2 decreased cell growth of NIH/3T3 mouse fibroblasts 
[Kim et al. 2004]. Additionally, SOD2 overexpression led to an alteration of 
different signal transduction pathways in diverse cell types via mechanisms such 
as inhibition of transcription factors AP-1 and NF-κB and hence might also affect 
downstream targets [Li et al. 1998b]. 
Although SOD2 mRNA was increased, no induction of SOD2 protein after EPA or 
DHA exposure was found. Such effects have been described before and were 
discussed as translational block of SOD2 expression: using in vitro rodent 
models, SOD2 activity did not correspond to the oxygen-related SOD2 mRNA 
increase [Gomi & Matsuo 2002]. Furthermore, lipopolysaccharide-induced 
transcriptional SOD2 induction did not result in elevated SOD2 activity in rat 
astrocytes [Niu et al. 1998]. However, there is still a lack of clarity, whether 
SOD2 induction may be also translated at the protein level in vivo.  
Generally, GST upregulation is considered to be of benefit by enhancing 
detoxification via conjugation of potential carcinogens to glutathione. GST 
catalyses the first of four steps required for the synthesis of mercapturic acids 
[Keen & Jakoby 1978]. Subsequently, the sequential removal of the γ-glutamyl 
moiety and glycin from the glutathione conjugate will follow prior to N-
acetylation of the remaining cysteine conjugate. Once formed, the glutathione 
conjugates are eliminated from the cell by MRP, a family of ABC transporters, 
more precisely MRP1 and MRP2 [Morrow et al. 2000; Paumi et al. 2001]. 
Conjugation of exogenous compounds to glutathione almost always results in the 
formation of less reactive products that are readily excreted. However, in a few 
instances the resulting glutathione conjugate is more reactive than its parent 
Discussion 
102 
compound [Hayes et al. 2005]. For example those compounds with two 
functional groups are still able to modify DNA by the remaining electrophilic 
centre after glutathione conjugation (e.g. dichloromethane [Guengerich et al. 
2003]). Mercapturic acid derivatives are excreted in the urine. However, some 
glutathione conjugates are also found to be eliminated via bile duct and thus 
found in the colon (e.g. simvastatin- [Subramanian et al. 2002] or 4,4′-
methylenedianiline-conjugates [Chen et al. 2008]), where they also may be 
deconjugated by enzymatic activity of the gut flora implying the result of 
potential harmful and reactive intermediates in the gut. 
As shown by our results, EPA exerts a GSTT2 mRNA-inducing effect which was 
significant for HT29 cells after 24 hours. Interestingly, DHA repressed GSTT2 
mRNA after 10 hours in HT29 cells. Since these two n-3 PUFAs act in opposite 
ways on GSTT2 modulation at the gene level, more specific mechanisms than 
simple lipid peroxidation and resulting oxidative stress must account for these 
effects. The GST theta class genes lack both TATA and CAAT boxes in their 5’ 
flanking region thus multiple heterogeneous transcription boxes have been 
described (SP1 transcription factor, SP1; spleen focus forming virus proviral 
integration oncogene, spi1; polyomavirus enhancer activator-3, PEA3; activating 
enhancer binding protein 2 alpha, AP-2) [Ogura et al. 1994]. Also, EpRE was first 
described in the rat GSTP1 gene [Okuda et al. 1989] and later other rat GST 
family members were also characterised as EpRE harbouring genes [Rushmore 
et al. 1991; Rushmore & Pickett 1990]. Similar, GST activity was found to be 
increased by DHA in human fibroblasts [Arab et al. 2006].  
The functional consequence of altered GSTT2 protein still remains to be 
elucidated; this is due to missing appropriate tests, e.g. human-specific 
antibodies for Western Blot or specific substrates for activity assays. Whether or 
not the alteration of GSTT2 beneficially affects the cellular defence is not only 
dependent on the exposition to potential carcinogens, as e.g. benzo(a)pyren, 
aflatoxin, 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine, but also the activity 
of glutathione supply (catalysed by glutamate cystein ligase and glutathione 
synthase) and glutathione conjugate removal (enabled by MRP1 and 2) [Hayes et 
al. 2005]. 
Inflammation is an important tumour-promotor [Erlinger et al. 2004]. A well-
known hypothesised mechanism for the chemopreventive action of n-3 PUFAs is 
their suppressive potential on the production of ARA-derived prostanoids [Rees 
et al. 2006]. Eicosanoids from EPA and ARA have very similar structures but 
markedly different effects. Generally, EPA-derived eicosanoids are much less 
potent inducers of inflammation than ARA-derived eicosanoids [Shapiro et al. 
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1993]. The predominance of n-6 fatty acids will result in a pro-inflammatory 
status with prostaglandins of the 2-series and leukotrienes of the 4-series. As the 
relative amount of n-3 PUFAs increases, the production of prostaglandins of the 
3-series and leukotrienes of the 5-series will do in turn [Lee et al. 1985]. Some 
studies suggest a downregulation of COX-2 by EPA and/or DHA by affecting 
nuclear transcription factors and altering signal transduction and cell signalling. 
Findings from publication III support this hypothesis as they show a 
downregulation of COX-2 mRNA and COX-2 protein by DHA in both LT97 colon 
adenoma and HT29 adenocarcinoma cells. COX-2 inhibition has previously been 
shown in cancer cell lines by supplementation with 30µM EPA or DHA (24 hours) 
in HT29 cells in vitro [Calviello et al. 2004]. However, we found a COX-2 
induction by 50µM EPA in LT97 cells after 24 hours. The key link between 
PUFAs and inflammation is that eicosanoids are generated from C20 PUFAs. EPA 
can also act as a substrate for lipoxigenases and COX, resulting in a production 
of eicosanoids with a slightly different structure than those from ARA. The 
functional consequence is that the formed mediators appear to be less potent 
than ARA-derivatives. Additionally, EPA and DHA have been found to act as a 
substrate for the generation of alternative eicosanoids, termed resolvins [Serhan 
et al. 2008]. Resolvins are formed by the action of COX-2 and appear to exert 
anti-inflammatory actions [Serhan et al. 2008] and this pathway may be 
enhanced when supplementing LT97 adenoma cells with EPA. Previously it was 
shown that COX-2 regulation is facilitated in a prostaglandin E2-dependent (via 
NR4A2) but also in a prostaglandin-independent manner [Holla et al. 2006].  
Concluding remarks: 
Taken together, these results show that EPA and DHA exert colon cancer 
chemopreventive effects by altering gene expression, more precisely they 
upregulate SOD2, they alter GSTT2, and downregulate COX-2 mRNA and protein 
in LT97 adenomatous cells. This is the first time that such effects have been 
described not only in carcinoma cell models but also including adenoma cells in 
vitro. 
5.2 Alteration of markers of chemoprevention after fish consumption 
by faecal water ex vivo 
The FISHGASTRO study was performed as a randomised controlled trial aiming 
to test the effects of fish-consumption on colorectal carcinogenesis in humans 
[Pot et al. 2009]. To test the health-promoting effects of n-3 PUFAs, two types of 
fish were used within the study, a lean fish (cod) and an oil-rich fish (salmon) 
compared to no extra fish. All participants were encouraged to eat a healthy diet.  
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Besides influencing membrane fluidity [Lund et al. 1999] n-3 PUFA are involved 
in many physiological processes and with regard to colon carcinogenesis 
systemic effects of n-3 PUFAs were proposed. Thus, fish oil decreased the 
concentration of secondary bile acids in the colon as compared to a diet high in 
n-6 PUFAs and saturated fats [Bartram et al. 1995; Bartram et al. 1998]. It has 
therefore been hypothesised that the secondary bile acids deoxycholic acid and 
lithocholic acid which are derived from the bacterial degradation of the primary 
bile acids, cholic acid and chenodeoxycholic acid, respectively, may be involved 
in the aetiology of colon cancer. Secondary bile acids are known to increase 
proliferation and act as colon tumour promotors [Nagengast et al. 1995]. 
Furthermore, secondary bile acids are known to be genotoxic [Rosignoli et al. 
2008] and apoptosis decreases with higher hydrophobicity of bile acids 
(chenodeoxycholic acid < deoxycholic acid) [Katona et al. 2009]. This provided a 
rationale to use faecal water as a source of human derived material for the 
identification of biomarkers of local effects of fish consumption on colonocytes; 
for example by detecting DNA damage inducing potential (Comet Assay) and 
induction of apoptosis (flow cytometrical detection of Annexin-V-FITC/7-
actinoaminomycin) on cultured cells in vitro.  
Increase of fish consumption is also recommended on the basis that it also 
contains other beneficial compounds such as selenium [Jackson & Combs, Jr. 
2008] and 25-hydoxy vitamin D [Garland et al. 2009]. The absorption of selenium 
from fish is high (~95%) regardless the processing of the fish [Fox et al. 2004]. 
Selenium is an essential part of selenoproteins which include glutathione 
peroxidases [Allan et al. 1999], and additionally it is hypothesised to be an anti-
cancer agent because of its role as antioxidant [Rayman 2000]. Dietary 
supplementation of selenium inversely affected colon cancer incidence (by 58%) 
in persons with low selenium level [Clark et al. 1996], whereas an additional 
intake of selenium in people with adequate levels is not beneficial [Lippman et al. 
2009]. There was a profound inverse association of serum 25-hydroxy vitamin D 
and colon cancer [Freedman et al. 2007]. Thus, there was a line of evidence to 
suggest beneficial effects of vitamin D and underlying mechanisms include 
upregulation of adherence and signalling between epithelial cells, differentiation, 
promotion of apoptosis, and downregulation of the Wnt-pathway. 
And finally, the alteration of blood lipids is discussed for experimental diets with 
fish protein [Shukla et al. 2006]. 
Fish may exert health benefits but besides, it may also contain contaminants 
which resulted in confusion about the role of fish consumption as part of a 
healthy diet. However, it was concluded, that the benefits of a modest fish 
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consumption (up to 2 portions per week) outweigh the risk among adults 
[Mozaffarian & Rimm 2006]. Mercury is a heavy metal and in form of the organic 
methylmercury it can be readily absorbed and actively transported into tissue. 
Thus, methylmercury bioaccumulates in aquatic food chains and concentrations 
depend on level of environmental contamination. Toxicity appears to be related 
to binding of methylmercury to sulfhydryl groups of enzymes, ion channels, and 
receptors inhibiting antioxidant systems and leading to oxidative stress [Mergler 
et al. 2007; Mozaffarian & Rimm 2006]. Fish also tends to accumulate 
halogenated organics including polychlorinated biphenyls (PCBs) and dioxins 
which had been previously used in industrial processes (paper bleaching, 
pesticide production, production of polyvinylchloride plastics). Due to the long 
persistence of these types of compounds, they continue to be present in low 
concentrations in many foods, also in particularly oil-rich fish [European 
Commission 2000]. It is suggested that PCBs and dioxins are carcinogenic 
possibly related to effects on the aryl hydrocarbon receptor, a transcription 
factor affecting gene expression [Bock & Kohle 2006]. In the FISHGASTRO study 
only 2,3,4,5-tetrachlorodibenzo-p-dioxin (TCDD) equivalents (TEQ) in salmon 
(0.45pg TEQ/g) and cod (0.04pg TEQ/g) was measured and it was found to be 
well below the current maximum tolerable intake of 8pg TEQ/g fish [European 
Union 2006] and thus unfavourable effects in the FISHGASTRO study due to 
toxins in salmon or cod were considered to be small (publication V). 
5.2.1 Ex vivo effects of faecal water on the modulation of DNA-damaging 
effects, apoptosis-inducing potential, and global gene 
expression 
One marker for colon cancer risk is thought to be the genotoxic burden exposing 
the gut, commonly measured by treatment of in vitro cultured cells with faecal 
water or specific fractions of that (e.g. lipophilic faecal water fraction) ex vivo. 
Several previous studies revealed the rapid modification of faecal water 
genotoxicity by changes in dietary treatments [Glinghammar et al. 1997; Rieger 
et al. 1999] while others have shown no effects [Haza et al. 2000; Hughes et al. 
2002]. 
In a rodent model of chronic inflammation and oxidative stress, fish oil feeding 
resulted in lower level of 8-hydroxydeoxyguanosine [Bancroft et al. 2003; Hong 
et al. 2005]. It is hypothesised that protective effects of n-3 PUFAs are partially 
attributed to the reduction of oxidative DNA damage. Oxidised pyrimidine and 
purine DNA bases can be detected with a modified version of the Comet Assay 
using endonuclease III and formamidopyrimide DNA glycosylase which are 
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bacterial repair enzymes detecting oxidised base alterations [Collins et al. 1996]. 
The alkaline Comet Assay which was used in publication V detects single and 
double strand breaks, and alkali labile sites of the DNA, so oxidised DNA bases 
were not investigated. It is feasible, that a fish diet in humans also alters the 
oxidative status in the gut resulting in an impaired level of oxidised DNA bases. 
However, both rat studies used a dextran sodium sulphate treatment to mimic a 
chronic inflammatory state featuring a highly oxidative environment which may 
not reflect the situation of apparently healthy humans. After this inflammatory 
burst the authors found a decrease in oxidative DNA damage in rats receiving 
fish oil [Bancroft et al. 2003; Hong et al. 2005]. In humans, parameters of 
oxidative stress in urine were not altered by giving EPA + DHA supplements 
[Dawczynski et al. 2009]. It remains elusive as to what extent n-3 PUFAs 
contribute to a decrease of DNA base oxidation in healthy colon and perhaps 
should be the focus of future studies.  
As affective concentration 50% of the faecal water was chosen for a 30min 
(37°C) exposition of HT29 cells. Prior to the screening of the faecal water 
samples a dilution series of three randomly chosen faecal waters was conducted. 
By exposing the cells with 50% faecal water a medium level of genotoxicity was 
mediated without affecting viability of the cells (see appendix, Figure 13 on page 
125). 
It is feasible that fatty acids modulate faecal water genotoxicity by decreasing 
the luminal concentration of bile acids in the colon. Though bile acids were not 
measured in the FISHGASTRO samples it remains speculative whether or not 
salmon consumption resulted in decreased levels of especially secondary bile 
acids. Yet, an estimation of the necessary dose of fish to achieve a reduction of 
mainly secondary bile acids by fish consumption is not known.  
Additionally, probable DNA damage preventing effects exerted by faecal water 
were measured in analogy by the Comet Assay (30min treatment, 37°C, so-called 
“antigenotoxicity”). As DNA damage-inducing agent hydrogen peroxide (75µM) 
was used. Also with this, no beneficial effects of additional fish consumption 
were detected (appendix, Figure 14 on page 126). In literature, antigenotoxicity 
against hydrogen peroxide-mediated genotoxicity by ileostomy samples from 
volunteers receiving cloudy apple juice [Veeriah et al. 2008], and also by gut-
flora mediated fermentation supernatants of wheat bran arabinoxylanes were 
described [Glei et al. 2006]. For faecal water following fish consumption or fish 
oil no such test was performed before. 
However, since ex vivo DNA damage in cultured cells mediated by faecal water 
does not necessarily reflect the effects found for colonocytes in vivo 
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(publication V), the picture is far from clear. One reason for this could be that 
genotoxicity of faecal water and DNA damage in colonocytes are different 
endpoints; the faecal water-induced DNA damage represents the genotoxic 
burden of excreted faeces, which is mainly modulated by dietary exposure and 
processes of the gut flora [Burns & Rowland 2004], whereas the DNA damage 
measured in colonocytes also reflects the effects in the cells which additionally 
depend on the expression of biotransformation enzymes or the extent of DNA 
repair mechanisms [Rigas et al. 2001] and systemic burden. 
An induction of apoptosis was examined in LT97 cells treated with DHA>EPA 
(publication IV). However, the modulation of the luminal environment by 
eating additional portions of lean or oil-rich fish (1.3-1.4 portions/week, 
respectively) has not been examined so far. Results from publication IV do not 
indicate a pro-apoptotic environment in faecal water of the FISHGASTRO study. 
There is only one study to date examining the effect of faecal water on apoptosis 
ex vivo in HT29 cells [Haza et al. 2000]. In this preliminary study a markedly 
individual difference in effects was observed, apoptosis induction was attributed 
to the presence or absence of bile acids and butyrate. Bile acids are observed to 
alter apoptosis [Bernstein et al. 2005] and also the gut-fermentation product 
butyrate can induce apoptosis [Scharlau et al. 2009]. Changes in faecal water as 
a result of consuming fish are probably not related to elevated DHA/EPA 
concentrations directly but rather to changes in bile metabolism. To further 
clarify this issue, the analysis of bile acids and short chain fatty acids as butyrate 
in the faecal water samples of the FISHGASTRO study would be useful.  
Additionally, faecal water was screened for its apoptosis inducing potential. By 
consuming cod or salmon, no additional apoptotic events were examined 
(publication IV). Preliminary tests aiming to find an effective dilution of six 
different faecal water samples are shown in appendix, Figure 12 on page 124.  
Finally, the impact of faecal water on global gene expression of LT97 cells was 
examined (additional results). One could argue that the used 3.5% faecal 
water concentration is too low to exert effects in the cells. This concentration 
was used basing on preliminary tests on cell growth inhibition of LT97 cells 
which are summarised and further explained at the appendix, Figure 11 on page 
123. Only one prior study examining the impact of faecal water on modulation of 
gene expression has been reported to date [Zeng & Davis 2003] which found an 
alteration of cell cycle genes. These authors used a concentration of 5% faecal 
water to treat HT29 cells, thus the tested concentration is comparable to the one 
applied for the Affymetrix analysis. It is noteworthy, that the study by Zeng et al. 
is preliminary and it does not use the parameter of gene expression alteration to 
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detect its modification during an intervention trial but rather only the general 
impact of faecal water. Also, probable reactive compounds found in faecal water 
(e.g. bile acids, short chain fatty acids, or polyphenolic compounds) were not 
analysed.  
Concluding remarks: 
An additional consumption of cod or salmon did neither result in alteration of the 
genotoxic impact of the tested faecal water (publication V) nor in potential 
beneficial effects by preventing hydrogen peroxide-mediated DNA damage. For 
the first time, impact of fish consumption on alteration of the luminal contents 
towards apoptosis-induction was examined but no changes by cod or salmon 
consumption were detected (publication IV). The approach of using faecal 
water-induced gene modulation to evaluate the impact of diet is new in this study 
(additional results). However, only marginal changes following the fish-diets 
were found. Unexpectedly (personal communication with Dr. Guido Hooiveld, 
Wageningen University, The Netherlands), only a few genes were altered and 
additionally, the extent of mRNA expressional changes were small (Table 5 and 
Table 6). Furthermore, abundant compounds being always present in faeces 
might overwhelm probable changes by the fish-diet. 
5.2.2 Evaluation of faecal water as a biomarker of colon cancer risk 
within a fish-intervention trial 
An early diagnosis of colorectal cancer is needed to intervene the further 
progression of the disease, as treatment is most successful when no metastasis is 
present [Eisenberg et al. 1982]. Sigmoidoscopy and colonoscopy are highly 
specific and sensitive tests for colorectal neoplasia, but they are limited by 
patients’ compliance and physician’s availability and costs [Frazier et al. 2000]. 
The faecal occult blood test is a non-invasive and simple technique which was 
shown to reduce incidence and mortality of colorectal cancer. The limitation is 
that the faecal occult blood test is an indirect one, patients with positive results 
are referred to colonoscopy to confirm the presence of polyps or cancer (for 
review see [Burt 2000]). For this reason, the development of surrogate tissues or 
biomarkers for colorectal cancer risk is ongoing. 
In most human dietary intervention studies focusing colon carcinogenesis so far, 
a surrogate tissue, e.g. peripheral lymphocytes was used to assess effects of 
changes in nutrition [Bouwens et al. 2009]. When the primary interest of an 
intervention study emphasises the impact on the gut the situation is complicated. 
On the one hand, effects in lymphocytes do not necessarily reflect the effects in 
the target tissue colon, but on the other hand they provide an easily obtainable 
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and non-invasive biomarker which is what is needed for dietary intervention 
studies.  
The parameter of faecal water-induced genotoxicity is often used and has been 
shown to be influenced by nutrition. Gut luminal genotoxicity can be regarded as 
a biomarker of exposure of the colon to potential beneficial/harmful compounds. 
Though the concentrations of these compounds are thought to be influenced by 
diet, a modulation of faecal water-genotoxicity can be referred to as biomarker of 
effect of dietary changes. 
In this work, a new type of exploration was the use of faecal water to analyse 
potential chemopreventive effects ex vivo, but no beneficial effect of fish 
consumption was apparent: there was no change of faecal water genotoxicity 
(publication V) and apoptosis-inducing potential (publication IV), furthermore 
there was only a small effect on the global gene expression (additional 
results). It is difficult to argue whether these null-results are an effect of lacking 
benefit of a high-fish diet or whether these are due to a methodological problem 
suggesting that faecal water may not be an appropriate surrogate for biomarker 
identification.  
If n-3 PUFAs are the compounds accountable for beneficial effects of oil-rich fish 
a lack of impact of faecal water after high oil-rich fish consumption is not 
surprising. Alimentary fatty acids are expected in faeces only in small amounts. 
The digestion of fat takes place in the stomach and the intestine with several 
enzymes contributing to their degradation. Gastric predigestion facilitates fat 
digestion in the duodenum and affects 10-30% of the dietary fat. Preduodenal 
lipases preferentially hydrolyse the sn3-ester-bond resulting in the formation of 
sn1,2 diacylglycerol and free fatty acids [Hamosh & Scow 1973]. The major 
digestion results from pancreatic lipase in the duodenum. Pancreatic lipase 
activity results in the formation of sn-2 monoacylglycerol and free fatty acids 
[Lowe 1997]. The fats are emulsified by bile acids, which are strong detergents, 
and the available surface is thus increased. This implies a general conservation 
of 75% of all fatty acids in sn-2 position [Mu & Hoy 2004]. Pancreatic lipase 
activity towards n-3 fatty acids is lower and moreover the lymphatic recovery of 
EPA and DHA were found to be lower compared to other fatty acids [Ikeda et al. 
1995]. Products of triacylglycerol digestion may cross the enterocyte membrane 
by diffusion or by a carrier-mediated process. The chain length of a fatty acid 
affects its transport and metabolism. Medium chain fatty acids with up to ten 
carbon atoms can be solubilised in the aqueous phase of intestinal contents, and 
bound to albumin. They are transported in the vena portae to the liver. Longer-
chain fatty acids are transported by the lymphatic system [Hunter 2001]. Once 
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they enter the enterocyte monoacylglycerol and free fatty acids are used to 
resynthesise first diacylglycerol and than triacylglycerol in the smooth 
endoplasmic reticulum resulting in the deposition of fat droplets in its lumen [Mu 
& Hoy 2004]. Lipids are then packed into lipoproteins, predominantly 
chylomicrons and very low density lipoproteins, which are stable for transport in 
the aqueous environment. Chylomicrons are light particles (diameters <1.000 
g/ml) which are heterogeneous in size (diameters 80–1000 nm) and consist of 
90% neutral lipid, predominantly triacylglycerol with some cholesteryl ester, 
stabilised by a shell of amphipathic lipids, phospholipid and cholesterol, and 
protein. Intestinal lipoproteins do not enter the blood stream directly. Instead, 
they are secreted into lymph vessels to be found inside the intestinal villi, and 
then they enter the circulation in the vena subclavia via ductus thoracicus. After 
reaching the liver they are distributed throughout the body. In extrahepatic 
tissue, the chylomicrons’ triglycerides are rapidly hydrolysed by the activities of 
lipoprotein lipase to form chylomicron remnants. The liver recognises these 
remnants and they are assimilated by active transport. Triacylglycerides are 
secreted in form of very low density lipoproteins by the liver, hydrolytic activity 
of lipoprotein lipase form intermediary density lipoproteins and finally hepatic 
triacylglycerol lipase forms low density lipoproteins, i.e. the major cholesterol 
transporting lipoprotein [Mu & Hoy 2004]. Fatty acids and as such also n-3 
PUFAs circulate in blood either in free form bound to albumin or esterified in 
triacylglycerol in the lipoprotein fraction.  
Efficient absorption of fatty acids, predominantly in the jejunum and ileum, 
allows less than 5% of the ingested lipids to reach the colon [Carey et al. 1983]. 
From ileostomy studies was estimated that 5-8g/d of dietary residual fat 
(monoglyceride and fatty acids) may reach the caecum [Hill 1998]. Of impact for 
the fatty acid content of the faeces are gut fermentation products. It was 
estimated that 20% of ingested carbohydrates pass into the colon and are then 
fermented by colonic bacteria to form short chain fatty acids (acetate, 
propionate, and butyrate). Short chain fatty acids are absorbed via passive 
diffusion in their protonated form across epithelial cell membranes [Cummings 
et al. 1995]. They serve as energy source for non-transformed colonocytes or, 
alternatively, they are transported to the liver after entering portal bloodstream. 
Although it is generally assumed that beneficial effects of fish consumption are 
mediated through increased concentrations of n-3 PUFAs in the blood it is also 
feasible that effects are exerted luminally. Studies on patients with ileostomies 
suggest that up to 2% of dietary fatty acids may escape absorption in the small 
intestine [Normen et al. 2006]. A meal containing a 300g portion of the study 
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salmon would contain 2.13g EPA and 4.11g DHA [personal communication with 
Gerda Pot]. If 2% escapes absorption that means 42.6mg EPA and 82.2mg DHA 
would arrive in the colon. If we estimate the volume of the colon to be in the 
range of 100-500ml2 then the concentration of EPA and DHA might reach about 
0.28-1.4mM EPA and 0.5-2.5mM DHA which in turn may suggest the lipid could 
have direct effect on the cells. However, the colonic bacteria will rapidly 
metabolise the fatty acids and so these high concentrations may only be present 
in the most proximal region of the large intestine.  
There might also be study-related reasons which need to be considered when 
judging the impact of fish consumption on health markers. Firstly, volunteers of 
the FISHGASTRO study had a higher baseline fish-consumption compared with 
subjects of other fish oil intervention studies. Perhaps a more pronounced effect 
would be observed in a population of non-fish consumers. Secondly, the fish 
which was provided to the volunteers was intended to serve as an additional 
source of 2 portions fish/week. But it appears that the subjects partially 
substituted the fish they normally consume by the study fish. This resulted in a 
lower level of ingested n-3 PUFAs than intended (0.99g long chain 
PUFAs/1.3 portions salmon/week vs. 1.4g long chain PUFAs/2 portions 
salmon/week). However, there were no correlations between: (i) DNA damage of 
colonocytes in vivo and genotoxicity of faecal water of the same volunteer 
measured in LT97 cells ex vivo, and (ii) apoptosis measured in colon crypts in 
vivo and after treatment of LT97 cells with faecal water ex vivo of the same 
volunteers. 
Since the number of subjects for comparative analysis of biomarkers, faecal 
water and colonocytes/biopsies is low, the results of both studies (apoptosis and 
genotoxicity) are explorative, and need to be confirmed in larger studies. 
This is the first human study to date that has examined health-promoting effects 
of fish-consumption within an intervention trial. Previously, studies using fish-oil 
capsules have been performed [Bartelt et al. 2008; Bouwens et al. 2009; 
Cummings et al. 1995; Lund et al. 1999; Rees et al. 2006]. It has also been 
argued as to whether the relative bioavailability of fatty acids from oil-capsules is 
the same as for food-items. It is noteworthy that the relative bioavailability of 
fatty acids from oil-rich fish is higher than that of fish-oil capsules [Visioli et al. 
2003]. So it was calculated, that more than a double EPA dose administered by 
capsules and almost a nine-fold dose of DHA would be required to reach the 
same increment in plasma as after a fish meal [Visioli et al. 2003].  
                                                          
2
 Basing on the volume of chymus which reaches the colon (500ml/d) [Elmadfa & Leitzmann 1990] 




The results of the faecal water experiments do not support the hypothesis that 
the biomarker of ex vivo analysis of faecal water genotoxicity, apoptosis 
induction and alteration of gene expression reflects nutritional changes of an oil-
rich fish intervention. First of all, fish intervention had no or only marginal 
impact on the above mentioned parameters. Secondly, the ex vivo faecal water 
experiments do not reflect in vivo findings regarding DNA damage in colonocytes 
(publication V) and apoptosis in colonic crypts [Pot et al. 2009] of the same 
study. 
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6. SUMMARY AND FUTURE PERSPECTIVES 
The objective of this study was to elucidate the impact of fish-consumption on 
chemoprevention of colorectal cancer. Of all constituents, n-3 PUFA abundant in 
fish fat, namely EPA and DHA were proposed to be the compounds which act 
beneficially. Thus, examinations in human colon cells in vitro were the subject of 
the investigations to the chemopreventive effects of fish n-3 PUFA in this work: 
Uptake of fatty acids into LT97 and HT29 cells and impact of fatty acids on LT97 
and HT29 cell growth (publication I) 
All examined fatty acids (LA, ALA, GLA, ARA, EPA, and DHA) were taken up by 
LT97 and HT29 cells in the same manner being a prerequisite for fatty acids to 
exert cellular effects. Furthermore, cell growth was reduced in a concentration- 
and time-dependent manner. Effects were more pronounced in adenomatous 
LT97 compared to adenocarcinoma HT29 cells. To elucidate effects of EPA and 
DHA on human colon cells of different transformation state, further in depth 
experiments are needed.  
Modulation of LT97 gene expression patterns by EPA and DHA (publication II) 
EPA and DHA are known to alter gene expression and the experiments with 
adenomatous LT97 cells revealed partially different effects by the tested fatty 
acids EPA and DHA. Also, a time effect in the gene expression response was 
observed (10 vs. 24 hours). These preliminary results show probable regulated 
genes which need to be verified in the future and may then serve as target genes 
for further studies in this field of research. Additionally, the results also show the 
importance of treatment times for in vitro testings. 
Modulation of SOD2, GSTT2, and COX-2 expression in LT97 and HT29 cells 
(publication III) 
EPA and DHA may reduce oxidative stress by inducing SOD2. Effects on GSTT2 
were opposite for EPA (downregulation) and DHA (upregulation) in HT29 cells. 
Furthermore, anti-inflammatory effects may follow the DHA-caused reduction of 
COX-2 in HT29 cells (10 and 24 hours) and LT97 cells (10 hours). In contrast, 
EPA induced LT97’s COX-2 (24 hours) potentially resulting in anti-inflammatory 
EPA-derivatives by enzymatic COX-2 activity which needs further clarification. 
Induction of apoptosis by EPA and DHA in LT97 and HT29 cells (publication 
IV) 
A mechanism to remove altered cells is the induction of apoptosis. EPA and DHA 
induced apoptosis (measured by flow cytometry) and both, extrinsic (cleavage of 
procaspase 8 and truncation of bid) and intrinsic pathway molecules (reduction 
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of Bcl-2) were altered. Furthermore, downstream targets such as cleavage of 
procaspase 3 to become an executioner caspase and PARP cleavage were 
detected. LT97 cells were more prone to apoptosis inducing potential of DHA 
and EPA compared to HT29 cells and DHA was more effective in inducing 
apoptosis than EPA. 
In further studies, a biomarker approach was chosen to test the impact of fish-
consumption on colonic health. Faecal water of a subset of the volunteers of the 
FISHGASTRO study was used to test effects ex vivo: 
Modulation of chemoprevention markers by faecal water of 89 volunteers ex vivo 
(publication IV and publication V) 
Results from this study do not support the hypothesis of a chemopreventive 
action by an additional consumption of oil-rich fish regarding the modulation of 
genotoxicity (measured in HT29 cells by the Comet Assay), and mediation of 
apoptosis (measured in LT97 by flow cytometry). Additionally, DNA damage in 
colonocytes from biopsy samples was not altered by fish-consumption. 
Furthermore, in vivo findings (DNA damage in colonocytes, apoptosis in colonic 
crypts [Pot et al. 2009]) did not correlate with ex vivo results (genotoxicity of 
faecal water, apoptotic impact of faecal water, respectively). Whether or not this 
is related to the lack of impact of a fish consumption on colon cancer still needs 
to be further elucidated.  
Modulation of global gene expression by faecal water of 39 volunteers ex vivo 
(additional results) 
Ex vivo global genome modulation by faecal water treated LT97 cells was 
conducted in a subset of the FISHGASTRO volunteers (n=39). Results showed 
differential expression of several pathways for the cod and the salmon group, 
though the effect size was rather low compared to other studies. The accordance 
with global gene expression alteration in colonic biopsies in vivo will be the 
subject of future examinations. 
Evaluation of faecal water as biomarker to monitor health beneficial effects of 
fish 
It was not possible to affirm the hypothesis that faecal water-associated 
biomarkers are suitable to test the impact of fish consumption ex vivo. 
Nevertheless, as faecal water contains a variety of compounds able to impair the 
gut health and modifiable by nutrition (e.g. bile acids by fat, butyrate by dietary 
fibre, polyphenolic compounds by vegetables and fruits), the analysis of the 
concentrations of these compounds in the analysed samples would be of interest. 
A further assessment of the analysed data regarding the influence of probable 
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confounding factors (e.g. bile acids) would be useful. There is promising 
evidence that future intervention studies may use faecal water as a biomarker. 
But a prerequisite is that potentially beneficial compounds reach the colon, are 
significantly altered by the dietary intervention, remain unaltered from bacterial 
degradation or result from it, and are present in faecal water, e.g. an 
intervention with dietary fibre results in fermentation by commensal bacteria 
and give rise in short chain fatty acids as butyrate which is discussed as serving 
beneficial during the development of colorectal cancer. 
Overall future perspectives 
To further investigate chemopreventive mechanisms of n-3 PUFAs in vitro, the 
inclusion of tests on primary human colon cells in comparison to adenoma and 
carcinoma cell culture is of interest. Since the culture of primary human cells 
e.g. from colon resection samples is not yet well established, this issue remains 
crucial. Cell culture models such as the used LT97 and HT29 or others like the 
human colon epithelial cells FHC which are of foetal origin and primary-like 
could be used to further clarify the influence of EPA and DHA in vitro on 
advanced markers of apoptosis. As it was shown, apoptosis is triggered by both, 
intrinsic and extrinsic pathway. However, apoptosis-mediation by a specific 
receptor pathway-activation remains unclear. Also investigations regarding 
mechanisms of intrinsic apoptosis (cytochrome c, oxidative stress etc.) are 
feasible. 
As the FISHGASTRO study was to date the first human intervention trial giving 
fish, future in vivo studies to prove the epidemiological evidence of fish being 
beneficial for colon cancer prevention would be useful. To strengthen the effect 
of fish, some alterations compared to the FISHGASTRO study should be made. 
As it is probably not possible to increase the additional consumption of fish to 
more than two extra-portions per week, it would be promising to compare fish 





Of all constituents, n-3 polyunsaturated fatty acids are thought to be the crucial 
cancer chemopreventive factors to which anti-cancer properties of oil-rich fish 
may be attributed. However, the molecular mechanisms of these effects are not 
well understood. Thus, the cancer chemopreventive properties of 
eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA) were the core 
subject of in vitro studies. Furthermore, ex vivo studies examining samples of the 
first randomised controlled human trial intervening with lean and oil-rich fish, 
the FISHGASTRO trial, were screened for markers of chemoprevention. 
For this, the impact of EPA and DHA on growth (DNA staining by 4',6-diamidino-
2-phenylindole) and on metabolism (conversion of resazurin to resofurin) of 
HT29 human colon adenocarcinoma and LT97 human colon adenoma cells were 
elucidated. Furthermore, different endpoints of apoptosis were analysed [flow 
cytometrical detection of Annexin-V-FITC and 7-actinoaminomycin; Real-Time 
RT-PCR analysis of Bcl-2 (B-cell chronic lymphocytic leukemia/lymphoma 2)-
expression, Western Blot detection of caspases 3, 8 and 9, Bid (Bcl-2 Interacting 
Domain) and poly (ADP-ribose) polymerase (PARP)] in HT29 and LT97 cells. 
Additionally, the modulation of gene expression patterns in general (PIQORTM 
Custom Array, only LT97), and specifically the modulation of antioxidative and 
inflammatory enzymes [Real-Time RT-PCR analysis of glutathione S-transferase 
T2 (GSTT2), superoxide dismutase 2 (SOD2), and cyclooxygenase-2 (COX-2) 
mRNA, Western Blot for SOD2 and COX-2 protein] were determined. For the 
evaluation of fish consumption in humans, a biomarker approach using faecal 
water was chosen. Faecal water was collected from a subset (89 volunteers) of 
the FISHGASTRO participants which additionally consumed lean (cod) or oil-rich 
(salmon) fish twice a week for half a year compared to a dietary advice. Using 
faecal water, the modification of genotoxicity (Comet Assay) and induction of 
apoptosis (flow cytometrical detection of Annexin-V-FITC and 7-
actinoaminomycin) as well as the alteration of global gene expression (Affymetrix 
GeneChip®) were examined. 
It was shown that EPA and DHA impair cell growth (LT97 cells were more 
susceptible compared to HT29 cells) and induce apoptosis (DHA was more active 
compared to EPA and effects in HT29 cells were weaker compared to LT97 
cells). Gene expression was affected in a time- (10 vs. 24 hours) and substance-
specific (EPA vs. DHA) manner. Overall, genes connected with 
biotransformation, cell cycle control, signalling pathways, apoptosis, and 
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inflammation were altered. More specifically, SOD2 induction and probably an 
enhanced peroxidase activity due to GSTT2 induction indicate reduction of 
oxidative stress. Whereas GSTT2 was induced by EPA it was reduced by DHA in 
HT29 cells. Anti-inflammatory activity can be attributed to COX-2 decrease by 
DHA in both cell types. In contrast, EPA induced COX-2 in LT97 cells. 
It was not possible to prove that faecal water-incubated LT97 cells were an 
appropriate source for biomarker identification to test the hypothesis that 
additional consumption of fish is beneficial for gut health. There was no marked 
alteration of genotoxicity or apoptosis by the fish-intervention. The evidence of 
the comparably small impact of faecal water on the modulation of global gene 
expression in LT97 cells and the influence of an additional consumption of fish 
still require final assessment. The extent to which these findings may be related 
to a lack of impact of oil-rich fish needs further clarification. 
In conclusion it was shown, that EPA and DHA exert chemopreventive properties 
in cell culture models. As the results from the human intervention study were not 
appropriate to judge the in vivo situation, there is still a need to prove the 






Die chemopräventiven Effekte des Verzehrs von fettreichem Fisch sind 
vermutlich auf die n-3 mehrfach ungesättigten Fettsäuren zurückzuführen. 
Zugrundeliegende molekularbiologische Mechanismen innerhalb der 
Kolonkarzinogenese bedürfen allerdings noch der genaueren Aufklärung. 
Gegenstand der vorliegenden Arbeit waren daher in vitro Analysen zur Rolle von 
Eicosapentaensäure (EPA) und Docosahexaensäure (DHA) in der 
Chemoprävention von Kolonkrebs. Darüber hinaus erfolgten ex vivo 
Untersuchungen zum Einfluss von Proben aus der ersten randomisierten, 
kontrollierten Humanstudie, der FISHGASTRO Studie, in der mit magerem und 
fettreichem Fisch interveniert wurde, auf verschiedene Marker der 
Chemoprävention. 
Es wurde der Einfluss von EPA und DHA auf das Zellwachstum (DNA Färbung 
mittels 4',6-Diamidino-2-Phenylindol) und den Metabolismus (Konversion von 
Resazurin zu Resorufin) von humanen HT29 Kolontumor- und LT97 
Kolonadenomzellen bestimmt. Des Weiteren wurden verschiedene Endpunkte 
der Apoptose [durchflusszytometrische Messung von Annexin-V-FITC und 7-
Aminoactinomycin; Bcl-2 (B-cell chronic lymphocytic leukemia/lymphoma 2)-
Expression mittels Real-Time RT-PCR, Western Blot-Untersuchung der Caspasen 
3, 8 und 9, sowie Bid (Bcl-2 Interacting Domain)-Abnahme und Spaltung der Poly 
(ADP-Ribose) Polymerase (PARP)] in HT29 und LT97 Zellen analysiert. Darüber 
hinaus galt es die Modulation des Genexpressionsmusters (PIQORTM Custom 
Array, nur LT97 Zellen) und speziell die Modulation antioxidativer und 
inflammatorischer Enzyme (Superoxiddismutase 2 (SOD2), Cyclooxygenase-2 
(COX-2) und der Glutathion S-Transferase T 2 (GSTT2) mittels Real-Time RT-PCR 
zu untersuchen, sowie SOD2- und COX-2-spezifische Western Blot-Analysen 
durchzuführen. Für die Einschätzung der Wirkung des Fischverzehrs im 
Menschen sollte ein Biomarker-Ansatz dienen. Dafür wurden Fäzeswässer eines 
Teils der Probanden der FISHGASTRO Humanstudie, bei der zusätzlich zwei 
Portionen magerer (Kabeljau) oder fettreicher (Lachs) Fisch pro Woche über 
einen Zeitraum von sechs Monaten im Vergleich zu einer Ernährungsempfehlung 
verzehrt wurde, gewonnen. Die Fäzeswässer wurden im Hinblick auf ihr 
Potential die Genotoxizität (Comet Assay), die Apoptose (durchfluss-
zytometrische Bestimmung von Annexin-V-FITC und 7-Aminoactinomycin) sowie 
die globale Genexpression (Affymetrix GeneChip®) zu modifizieren untersucht. 
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Eine Verminderung des Zellwachstums durch EPA und DHA (LT97 Zellen waren 
empfindlicher im Vergleich zu HT29 Zellen) sowie die Induktion der Apoptose 
(DHA war aktiver im Vergleich zu EPA und HT29 Zellen reagierten schwächer 
als LT97 Zellen) konnten gezeigt werden. Die Genexpression wurde sowohl zeit- 
(10 vs. 24 Stunden) als auch substanz- (EPA vs. DHA) abhängig beeinflusst. 
Dabei wurden vor allem Gene der Biotransformation, des Zellzyklus, von 
Signaltransduktionswegen, der Apoptose und der Inflammation moduliert. Es 
könnte zu einer Veränderung des oxidativen Stresses speziell durch die 
Induktion von SOD2 und einer möglichen Peroxidaseaktivität von GSTT2 führen, 
wobei GSTT2 in HT29 Zellen durch EPA gesteigert und durch DHA vermindert 
wurde. Darüber hinaus können aus der durch DHA-bedingten und in beiden 
Zelllinien gefundenen Abnahme der COX-2 anti-inflammatorische Wirkungen 
resultieren. EPA hingegen induzierte COX-2 in LT97 Zellen (24 Stunden). 
Fäzeswasser erwies sich nicht als geeigneter Biomarker zur Bestätigung der 
Hypothese, dass ein zusätzlicher Verzehr von Fisch zuträglich für die 
Darmgesundheit ist. Durch die Inkubation von HT29 bzw. LT97 Zellen mit 
Fäzeswässern unterschiedlicher Spender konnten weder die Parameter 
Genotoxizität noch die Induktion von Apoptose signifikant moduliert werden. Die 
genaue Bedeutung des gefundenen vergleichsweise kleinen Einflusses von 
Fäzeswässern auf die globale Genexpression von LT97 und die Bedeutung eines 
zusätzlichen Fischverzehrs benötigt abschließender Analysen. Inwieweit diese 
Ergebnisse einem fehlenden Einfluss durch den Verzehr von fettreichem Fisch 
zuzuschreiben ist, bleibt weiteren Untersuchungen vorbehalten. 
Insgesamt haben die vorliegenden in vitro Ergebnisse chemopräventive 
Eigenschaften von EPA und DHA in Zellkulturmodellen gezeigt. Für die 
Beurteilung der in vivo Situation sind die Ergebnisse der FISHGASTRO 
Humanstudie allerdings nicht ausreichend. Um zu überprüfen, ob sich 
fettreicher Fisch chemopräventiv auf die Entwicklung von Dickdarmkrebs 





9.1 Affymetrix data on LT97 global gene expression modulation 
Table 5. Differentially expressed genes of 19 volunteers after salmon intervention for six month. 
FC p value gene name Entrez ID description
1,3229 0,0197 RP4-747L4.3 84832 hypothetical protein MGC12538
1,3097 0,0311 SELM 140606 selenoprotein M
1,2845 0,0028 ADAM21 8747 ADAM metallopeptidase domain 21
1,2652 0,0016 IGFBP6 3489 insulin-like growth factor binding protein 6
1,2570 0,0077 TNNT1 7138 troponin T type 1 (skeletal, slow)
1,2538 0,0279 CTSZ 1522 cathepsin Z
1,2475 0,0088 ABCG2 9429 ATP-binding cassette, sub-family G (WHITE), member 2
1,2365 0,0009 FADS3 3995 fatty acid desaturase 3
1,2361 0,0045 PDE9A 5152 phosphodiesterase 9A
1,2355 0,0382 FOS 2353 v-fos FBJ murine osteosarcoma viral oncogene homolog
1,2348 0,0440 SSFA2 6744 sperm specific antigen 2
1,2296 0,0203 LRSAM1 90678 leucine rich repeat and sterile alpha motif containing 1
1,2271 0,0056 C17orf73 55018 chromosome 17 open reading frame 73
1,2187 0,0186 LY6G6D 58530 lymphocyte antigen 6 complex, locus G6D
1,2144 0,0004 GPR55 9290 G protein-coupled receptor 55
1,2074 0,0066 ALDH3A1 218 aldehyde dehydrogenase 3 family, memberA1
1,2063 0,0161 LRRC58 116064 leucine rich repeat containing 58
1,1983 0,0039 SULT1A1 6817 sulfotransferase family, cytosolic, 1A, phenol-preferring, member 1
1,1963 0,0433 ZDHHC20 253832 zinc finger, DHHC-type containing 20
1,1951 0,0179 CSRP2 1466 cysteine and glycine-rich protein 2
1,1909 0,0308 DHRS2 10202 dehydrogenase/reductase (SDR family) member 2
1,1908 0,0058 GSDMA 284110 gasdermin A
1,1905 0,0186 C7orf10 79783 chromosome 7 open reading frame 10
1,1870 0,0246 IQGAP1 8826 IQ motif containing GTPase activating protein 1
1,1850 0,0281 PPP2R2C 5522 protein phosphatase 2 (formerly 2A), regulatory subunit B, gamma isoform
1,1842 0,0179 NUMBL 9253 numb homolog (Drosophila)-like
1,1816 0,0166 CA11 770 carbonic anhydrase XI
1,1815 0,0398 UGT1A8 54576 UDP glucuronosyltransferase 1 family, polypeptide A8
1,1808 0,0411 LRP8 7804 low density lipoprotein receptor-related protein 8, apolipoprotein e receptor
1,1791 0,0459 SCPEP1 59342 serine carboxypeptidase 1
1,1768 0,0146 MMP1 4312 matrix metallopeptidase 1 (interstitial collagenase)
1,1755 0,0033 TM7SF2 7108 transmembrane 7 superfamily member 2
1,1712 0,0027 DMAP1 55929 DNA methyltransferase 1 associated protein 1
1,1711 0,0009 C14orf149 112849 chromosome 14 open reading frame 149
1,1702 0,0062 RTN2 6253 reticulon 2
1,1682 0,0006 ZMYND8 23613 zinc finger, MYND-type containing 8
1,1672 0,0040 CAGE1 285782 cancer antigen 1
1,1663 0,0390 IFNA16 3449 interferon, alpha 16
1,1657 0,0140 FNIP1 96459 folliculin interacting protein 1
1,1649 0,0161 MT1B 4490 metallothionein 1B
1,1644 0,0153 TUBA3C 7278 tubulin, alpha 3c
1,1637 0,0228 RBM14 10432 RNA binding motif protein 14
1,1607 0,0198 TBL1X 6907 transducin (beta)-like 1X-linked
1,1572 0,0026 LOC100129034 100129034 hypothetical protein LOC100129034
1,1566 0,0003 PLEKHH2 130271 pleckstrin homology domain containing, family H (with MyTH4 domain) member 2
1,1565 0,0063 LY6E 4061 lymphocyte antigen 6 complex, locus E
1,1529 0,0344 DAPK3 1613 death-associated protein kinase 3
1,1525 0,0184 IL6ST 3572 interleukin 6 signal transducer (gp130, oncostatin M receptor)
1,1525 0,0463 POLDIP3 84271 polymerase (DNA-directed), delta interacting protein 3
1,1519 0,0051 OR51B4 79339 olfactory receptor, family 51, subfamily B, member 4
1,1518 0,0116 LOC100133362 653325 similar to heterogeneous nuclear ribonucleoprotein A1
1,1498 0,0042 C7orf13 129790 chromosome 7 open reading frame 13
1,1442 0,0031 ACOT8 10005 acyl-CoA thioesterase 8
1,1434 0,0365 NELF 26012 nasal embryonic LHRH factor
1,1427 0,0137 DBNDD1 79007 dysbindin (dystrobrevin binding protein 1) domain containing 1
1,1427 0,0194 SPIRE1 56907 spire homolog 1 (Drosophila)
1,1420 0,0089 CDKN2A 1029 cyclin-dependent kinase inhibitor 2A (melanoma, p16, inhibits CDK4)
1,1419 0,0034 ANXA9 8416 annexin A9
1,1416 0,0309 MAP2K2 5605 mitogen-activated protein kinase kinase 2
1,1415 0,0139 PPM1J 333926 protein phosphatase 1J (PP2C domain containing)
1,1410 0,0144 ADCY7 113 adenylate cyclase 7
1,1402 0,0341 C11orf65 160140 chromosome 11 open reading frame 65
1,1396 0,0174 ZFPL1 7542 zinc finger protein-like 1
1,1395 0,0013 SLC6A20 54716 solute carrier family 6 (proline IMINO transporter), member 20
1,1376 0,0007 BAIAP3 8938 BAI1-associated protein 3
1,1363 0,0092 MOCS3 27304 molybdenum cofactor synthesis 3
1,1362 0,0017 TMEM132A 54972 transmembrane protein 132A
1,1361 0,0109 RNF146 81847 ring finger protein 146
1,1354 0,0111 KLRA1 10748 killer cell lectin-like receptor subfamily A, member 1
1,1354 0,0100 AIM1L 55057 absent in melanoma 1-like
1,1344 0,0393 MPI 4351 mannose phosphate isomerase
1,1343 0,0500 ANXA6 309 annexin A6
1,1341 0,0068 GCHFR 2644 GTP cyclohydrolase I feedback regulator
1,1338 0,0467 RAB6A 5870 RAB6A, member RAS oncogene family
1,1337 0,0120 C15orf17 57184 chromosome 15 open reading frame 17
1,1326 0,0329 CLIP2 7461 CAP-GLY domain containing linker protein 2  
FC fold change (after salmon intervention/before salmon intervention), continued on the next page. 
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Table 5 continued.  
FC p value gene name Entrez ID description
1,1320 0,0470 PYCARD 29108 PYD and CARD domain containing
1,1318 0,0218 PDAP1 11333 PDGFA associated protein 1
1,1314 0,0021 ARL4C 10123 ADP-ribosylation factor-like 4C
1,1310 0,0128 MICAL3 57553 microtubule associated monoxygenase, calponin and LIM domain containing 3
1,1306 0,0145 TNFRSF12A 51330 tumor necrosis factor receptor superfamily, member 12A
1,1305 0,0082 CEACAM1 634 carcinoembryonic antigen-related cell adhesion molecule 1 (biliary glycoprotein)
1,1301 0,0114 LOC100128919 100128919 similar to HSPC157
1,1299 0,0026 EML2 24139 echinoderm microtubule associated protein like 2
1,1281 0,0064 HIC2 23119 hypermethylated in cancer 2
1,1277 0,0059 UAP1L1 91373 UDP-N-acteylglucosamine pyrophosphorylase 1-like 1
1,1273 0,0403 KISS1R 84634 KISS1 receptor
1,1273 0,0079 PARP12 64761 poly (ADP-ribose) polymerase family, member 12
1,1260 0,0144 WDR46 9277 WD repeat domain 46
1,1255 0,0405 MME 4311 membrane metallo-endopeptidase
1,1247 0,0348 VCAN 1462 versican
1,1242 0,0018 TRIM2 23321 tripartite motif-containing 2
1,1241 0,0151 PAPSS2 9060 3'-phosphoadenosine 5'-phosphosulfate synthase 2
1,1238 0,0188 SH3GLB2 56904 SH3-domain GRB2-like endophilin B2
1,1224 0,0008 FLJ20712 55025 hypothetical protein FLJ20712
1,1215 0,0187 BTN2A2 10385 butyrophilin, subfamily 2, member A2
1,1213 0,0022 COL6A6 131873 collagen type VI alpha 6
1,1211 0,0134 ZNF121 7675 zinc finger protein 121
1,1210 0,0336 CPEB4 80315 cytoplasmic polyadenylation element binding protein 4
1,1189 0,0162 BCL7A 605 B-cell CLL/lymphoma 7A
1,1187 0,0209 FBXW12 285231 F-box and WD repeat domain containing 12
1,1175 0,0056 RPS6KA4 8986 ribosomal protein S6 kinase, 90kDa, polypeptide 4
1,1174 0,0269 PLCD3 113026 phospholipase C, delta 3
1,1171 0,0120 LOC652968 652968 hypothetical protein LOC652968
1,1169 0,0067 P2RX5 5026 purinergic receptor P2X, ligand-gated ion channel, 5
1,1164 0,0117 DKFZp686O24166 374383 hypothetical protein DKFZp686O24166
1,1160 0,0390 C6orf124 653483 chromosome 6 open reading frame 124
1,1157 0,0176 CCDC18 343099 coiled-coil domain containing 18
1,1155 0,0032 EIF5A 1984 eukaryotic translation initiation factor 5A
1,1148 0,0211 SULF2 55959 sulfatase 2
1,1146 0,0087 EIF2C2 27161 eukaryotic translation initiation factor 2C, 2
1,1143 0,0365 OTUB2 78990 OTU domain, ubiquitin aldehyde binding 2
1,1137 0,0296 ZNF620 253639 zinc finger protein 620
1,1134 0,0079 FBXL17 64839 F-box and leucine-rich repeat protein 17
1,1116 0,0252 SHF 90525 Src homology 2 domain containing F
1,1114 0,0089 ALOX15 246 arachidonate 15-lipoxygenase
1,1114 0,0362 FLJ40142 400073 FLJ40142 protein
1,1109 0,0006 ZFR2 23217 zinc finger RNA binding protein 2
1,1106 0,0233 HIGD1C 613227 HIG1 domain family, member 1C
1,1105 0,0033 GPATCH3 63906 G patch domain containing 3
1,1105 0,0056 SARM1 23098 sterile alpha and TIR motif containing 1
1,1103 0,0401 TSC2 7249 tuberous sclerosis 2
1,1102 0,0174 CCL24 6369 chemokine (C-C motif) ligand 24
1,1101 0,0034 CCL19 6363 chemokine (C-C motif) ligand 19
1,1100 0,0080 PNMT 5409 phenylethanolamine N-methyltransferase
1,1100 0,0353 IL33 90865 interleukin 33
1,1096 0,0193 GPR172A 79581 G protein-coupled receptor 172A
1,1094 0,0247 THSD4 79875 thrombospondin, type I, domain containing 4
1,1092 0,0307 TAGLN 6876 transgelin
1,1082 0,0051 THEM5 284486 thioesterase superfamily member 5
1,1081 0,0153 HMGA1 3159 high mobility group AT-hook 1
1,1080 0,0019 ATP1A3 478 ATPase, Na+/K+ transporting, alpha 3 polypeptide
1,1077 0,0190 C6orf118 168090 chromosome 6 open reading frame 118
1,1074 0,0257 WDR1 9948 WD repeat domain 1
1,1073 0,0429 HDX 139324 highly divergent homeobox
1,1068 0,0065 KLK12 43849 kallikrein-related peptidase 12
1,1063 0,0109 GP6 51206 glycoprotein VI (platelet)
1,1063 0,0208 ATP6AP1 537 ATPase, H+ transporting, lysosomal accessory protein 1
1,1057 0,0220 FKBP8 23770 FK506 binding protein 8, 38kDa
1,1051 0,0348 KIAA1407 57577 KIAA1407
1,1039 0,0154 RP11-278E11.2 442454 ubiquinol-cytochrome c reductase binding protein pseudogene
1,1038 0,0206 RRAS 6237 related RAS viral (r-ras) oncogene homolog
1,1035 0,0143 MRM1 79922 mitochondrial rRNA methyltransferase 1 homolog (S. cerevisiae)
1,1032 0,0277 ENTPD4 9583 ectonucleoside triphosphate diphosphohydrolase 4
1,1031 0,0267 CDYL 9425 chromodomain protein, Y-like
1,1026 0,0437 FGF2 2247 fibroblast growth factor 2 (basic)
1,1025 0,0253 LDLR 3949 low density lipoprotein receptor
1,1021 0,0144 FBXL19 54620 F-box and leucine-rich repeat protein 19
1,1021 0,0397 ZNF341 84905 zinc finger protein 341
1,1019 0,0227 ASZ1 136991 ankyrin repeat, SAM and basic leucine zipper domain containing 1
1,1018 0,0125 LMBR1 64327 limb region 1 homolog (mouse)
1,1014 0,0029 DALRD3 55152 DALR anticodon binding domain containing 3
1,1012 0,0188 IER3 8870 immediate early response 3
1,1012 0,0036 LOC645314 645314 similar to hCG1642995
1,1006 0,0030 PRCC 5546 papillary renal cell carcinoma (translocation-associated)
1,1004 0,0237 CHD4 1108 chromodomain helicase DNA binding protein 4
1,1003 0,0244 SECISBP2 79048 SECIS binding protein 2
1,1003 0,0402 ARTN 9048 artemin
1,1001 0,0036 CXCL17 284340 chemokine (C-X-C motif) ligand 17  
FC fold change. 
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Table 6. Differentially expressed genes of 20 volunteers after cod intervention for six month. 
FC p value gene name Entrez ID description
1,2912 0,0008 AKR1B10 57016 aldo-keto reductase family 1, member B10 (aldose reductase)
1,2816 0,0005 SLC7A11 23657 solute carrier family 7, (cationic amino acid transporter, y+ system) member 11
1,2763 0,0005 ALDH3A1 218 aldehyde dehydrogenase 3 family, memberA1
1,2488 0,0060 UGT1A8 54576 UDP glucuronosyltransferase 1 family, polypeptide A8
1,2436 0,0004 SEMA6A 57556 sema domain, transmembrane domain (TM), and cytoplasmic domain, (semaphorin) 6A
1,2205 0,0005 STC2 8614 stanniocalcin 2
1,2028 0,0064 MBD6 114785 methyl-CpG binding domain protein 6
1,2015 0,0028 EGF 1950 epidermal growth factor (beta-urogastrone)
1,1832 0,0181 FLT3LG 2323 fms-related tyrosine kinase 3 ligand
1,1770 0,0047 MME 4311 membrane metallo-endopeptidase
1,1761 0,0138 CHAC1 79094 ChaC, cation transport regulator homolog 1 (E. coli)
1,1757 0,0009 TXNRD1 7296 thioredoxin reductase 1
1,1752 0,0003 EPHX1 2052 epoxide hydrolase 1, microsomal (xenobiotic)
1,1751 0,0005 ZNF557 79230 zinc finger protein 557
1,1737 0,0013 SRXN1 140809 sulfiredoxin 1 homolog (S. cerevisiae)
1,1633 0,0492 PIWIL4 143689 piwi-like 4 (Drosophila)
1,1623 0,0215 PLEC1 5339 plectin 1, intermediate filament binding protein 500kDa
1,1620 0,0089 RICH2 9912 Rho-type GTPase-activating protein RICH2
1,1541 0,0003 CBFA2T3 863 core-binding factor, runt domain, alpha subunit 2 ///  translocated to, 3
1,1540 0,0023 CBR1 873 carbonyl reductase 1
1,1507 0,0054 CYP4F11 57834 cytochrome P450, family 4, subfamily F, polypeptide 11
1,1505 0,0388 FLYWCH1 84256 FLYWCH-type zinc finger 1
1,1498 0,0002 CPA4 51200 carboxypeptidase A4
1,1493 0,0020 TCP11L2 255394 t-complex 11 (mouse)-like 2
1,1443 0,0138 CPEB2 132864 cytoplasmic polyadenylation element binding protein 2
1,1435 0,0074 EPB41L4A 64097 erythrocyte membrane protein band 4.1 like 4A
1,1432 0,0053 SMURF1 57154 SMAD specific E3 ubiquitin protein ligase 1
1,1425 0,0004 PIR 8544 pirin (iron-binding nuclear protein)
1,1409 0,0211 UCHL1 7345 ubiquitin carboxyl-terminal esterase L1 (ubiquitin thiolesterase)
1,1391 0,0245 MCOLN3 55283 mucolipin 3
1,1358 0,0068 LTBP3 4054 latent transforming growth factor beta binding protein 3
1,1358 0,0043 SBF1 6305 SET binding factor 1
1,1347 0,0250 ARL6 84100 ADP-ribosylation factor-like 6
1,1346 0,0389 TTTY13 83868 testis-specific transcript, Y-linked 13
1,1342 0,0029 TBC1D2 55357 TBC1 domain family, member 2
1,1333 0,0153 ZNF711 7552 zinc finger protein 711
1,1326 0,0155 LOC100129624100129624 hypothetical LOC100129624
1,1320 0,0410 KIF21B 23046 kinesin family member 21B
1,1307 0,0160 FLJ10357 55701 hypothetical protein FLJ10357
1,1305 0,0227 APC 324 adenomatous polyposis coli
1,1296 0,0141 WIZ 58525 widely interspaced zinc finger motifs
1,1280 0,0224 PRKAR1B 5575 protein kinase, cAMP-dependent, regulatory, type I, beta
1,1276 0,0113 PARVB 29780 parvin, beta
1,1258 0,0049 C5orf36 285600 chromosome 5 open reading frame 36
1,1241 0,0050 LHFPL1 340596 lipoma HMGIC fusion partner-like 1
1,1240 0,0105 PEX10 5192 peroxisomal biogenesis factor 10
1,1215 0,0020 PGD 5226 phosphogluconate dehydrogenase
1,1213 0,0119 C8orf62 137133 chromosome 8 open reading frame 62
1,1209 0,0088 PRKCD 5580 protein kinase C, delta
1,1207 0,0367 FBXL6 26233 F-box and leucine-rich repeat protein 6
1,1207 0,0139 ATG9A 79065 ATG9 autophagy related 9 homolog A (S. cerevisiae)
1,1201 0,0282 NFKBID 84807 nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, delta
1,1198 0,0049 PLEKHH1 57475 pleckstrin homology domain containing, family H (with MyTH4 domain) member 1
1,1198 0,0011 TRPC5 7224 transient receptor potential cation channel, subfamily C, member 5
1,1182 0,0238 RNF123 63891 ring finger protein 123
1,1181 0,0416 EPB41L5 57669 erythrocyte membrane protein band 4.1 like 5
1,1167 0,0062 OR2F1 26211 olfactory receptor, family 2, subfamily F, member 1
1,1166 0,0214 PLXDC1 57125 plexin domain containing 1
1,1161 0,0084 HOXC4 3221 homeobox C4
1,1159 0,0258 GLTSCR1 29998 glioma tumor suppressor candidate region gene 1
1,1158 0,0212 CLGN 1047 calmegin
1,1152 0,0219 PLCG2 5336 phospholipase C, gamma 2 (phosphatidylinositol-specific)
1,1140 0,0422 RAB27B 5874 RAB27B, member RAS oncogene family
1,1138 0,0193 HSD11B1L 374875 hydroxysteroid (11-beta) dehydrogenase 1-like
1,1130 0,0385 SHD 56961 Src homology 2 domain containing transforming protein D
1,1129 0,0424 LRP5 4041 low density lipoprotein receptor-related protein 5
1,1127 0,0196 L2HGDH 79944 L-2-hydroxyglutarate dehydrogenase
1,1122 0,0078 CDC42BPA 8476 CDC42 binding protein kinase alpha (DMPK-like)
1,1118 0,0467 RORA 6095 RAR-related orphan receptor A
1,1113 0,0064 ZNF296 162979 zinc finger protein 296
1,1104 0,0199 C14orf149 112849 chromosome 14 open reading frame 149
1,1099 0,0205 TFPI2 7980 tissue factor pathway inhibitor 2
1,1089 0,0032 PPP1R12B 4660 protein phosphatase 1, regulatory (inhibitor) subunit 12B
1,1080 0,0035 MMP27 64066 matrix metallopeptidase 27
1,1080 0,0094 NDP 4693 Norrie disease (pseudoglioma)
1,1080 0,0023 RARG 5916 retinoic acid receptor, gamma
1,1063 0,0015 SLCO1C1 53919 solute carrier organic anion transporter family, member 1C1
1,1057 0,0402 SCARB1 949 scavenger receptor class B, member 1
1,1055 0,0138 HTR1D 3352 5-hydroxytryptamine (serotonin) receptor 1D
1,1053 0,0134 ZNF595 152687 zinc finger protein 595
1,1052 0,0084 CAMKK1 84254 calcium/calmodulin-dependent protein kinase kinase 1, alpha
1,1023 0,0287 SOLH 6650 small optic lobes homolog (Drosophila)
1,1022 0,0227 CCNL1 57018 cyclin L1
1,1018 0,0287 C17orf68 80169 chromosome 17 open reading frame 68
1,1017 0,0298 ZNF772 400720 zinc finger protein 772
1,1016 0,0442 JMJD4 65094 jumonji domain containing 4
1,1008 0,0055 GOLGB1 2804 golgin B1, golgi integral membrane protein
1,1001 0,0031 C6orf142 90523 chromosome 6 open reading frame 142  
FC fold change. 
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9.2 Preliminary experiments on faecal water 
9.2.1 Modulation of LT97 cell growth 
 




















Figure 11. Impact of a 24 hour faecal water-treatment (n=6) with indicated concentrations on cell 
growth of LT97 cells. Data are presented as normalised fluorescence intensities setting the 
medium control to equal 100%. Dashed line indicates 75% cell growth, dotted line 50% cell growth. 
Total faeces from the FISHGASTRO study was collected and stored at -80°C until further processing. Samples 
were defrosted, homogenised by stirring, transferred to aluminium cab-locked polycarbonate tubes 
(Beckman/Coulter GmbH, Krefeld, Germany), mixed with the same amount of ice-chilled PBS and centrifuged 
(Optima LE-80K Ultracentrifuge, Beckman/Coulter, Krefeld, Germany) at 25.000g for 2h at 4°C. The 
supernatant, representing the faecal water were aliquoted ant stored at -20°C. 
LT97 cells were seeded into 96-well plates (Greiner Bio One GmbH, Frickenhausen, Germany), incubated in 
culture medium until they reached a confluency of ~80% prior to exposure with the indicated faecal water 
concentrations. Faecal water was diluted in culture medium, the amount of PBS was adjusted, and this dilution 
was sterile filtered using a 0.45µM syringe filter. The cells were cultured in an incubator (37°C, 95% humidity, 
5% CO2) for 24 hours and afterwards cell culture supernatant was discarded. Prior to staining with 4',6-
Diamidino-2-phenylindole dihydrochloride (DAPI, diluted in PBS, Sigma-Aldrich Chemie GmbH, Taufkirchen, 
Germany) cells were fixed and lysed with methanol. After a 30min minimum incubation of the cells with DAPI, 
the resulting fluorescence intensity was measured using a microtiter plate reader (Spectra Fluor Plus, Tecan, 
Austria; Software: X-Fluor) (excitation at 360 nm / emission at 465 nm). The amount of DNA was considered to 
reflect the cell number. The data were analysed by setting the values of the control medium to equal 100%. 
This assay was conducted to consider the toxicity of the faecal water samples and to choose a concentration of 
the Affymetrix global genome analysis (see chapter 4.1, page 91). A concentration of 3.5% was chosen as a 
marked influence on the cells without necessarily impairing cell growth was expected. Cytotoxic concentrations 

















































Figure 12. Level of early apoptotic LT97 cells caused by faecal water of indicated concentrations 
after 24h treatment. Annexin-V-FITC positive cells were measured using flow cytometry (relative 
counts). Dashed line indicates level of early apoptosis in medium treated cells, solid line indicates 
level of early apoptosis of cells exposed to 10mM butyrate (positive control).  
Faecal water was extracted and applied as described in chapter 9.2.1, page 123. 
LT97 cells were seeded in 6-well plates and cultured in medium until they reached a confluency of ~80%. 
Respective concentrations were applied and apoptosis was measured using a flow cytometer as described in 
publication IV, pages 60ff. 
Aim of this preliminary test was the choice of a concentration for apoptosis assay applying faecal water to LT97 
cells. Finally, a concentration of 3.5% was taken. Apoptosis by faecal water was already detected at this 
concentration compared to the medium control (not significant). It was hypothesised that by consuming oil-rich 
fish the apoptotic effects of the faecal water would increase. At 3.5% faecal water such a raise in apoptosis 
would be detectable. A second advantage was that the same concentration was also taken for detection of 
changes in gene expression patterns using Affymetrix Arrays. Exposing the cells with equal concentrations 
would allow a direct comparison of both parameters. 
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9.2.3 Genotoxicity of faecal water (concentration series) 
 
Figure 13. Genotoxicity of of three randomly chosen faecal water samples from the FISHGASTRO 
Study measured using the Comet Assay. Dilution series (indicated concentrations) in order to find a 
concentration for screening genotoxicity and antigenotoxicity of the FISHGASTRO faecal water 
samples. Medium control was PBS adjusted, positive control were H2O2-treated HT29 cells (75µM), 
genotoxicity was measured in HT29 cells (30min incubation, 37°C), tail intensity measured as 
triplicates, on the right hand side cell viability after indicated treatment is shown which are 
individually represented by the dots. 
Faecal water was extracted and applied to HT29 cells and Comet Assay was conducted as described in 
publication V, page 71. Faecal water dilutions were adjusted by PBS. 
Aim of this study was to find a suitable concentration for genotoxicity and H2O2-antigenotoxicity screening of 
the FISHGASTRO faecal water samples. In conclusion, a concentration of 50% faecal water was taken for the 
screening assays. At this concentration a trend of genotoxicity was measured without affecting viability in the 
treated cells, which was the case e.g. after incubation with 100% of faecal water from sample A. Detected tail 
intensities at 50% faecal water incubations allow a simultaneous incubation with 75µM hydrogen peroxide in 




9.3 Antigenotoxicity against hydrogen peroxide induced DNA damage 
of faecal water from the FISHGASTRO study 
























Figure 14. Results of changes in antigenotoxicity of faecal water (after minus before intervention). 
The horizontal lines indicate the mean values per intervention group. 
DA dietary advice. 
Faecal water was extracted and applied to HT29 cells and Comet Assay was conducted as described in 
publication V, page 71. Faecal water dilutions were adjusted by PBS. DNA damage was induced using 75µM 
hydrogen peroxide and prevention of DNA damage by co-incubation with faecal water was measured (30 min 
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